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Regenerative medicine has evolved into the stage of “smart regenerative medicine” where 
biomaterials can actively influence cell fate and behavior to form and regulate tissue function. 
Tissue engineering is a prominent tool of regenerative medicine that can utilise stem cells for 
regenerative therapy because of their capacity to proliferate and differentiate into lineage 
specific cell types. The status of stem cells is dependent on the extracellular conditions, 
which include chemical signals such as growth factors, and the properties of extracellular 
materials in a three-dimensional (3D) environment. With the development of materials 
science and 3D bioprinting, it is possible to build complicated functional tissues in vitro for 
regrowth of lost and damaged tissues or organs. Therefore, through “additive manufacturing”, 
advanced tissue constructs can be fabricated using bioactive and biodegradable materials with 
integrated tissue-specific cells, whereby the mechanical structure and cell-cell interactions 
closely emulate in vivo tissue and function.  
The work described herein relates to the development of simple and reproducible approaches 
to constructing neural tissue by bioprinting human neural or induced pluripotent stem cells 
that are differentiated in situ to functional neurons and neuroglia. The supporting biomaterials 
(comprising alginate, carboxymethyl-chitosan and agarose) form a novel clinically relevant 
3D porous gel by stable crosslinking after printing, which encapsulates stem cells for 
subsequent expansion and differentiation. Differentiated neurons are spontaneously active, 
show a bicuculline-induced increased calcium response, and are predominantly gamma-
aminobutyric acid expressing. In addition to neural tissue, human induced pluripotent stem 
cells could be induced to generate the embryoids within printed constructs comprising cells 
of three germ lineages endoderm, ectoderm, and mesoderm. A second component to this 
thesis related to the investigation of electrical stimulation via conductive biomaterials for 
future potential application with 3D bioprinting for tissue engineering. Electric field is one 
ii 
important parameter involved in the cell growth and embryo development. In support of 
further controlling/regulating stem cell state, obtained results provisionally indicate that 
electrical stimulation via a conducting biopolymer augments human iPSCs to differentiate 
into neuronal cells. While further research will be necessary, the present findings provide 
support for the development of 3D configured conductive materials to enhance stem cell 
differentiation to neural and other tissues. Furthermore, conductive constructs may be 
produced by adapting the presently described 3D bioprinting platform.  
In conclusion, the methods described herein provide a foundation to build upon for advanced 
manufacturing of 3D human neural and other tissues for near-term research of tissue 
development, function and disease, and longer-term regenerative medicine including 
transplantation therapy.  
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Chapter 1  
Introduction 
___________________________________________________ 
This chapter presents work that has appeared in the published articles “Three dimensional 
bioprinting speeds up smart regenerative medicine” by Gu, Q., Zhu, H., Li, J., Li, X., Hao, J., 
Wallace, G. G., & Zhou, Q. (2016). National Science Review, 3 (3), 331-344. and “Three-
dimensional bioprinting” by Gu, Q., Hao, J., Lu, Y., Wang, L., Wallace, G. G., & Zhou, Q. 
(2015). Science China Life Sciences 58, 411-419 (cover paper). 
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The rapid growth of organ transplantation demand has led to potential recipients 
outnumbering donors. Although one million people benefit from organ transplantation 
globally, the death toll of the patients on the transplant waiting list is 15-30% [1]. 
Regenerative medicine, a broad field including tissue engineering and cell therapy, is a 
promising approach to restore the structure and the function of damaged tissues by 
regenerating cells or tissues [2]. Since the first U.S. Food and Drug Administration (FDA)-
approved cell-based therapy product for treating serious burns [3], many significant advances 
such as inventions of clinical materials have led the field closer to achieving its potential in 
improving the lives of countless patients. Regenerative medicine or tissue engineering aims 
to restore original function without or with low transplant rejection by the host by delivering 
the cells and material constructs fabricated in vitro into the body.  
Biomaterials have been used in medical devices such as artificial bones [4], heart valves[5], 
nerve conduits[6], cochlea [7] and even components of eyes [8]. Currently, an entire heart is 
undergoing pre-clinical animal model testing [9]. Biomaterials can be divided into three 
categories: synthetic, naturally-derived and hybrid materials [10]. Over the past 20 years, 
there has been a transition from the use of synthetic to natural materials in clinical medicine, 
with the latter possessing more similar mechanical and biological properties to native tissues. 
Nevertheless, combining cells with biomaterials provides a promising strategy in regenerative 
medicine because ensuing tissue growth from grafted tissue into the damaged tissues may 
restore tissue function[11]. Some biomaterials may be used as scaffolds for improved bio-
function and/or for cell delivery in cell therapy such as an FDA-approved product OrCel (a 
bilayer cellular matrix for the cell culture of dermal fibroblast as skin substitutes)[12].  
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Cells are the basic structural and functional units of organisms, with an ensemble of similar 
cells forming a tissue and multiple tissues grouping together to form an organ [13]. Therefore, 
an organ is composed of various cell types, and the function is dependent on the multicellular 
interaction. 3D printing, also known as additive manufacturing and rapid prototyping, was 
initially described as stereolithography [14]. It is a methodology that uses 3D computer-aided 
design (CAD) data to produce a 3D structure, layer by layer. The main features of 3D 
printing are customisation and high resolution that enables fast and cheap fabrication of a 
desired structure. 3D printing holds potential to reproduce complex bionic devices or 
fabricate organs with intricate 3D microarchitecture in vitro. Currently, 3D printing for 
biological applications has evolved to creating clinical devices for implantation, patterning 
arrays in drug screening system, cell encapsulation and even reconstruction of an entire 
organ[15]. Therefore, 3D bioprinting holds great promise for regenerative medicine.  
In this section, an overview of regenerative medicine is provided together with the 
development of biomaterials for research and regenerative medicine and 3D bioprinting in 
tissue engineering with emphasis on organ and bionic organ construction. 
1.2 Regenerative medicine 
Regenerative medicine, a term invented in 1999 by William Haseltine, is an emerging 
interdisciplinary field that involves engineering, replacing, or regenerating human cells, 
tissues or organs to establish or re-establish normal function to treat diseases and injuries[16, 
17]. Stem cells have tremendous promise in regenerative medicine due to their capability of 
self-renewing and differentiation. Stem cell therapies may include injection of stem cell-
derived specialized cells into target sites, infusion of biologically active molecules secreted 
by stem cells and possible growth of tissues or organs in vitro for transplantations into 
patients whose damaged organ are no longer able to self-repair [18, 19]. In addition to using 
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the patient's own tissues or cells to regenerate organs, the regenerated organ could potentially 
solve the problem of organ shortage and transplant rejection [16, 20].  
Regenerative medicine strategies generally fall into two categories: cell-based and non-cell-
based regenerative medicine [21]. For non-cell-based regenerative medicine, synthetic 
materials and biomaterials are utilized to replace diseased tissues or parts in the human body. 
The advent of new man-made materials such as Teflon and silicone has contributed to a wide 
array of devices that can be used in humans [22]. Currently, man-made tissue-like devices 
have already been used in clinical therapies, which include artificial hearts [23] and titanium 
alloy bones [24]. However, although these devices provided a structural replacement, the 
function of the repaired tissue was not restored as normal as the native ones[25]. For the cell-
based regenerative medicine, cells can be delivered via injection or an appropriate 
biomaterial scaffold such as hydrogels [26]. Biomaterials provide a 3D environment for cell 
survival, attachment and new tissue formation with appropriate structure and function[27]. In 
addition, biomaterials act as media for the delivery of cells and bioactive factors into the 
desired sites in the body [28]. Following on from this, consideration will now be given in the 
next section to the application of stem cells and biomaterials. 
1.2.1 Clinical application of stem cells 
Recently, there has been a growing interest in stem cells-based clinical treatment 
(https://clinicaltrials.gov/) [29], which includes pluripotent stem cells and adult stem cells. 
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are pluripotent stem 
cells that can be differentiated into any cell type of the three embryonic germ layers and have 
self-renewing capability [30, 31]. Adult stem cells such as hematopoietic stem cells (HSCs), 
marrow mesenchymal stem cells (MSCs) and neural stem cells (NSCs) are derived from 
specific tissues and retain the multipotent property of differentiating into major specialized 
tissue cell types. 
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The ability of stem cells offers a bright future for regenerative medicine. However, it is hard 
for stem cells to proceed through the safety assessment stage whilst few clinical studies have 
advanced to phase III. Only a handful have a curative effect on patients, because of the 
undeterminable differentiation after the graft [32]. Thus, the terminally differentiated cells, 
which resemble those in the lesion area, may provide a better treatment option with improved 
safety. In 2010, the first human ESC based therapy product, GRNOPC1, was used for treating 
spinal injury[33]. Later in 2012, the first human ESCs-derived terminally differentiated cells, 
retinal pigment epithelium cells, were used to treat age-related macular degeneration, for 
which two successful results were reported [34, 35]. Nevertheless, many problems in cell 
treatment remain, for instance, rejected cells can neither interact with the surrounding internal 
tissues nor reach diseased sites as expected [36]. Several studies have proposed the 
combination of cells and materials as a solution; especially in treating damaged cells and 
tissue transplantation [37-40]. Also, materials can act as stem cell regulators, dictating the 
function of stem cells and can be used to fabricate tissue-like structure at the macro- and 
micro-level [41]. Consideration will now be given in the next section for the roles of 
materials in regenerative medicine. 
1.2.2 Biomaterials in regenerative medicine 
The human body contains various tissues with different shapes and functions. In 
microbiology, cells are the basic unit of an organism with attachments of extracellular matrix 
(ECM) to support cell survival and to form functional tissues. Bionic materials are important 
tools in tissue engineering and are used to replace damaged tissues or mimic the functions of 
ECM in native tissues. These materials can imitate natural tissues and their environment 
partially or wholly [42]. Therefore, the research of bionics is a multidisciplinary field 
combining biology, chemistry, physics, and materials. With hundreds of millions of years of 
evolution, organisms have the most complex structure over different ranges of scale and 
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functions. The fact demonstrates not only the importance of the simulation of biological 
structures but also the functionality when designing bionic tissues or organs. 
The history of bionic devices in clinical settings can be divided into three stages (Table 1-1). 
From the 1960s to 1980s, the first generation of the bionic materials was the fabrication of 
hard-tissue like parts such as metal bone hammer [43] and ceramic teeth [44] which are still 
widely used in clinical therapy to date. As synthetic technology advanced, second generation 
were developed in the 1980s which included bio-ceramic [45, 46] and bioactive glasses [47] 
that could respond to physiological cues. Compared with the first generation bionic materials, 
there were no toxic side effects, or immune rejection response nor disruption of the immune 
system, but advantageously were corrosion resistant and possessed high tensile strength [48]. 
In the late 1990s, a new generation of biomedical materials started to be developed with 
properties biodegradability and improved influence on cell activities [49]. Currently, new 
biodegradable biomaterials are used, which could be referred to as intelligent or smart 
materials as they can respond to the environment [50]. With the involvement of these 
materials in regenerative medicine, smart regenerative medicine (SRM) has been developed.  
Table 1-1 Summary of the three generations of biomaterials 
 The first generation The second generation The third generation 
Type Ceramics Bioceramics  Biomedical composite 
 Metal Bioglass  




Feature Inert material Bioactivity or degradable Bioactivity ＆ degradable 
Ref [43, 44] [45-47] [49, 50] 
 
1.3 Extracellular matrix 
The extracellular matrix (ECM) is composed of different types of macromolecules including 
structural proteins such as collagen and elastin, adhesive glycoproteins such as fibronectin 
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and laminin and embedded proteoglycans such as hyaluronic acid and other polysaccharides 
[51]. The general structure of the ECM is shown in Figure 1-1. Cell survival is dependent on 
the support of the ECM. Nutrients and wastes are transported through the ECM and the 
conditions outside the cell could be communicated by chemical signals via the ECM, in order 
to regulate cellular functions. Cell movements including spreading, migration, proliferation, 
and differentiation are also dependent on the ECM, and thus the ECM plays an important role 
in cell pattern and cell gradients for tissue development.  
Collagen is a chief structural protein in vertebrates, representing 90% of the extracellular 
protein in bone and tendon. There have been at least 19 types of collagen reported, and they 
can be classified into fibril-associated collagens (FACIT), network-forming collagens, 
anchoring fibrils, transmembrane collagens, basement membranes, and others based on the 
molecular structure. Type I, II, III, V and XI belong to the FACIT group and contribute to the 
structural backbone and cartilage. Type IV collagens, are the microfibrillar collagens which 
are involved in the basis of basement membranes and contribute to the dermis, vessel walls, 
and intervertebral discs. One characteristic feature of all types of collagen is the triple helix; 









Figure 1-1 Diagram of the ECM 
The ECM contains structural proteins such as collagen and is embedded with proteoglycan. 









Table 1-2 Collagen types and distribution 
Type Molecular composition Genes Tissue distribution 
Fibril-forming collagens 
I α1(I)2α2(I) COL1A1,2 bone, dermis, tendon, ligaments, cornea 
II α1(II)3 COL2A1 cartilage, vitreous body, nucleus pulposus 
III α1(III)3 COL3A1 skin, vessel wall, reticular fibres of tissues 
V α1(V)α2(V)α3(V) COL5A1-3 lung, cornea, bone, fetal membranes 
XI α1(XI)α2(XI)α3(XI) COL11A1-3 cartilage, vitreous humour 
Basement membrane collagens 
IV α1(IV)2α2(I) COL4A1-6 basement membranes 
Microfibrillar collagen 
VI α1(VI)α2(VI)α3(VI) COL6A1-3 Descemet’s membrane, skin, heart 
Anchoring fibrils 
VII α1(VII)3 COL7A1 skin, cervix, cornea, mouth mucosa 
Hexagonal network-forming collagens 
VIII α1(VIII)2α2(VIII) COL8A1,2 Descemet’s membrane, endothelial cells 
X α1(X)3 COL10A1 Hypertrophic and mineralizing cartilage 
FACIT collagens 
IX α1(IX)α2(IX)α3(IX) COL9A1,2 cartilage, vitreous humor, cornea 
XII α1(XII)3 COL12A1 ligament, tendon 
Transmembrane collagens 
XIII α1(XIII)3 COL13A1 skin, hair follicle, chondrocyte 
 
Glycoproteins are proteins with covalently attached sugar residues, which are formed of 
numerous branched oligosaccharide chains and contain 1-60% carbohydrate by weight [52]. 
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Fibronectin is the major cell adhesion glycoprotein with two subunits linked through a pair of 
disulphide bonds near the C-terminus, which assemble fibrillary networks extended between 
adjacent cells[53]. As shown in Figure 1-2, each subunit consists of three types of repeating 
modules: 12 type I (termed FN1, hexagon), 2 type II (termed FN2, square), and 15-17 type III 
repeats (termed FN3, cylinder) [53, 54]. Fibrillin is a large glycoprotein, which binds elastin 
and is essential to assemble microfibrils, the cornerstone of the ECM [55]. Laminin is another 
adhesive glycoprotein, which is a heterotrimeric protein and helps cross-link components of 
the ECM [56]. Each laminin heterotrimer is comprised of one α, one β and one ϒ chain with 
individual genes encoding them [57] (Figure 1-3). The common structural motifs such as a 
large globular laminin N-terminal domain (LN domain), a laminin coiled-coil (LCC) domain, 
a rod-like stretch of LE domain and  LG domains (LG1–5) at the C-terminus are shared by all 
the chains [58]. The domains of laminin could bind to perlecan, nidogen, or laminin receptor 
proteins on the cell membranes. As another of the fibrous proteins/glycoproteins, elastin 
contains two types of short segments: hydrophobic segments and alanine- and lysine-rich α-
helical segments. Elastin chains are formed by the crosslinking of single elastin molecules 
which could uncoil to an extended conformation when stretched and then recoil 
spontaneously (Figure 1-4). Elastin is also the precursor of tropoelastin, but the shape and 
mechanism of the assembly of tropoelastin is still unclear. Some other microfibril proteins 
such as elastin microfibril interface located protein 1 (EMILIN-1), are derived from elastin 
and work together with fibulins to give tissue the property of elasticity [52].  
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Figure 1-2 Diagram of FN subunits.  






Figure 1-3 The structure of laminin. 
The figure is from Sigma and shows that the classical structure of laminin contains one 
central α-chain surrounded by β- and γ-chains. 
 
 
Figure 1-4 The network of elastin molecules with and without tension. 
Covalent bonds (red) maintain the cross-linked network. ECM is made up of two main 
classes of macromolecules: (1) fibrous proteins including collagen, elastin, fibronectin, and 
laminin, which have been described above and (2) proteoglycans, which are formed of 
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unbranched polysaccharide chains, glycosaminoglycans (GAGs), covalently linked to the 
core protein. Proteoglycans can be divided into several families including: the lecticans 
(aggrecan, versican, neurocan and brevican) which can interact with hyaluronan; the small 
proteoglycans (decorin, biglycan, fibromodulin, lumican and keratocan) with leucine-rich 
repeat structures and other proteoglycans which are not well understood such as phosphacan 
and neuroglycan [59, 60]. The GAGs can be separated into two groups including non-
sulphated GAGs, such as hyaluronic acid (HA) and sulphated GAGs, which can be further 
classified into four groups including hyaluronan, chondroitin sulfate, dermatan sulfate, 
heparan sulfate and keratan sulfate. GAGs are negatively charged because of their repeated 
disaccharide sequences, making them the most anionic molecules in animal cells (Figure 
1-5). There are three other negative molecules produced in animal cells: phospholipids, 
nucleic acids, and deoxyribonucleic acid. GAGs are also hydrophilic and can be associated 
with a huge volume of water after combination with cations. GAGs play a vital role in 




Figure 1-5 Repeating disaccharide units of various GAGs. 
Four types of non-sulphated GAGs are shown in the figure. 
1.4 Biomaterial development for stem cells 
Tissue engineering is one area of interdisciplinary research which requires the collaboration 
of a number of fields including cell biology, materials research and 3D prototyping 
technologies. Biomaterials are materials with bioactivity when used in cell culture which 
could facilitate the application of stem cells in tissue engineering [61]. Despite early 
recognition of the need to preserve or recreate in vivo conditions (i.e. the stem cell niche) and 
characteristics of stem cells in vitro, conventional culture methods inevitably alter the cellular 
microenvironment, inter- and intra-cell signalling, and behaviour, with cells showing 
different morphologies and the capability to differentiate compared with their in vivo 
counterparts [62-64]. For example, Figure 1-6 shows photomicrographs of the inner cell 
mass (ICM) of a human embryo at blastocyst stage compared with the ESCs generated from 
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ICM and cultured in vitro as cell colonies. Unlike the in vivo ICMs, cultured ESCs are 
maintained under controlled conditions outside their natural environment, unable to interact 
with other cell types, and endogenous substrates and nutrients, which are substituted with 
artificial culture platforms and media. Moreover, traditional methods are based on 2-
dimensional (2D) culture. Therefore, it is not surprising that the established ESC lines exhibit 
different patterns of gene expression and cell signals compared to ICM [65]. Newer 3D 




Figure 1-6 Comparison of ESCs in vivo (A) and in vitro (B). 
A shows a human blastocyst, with the dashed circle indicating the ICM, and B shows an ESC 
colony (black dashed circle) derived from the ICM. Scale Bars as indicated in the figures. 
 
Good stem cell and tissue culture are desirable for the integration of a myriad of components 
within the in vivo niche to mimic an organism’s biology including mechanical, biochemical, 
and in the case of excitable cells, electrical properties [66, 67]. Normally, stem cells are 
cultured and differentiated on polystyrene plates with some wet oxidization or synthetic 
modification [68, 69]. Advances in tissue engineering using intelligent materials, which could 
effectively recreate the 3D micro-niche, have provided a solution to bio-fabricating the 
complex constructs necessary for tissue regeneration and replacement. For example, cancer 
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cells cultured on 3D scaffolds demonstrated improved cell viability and could be used for 
drug screening[70]. Fibroblasts, PSCs, MSCs and NSCs have also been cultured on various 
3D scaffolds [71-74]. The development of tissue engineering is now booming through the 
utilization of biomaterials. Advanced functional biomaterials enable the intersection of 
biology for in situ stem cell actuation, by promoting cell adhesion, survival, proliferation, and 
differentiation [41]. Importantly, nanomaterials and conductive materials are being used as 
devices in clinics and in basic biological research, paving the way for the development of 
advanced tissue engineering in regenerative medicine. Given below is a review of the 
difference between 2D and 3D culture. The application of 3D materials in tissue engineering 
and the properties of materials will also be discussed.  
1.4.1 2D verses 3D stem cell culture 
Most stem cell related research and development (R&D) routinely employs flat-bed 2D 
culture because of the difficulty of maintaining and characterizing cells using 3D platforms. 
However, the limitations of 2D culture are obvious when compared with the three 
dimensionalities of the stem cell niche, whereby in vivo cells are embedded in the ECM 
excreted by cells, which is organised as a complex 3D structure that ensures cell adhesion and 
cell-cell-communication and which acts as an optimal store and source of growth factors. To 
reiterate, the ECM is composed of different types of macromolecules including structural 
proteins such as collagen and elastin, adhesive glycoproteins such as fibronectin and laminin 
and embedded proteoglycan such as hyaluronic acid and other polysaccharides (Figure 1-1) 
[51, 75-77]; although there are many other minor and/or uncharacterized components existing 
in various tissues. The ECM plays the important role of converting the extracellular 
conditions into chemical signals to regulate cell growth. Now 3D biomaterials have been 
developed to imitate the 3D conditions for cell culture.  
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As Table 1-3 shows, there are two types of 3D cell culture: 3D scaffolds, which are 3D hard 
structures for cell support and attachment of some parts of the cell surface, and 3D 
encapsulation which is where the cells are encapsulated into the materials with all parts of the 
cell surface surrounded by materials. The materials used for 3D scaffolds or 3D encapsulation 
fabrication have also been indicated at the bottom of the figures. The 3D scaffolds or 
encapsulation environment could contribute to cell functionalization. In 2D conditions, cell 
morphology or cell colonies are flat. The same cells grown under 3D conditions were found 
to grow in multilayer cell structures. The 3D structure significantly influenced the phenotypes 
of the relative cell types including proliferation and migration [78, 79]. Further molecular 
characterization reinforced this point. It was demonstrated that 3D conditions could improve 
the differentiation efficiency of stem cells for osteogenic differentiation and bone 
differentiation from MSC [80, 81]. For the pluripotent stem cells, 3D conditions have been 
used to induce iPSC generation [82, 83]. 3D conditions could mimic the physiological 
environment better than conventional 2D cultures[84]. 
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Table 1-3 2D vs 3D for cell culture* 






















































Biocompatible and bioactive materials are required for positive interaction with cells [93]. 
The ECM contains many properties, and so the materials are fabricated with various 
modifications to meet the requirements for the cellular properties. Numerous polymers and 
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natural materials extracted from organisms have been used for 3D cell culture (Table 1-3). 
The nanoscale interface structure could also improve the biocompatibility and bioactivity of 
the materials with cells [94]. Apart from the topography, the chemical properties are also 
important for the design of biointerfaces. Peptide sequences have been covalently linked to 
materials to facilitate cell proliferation and attachment [95, 96]. ECM proteins and growth 
factors have been patterned onto materials to control cell viability and contact [97]. Some 
other functional materials with electrical and mechanical properties could also improve the 
biocompatibility and bioactivity of materials. These properties will be detailed in the Section 
1.4.3 below. 
1.4.2 Biomaterials for 2D/planar stem cell culture and differentiation 
Biological materials were used initially to study native materials including bone, feathers and 
others [98, 99]. Then these materials were developed to be used for clinical therapy. 
Subsequently, the materials containing natural-based polymers such as collagen, gelatin, 
fibrin (fibrinogen), laminin and fibronectin have been modified for cell culture (Table 1-4). 
Collagen is a common protein in the body. Non-fibrillar collagen such as type IV is found in 
membranes and connective tissues are rich in fibrillar collagen such as type I and III. 
Collagen scaffolds composited with type I, II or III have been used for mesenchymal stem 
cells (MSCs) [100], fibroblasts and cancer cells culture [86] and cartilage and skin 
engineering [101]. The fibrillary collagen matrices or surfaces have been used for cell-
reorganization and in vivo function mimics. Fibroblasts spread to a greater extent on collagen 
coated plates than those without coating [102]. At the appropriate density, the collagen coated 
plates induced stem cell differentiation [103]. The expression of cell membrane proteins 
containing vinculin, integrin, paxillin, and zyxin could interact with collagen matrices. 
Different cell types and different densities induced the expression different quantities of 
membrane proteins[104]. Gelatin has been widely used for coating polystyrene flasks and 
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plates. Feeder cells such as fibroblasts, cancer cells such as Hela cells and endothelial cells 
adhered to the bottom of plates better and longer when cultured on the gelatin [105, 106]. 
Fibrinogen, a soluble matrix protein which could be generated from hepatocytes, induced 
endothelial cells adhesion and spreading in vitro through interaction with specific adhesive 
receptors [107, 108]. In the presence of fibronectin, the fibroblasts and muscle cells also 
adhered to fibrin substrates [66]. Laminin has been widely used for the expansion of neural 
stem cells and neuronal differentiation [109, 110]. Fibronectin promoted the attachment of 
various cells and the fibronectin coated vessels sustained human ESCs, mouse ESCs and 
NSCs without differentiation [111, 112]. Matrigel®, derived from mouse tumour cells, 
supported human ESCs and NSCs survival [113, 114]. Vitronectin is reported to be an 
alternative to Matrigel® for sustaining human PSCs in the feeder-free system [115, 116]. 
Human PSCs hold great promise in regenerative medicine however they are difficult to 
maintain without feeder cells; therefore 2D synthetic surfaces have been developed to expand 
human ESC culture by using peptide-acrylate [117], PMEDSAH [118], glycosaminoglycan 
[119] and polyacrylate [120]. Although these surfaces could not sustain the PSCs for as long 
as feeder cells, this represents a tremendous advance in the combination of materials with 
human PSCs. The aforesaid 2D polymers possess sought after properties including wettability, 
roughness, and elasticity. 2D biomaterials have now been used as carriers to locate cells in 
cell therapy such as the FDA-approved product OrCel for skin replacement [121]. 
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Table 1-4 2D polymers for cell culture 
Materials Cell types Roles Ref 






cells adhesion [106, 125] 
Fibrinogen endothelial cells cells adhesion [107, 108] 
Laminin NSCs, PSCs cells adhesion [126] 
Fibronectin MSC, PSCs, NSC cells adhesion [111, 112] 
Vitronectin PSCs cells adhesion [115, 116] 
Matrigel® PSCs cells adhesion [113, 114] 




PMEDSAH PSCs cell adhesion [118] 
glycosaminoglycan PSCs cell adhesion  [119] 
polyacrylate PSCs cell adhesion [120] 
 
1.4.3 Biomaterials including alginate, chitosan and agarose for 3D stem cell culture 
and differentiation 
The current scaffolds that have been investigated for cell culture have been listed in Table 
1-5 which contains information on the types of scaffolds, the materials employed and the 
cells studied. It can be concluded that the cells used in the 3D scaffolds are mainly fibroblast-
like cells because of their adherent property. The types of scaffolds used depended on the 
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morphology of the cells. Fibrous scaffolds have been used for the functionalization of stem 
cells. Neural stem cells can be differentiated into functional neurons [101]. Porous scaffolds 
are very common scaffolds and have been used for cell proliferation and growth, such as for 
fibroblasts, chondrocytes and MSCs. There have been reports of human ESCs (H9) cultured 
on PLGA porous scaffolds free from feeder cells, a system which allowed specific lineage 
differentiation[102]. Fibrous and porous scaffolds can conveniently bind pre-designed factors 
and then release them to improve cell manifestation during culture, whereas the normal 2D 
conditions inhibited the efficacy of this feature [104]. Microspheres can be used to carry 
culture cells in suspension. They have also been used for embryoid formation from human 
PSCs and to improve their differentiation efficiency [103]. Custom scaffolds are fabricated 
using some prototyping techniques such as 3D printing with various morphologies as 
required. Low bio-compatibility, however, has limited their application. Therefore they are 
commonly combined with bio-compatible materials, like natural polymers including gelatin, 
alginate, and collagen [80, 127-130]. Through decellularization, native tissues are converted 
into ECM scaffolds which have high biocompatibility because of native bio-composition. 
Scaffolds from hydrogels (made from mannitol, chitosan, collagen, OPF, alginate, HA, PEG, 
fibrin and others) are very popular in stem cell research. Their biodegradable and 
biocompatible properties are similar to those of native tissue [131]. In fact, natural polymers 
used for 2D conventional cultures are also hydrogels, which are suitable for the fabrication of 
3D scaffolds [132-135]. 
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Table 1-5 Types of 3D scaffolds used in stem cells study 
Types Materials Cells Ref 
Fibrous Titanium, PCL-b-PLLA, 
PCL, Poly (L-lactic acid) 
Chondrocytes, PC 





Porous PLCL, PLGA, BG, PEC, 






Microspheres Gelatin, Collagen, Chitosan, 
PLGA, PLA 
Chondrocytes, NP, 
MSCs, RB, BBCs, 
MCF-7, ADSCs 
[140-142] 
Custom PEG, GelMA, PGA, PLA, 






Native tissue silk, cartilage, SIS, collagen 
membranes, Porcine aortic 






One important class of 3D scaffold enables 3D encapsulation, with the materials used having 
the potential to be used in tissue engineering because of their bioactive properties. After 
encapsulation, the cells can be delivered into the site(s) of interest. In addition, different cell 
types can be used to fabricate tissues by directly curing the hydrogel with different cells at 
different locations [150]. Table 1-6 includes examples of natural and synthetic materials used 
for 3D cell encapsulation with natural polymers, such as those polysaccharides and proteins 
derived from seaweeds and ECMs of animals, most commonly used [151-153]. The 
components of polymers have specific effects on cell culture, which can also determine the 
different properties of the materials, which are described in the sections below. 
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Table 1-6 Types of materials used for stem cell encapsulations 
Materials Sources Crosslinking 
methods 
Cell types 
Agarose polysaccharide from seaweed Thermally induced bacteria[154], 
MSCs[155] 
Alginate polysaccharide from seaweed Ionic crosslinking ADSC[151], 
human PSCs[72, 


















gelatin is denatured, 
hydrolysed collagen and 
could be modified by 
methacrylamide or 
furfurylamine 


























Collagen natural protein from ECM Thermal cross-
linking/pH variation 
MSC[169, 170],  
NSCs[171] 




























ECM ECM for tissues Thermal cross-


















1.4.3.1 Micro-surface of the scaffold 
It is believed that surface topographical features can induce a surface signal through, for 
instance, integrin-mediated adhesion, to regulate cell movement [185, 186]. Cell attachment 
is dependent on the roughness of the substrate porosity (Figure 1-7) and the porous substrate 
is suitable for cell adhesion and extension [187]. Hydrophilic modification of PCL nano-
fibres can improve the proliferation of neural progenitors and help them to keep their normal 
morphology [188]. Nanoparticle coated silk nanofibres were more suitable for spreading 
MSCs than the non-coated silk nanofibres [189]. Recently, nano-topographical surfaces were 
also used for human ESC colony preservation. This provided a new platform for the study of 
human ESC feeder-free cell culture[190]. One study systematically explained the effect of 
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topographic features, ranging in size from 0.4 - 10um, on the neural differentiation from 
MSCs, and the results showed that the surface with smaller gratings could enhance regulation 
of neuronal markers such as MAP2 [191]. These reports provide evidence that topographical 
features can guide cell growth through cytoskeletal arrangement and adhesion of the cells 
[192]. Cell gradients are important for cell patterning in the human body and biomaterials 
have also been developed with spatio-temporal gradients to induce tissue regeneration [193]. 
Precise technologies such as electrospinning [194], laser etching [195],  and self-assembly-
assisted nanolithography [195] have been developed to produce surface topography with 
special patterns for cell culture and to promote stem cell differentiation [196]. In addition, the 




Figure 1-7 Microscopy of the surface from two cell plates. 
A is a Corona plate. B is a CellBind® plate with the latter having greater porosity and larger 
pores. Both of them are from Corning®. 
 
1.4.3.2 The mechanical properties of scaffolds 
The interaction between cells and the elasticity of substrates can influence stem cell fate. 
Stem cells have low elasticity (about 100~1000 Pa), and human tissues have higher elasticity 
(about 1000~10,000 Pa) compared to stem cells. The differentiation of stem cells into 
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specific tissue cells can be improved when cultured on substrates which have elasticities 
similar to those of the intended tissues [158, 198, 199]. Stem cells can maintain self-renewal 
on biomaterials with low elasticity such as Matrigel®. The specializations from human MSCs 
can be directed by the specific stiffness of the matrix, and there have been diverse assays of 
genetic expression on the substrates with different elastic properties [200]. Other in-depth 
research has shown that the stiffness of soft hydrogels such as polyacrylamide (PAAm) 
influences stem cell states by adjusting the pore size in the materials [103]. The specification 
of stem cells is dependent on the complex ECM environments. The variations of stem cell 
ECM can affect the activity of membrane proteins. The protein-receptor interaction also 
contributes to stem cell fate determination. Integrin transmits the attachment into the 
cytoplasm and the information is transduced into some pathway signals which control cell 
activities. Many studies have started to explore the mechanisms behind the effects of 
mechanical properties on cell growth. When the materials are used for substrates of cells, the 
cells will have one or more contact points with them. As natural materials, collagen, 
fibronectin, and Matrigel® have been used to change the mechanical properties of substrates 
for cell culture [201]. Some other synthetic materials as aforesaid also have different 
mechanical strength, flexibility, and stiffness. In vivo, the mechanical properties of the ECM 
have important roles to play in determining the structure of tissues and the connection of 
adjacent tissues by adjusting the network of collagen, fibronectin and fibrin in order to alter 
stiffness [202]. The mechanical properties are transduced into biochemical signals through 
the interaction between the ECM and the cells to initiate the cell action [203]. The elastic 
moduli of tissues range from a few Pa in the brain to a few GPa in the bone [204]. 
Furthermore, the contractile nature of cells and tissues can be greatly impacted by mechanical 
properties. Normally, differentiated cells prefer materials with a higher elasticity than those 
preferred by stem cells. As Figure 1-8 shows, mechanical properties have been used to 
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promote stem cell differentiation and morphologies [205]. Cell remodeling on substrates with 
different contraction is determined by myosin-actin and integrin organization [206]. On the 
stiff substrates, there is a strong development of actin which is involved in the Rho GTPase 
signaling a pathway to force stem cell differentiation [207, 208].  
 
Figure 1-8 Stem cells on substrates with different mechanical properties. 
A Stem cells can proliferate on the scaffold with lower elasticity 
B Stem cells can differentiate when cultured on a hard substrate 
 
1.4.3.3 Other properties of materials 
Materials could be developed with specific peptide modification to improve cell viability and 
attachment. The cell adhesive peptide RGD which is derived from integrin-binding and 
fibronectin has been widely used covalently immobilized with alginate [209], PEG [210, 211] 
and gellan gum[212] for tissue engineering. The peptides including YIGSR, IKVAV, DGEA, 
and MNYYSNS from other structural proteins such as laminin, collagen and vitronectin also 
hold promise in the bioactivity modification of materials[213]. Additionally, the porous 
structure in the 3D materials is essential for cell nutrition and migration. Salt leaching, gas 
foaming, phase separation and freeze-drying are used during fabrication of the scaffolds to 
control the pore size [214]. Electrical property is also important for materials. Electric fields 
have been found to have promising potential in promoting cellular events and physiological 
development. Nervous system repair needs electrical signal communication between the 
implanted devices and the internal nerve system. Conductive materials such as graphene 
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could be coated on non-conductive materials to be used as electrodes without influencing the 
device’s biocompatibility[215]. Conducting materials play important roles in neural 
prosthesis including cochlear and ocular implants. These materials including polypyrrole, 
polyaniline and some other conductive polymers are also proven to stimulate neural stem cell 
differentiation [216-218].  
1.5 3D bioprinting 
Bioprinting has the potential to reduce the demand for donor organs as it combines different 
kinds of cells and materials (either naturally-derived polymers or synthetic molecules) to 
generate various tissues such as heart tissues, blood vessels and cartilages[219]. To print 
materials with cells simultaneously, hydrogels are often chosen for encapsulating cells. 
Hydrogels could be printed because the “ink” could be cross-linked after printing by 
changing the chemical or physical properties. Many reports have considered suitable 
materials for cell printing including alginate, gelatin and HA. Before crosslinking, the ink has 
the right consistency and stiffness to meet both the printing and scaffold requirements. PCL, 
PLGA and some other materials are used to print some scaffolds because they can be melted 
at high temperature and could be solidified by reducing the temperature [220]. This section 
mainly summarizes the development of 3D bioprinting and the benefits of its application in 
regenerative medicine. 
1.5.1 Bioprinting technologies 
3D printing technology was first described by Charles W. Hull in the 1980s [221] and there 
have been 30 years of development to date. It is regarded as one of “The top ten fastest-
growing production industries in America” [222]. Presently, the use of 3D printing spans 
various fields, from medicine, textiles, machinery, architecture, military, jewellery to 
aerospace. 3D bioprinting, on the other hand, is a newly-emerging technology that holds 
promise in the medicinal field [223]. It is a new interdisciplinary field of regenerative 
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medicine and tissue engineering, which combines rapid prototyping technology with bio-
manufacturing techniques to fabricate 3D structures, through the layer-by-layer precise 
positioning of bioink containing biomaterials and cells. Considering the shortage of donor 
organs and the inevitable allograft rejection reaction, 3D bioprinting has many advantages 
compared with traditional tissue engineering, such as time-saving, rapid speed, high 
resolution, individualization and high levels of mimicry. The main technologies in 
bioprinting are inkjet [224, 225], microextrusion [226, 227] and laser-assisted printing [228, 
229]. In these systems, inks of cell suspensions are placed in a printer cartridge where a 
computer controls the printing patterns. However, the different features such as surface 
resolution, cell viability and the biological materials used for printing can influence the 
quality of the products of these technologies (Table 1-7). Each printing technology has been 
investigated comprehensively and has its own merits and shortcomings as illustrated in Table 
1-7 and below [230-237].  
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Table 1-7 Schematics and features of selected biofabrication patterning techniques 




using thermal or 
piezo technology to 




extrusion of materials 
Non-contact, 
via pulsed laser directly 
onto gel with cell 
suspension 
Print speed 1-10,000 droplets/s 10-50 μm/s 200-1,600 mm/s 
Resolution 
(μm) 
>50 5-200 1-3 
Cell 
viability 
75%-90% 40%-80% >95% 
Benefits High print speed, 
low cost, 
high resolution, wide 
availability 
Better resolution spatial 
controllability and more 
flexibility in the 
material 
High adaptability with 
materials, high cell 
viability, high resolution, 
clogging avoided, high cell 
concentrations 
Limitations Low droplet 
directionality, 
nonuniform droplet 
size, low cell 
concentrations, 
materials must be 
liquid 
Slow print speed, 
printer cost medium, 
low cell availability, 
low resolution 
High cost, low overall 
flow-rate 
Ref. [225, 238, 239] [227, 240, 241] [229, 233, 242-244] 
 
1.5.1.1 Inkjet bioprinting 
Inkjet-based bioprinting is a non-contact technology. It laminates droplets of biological 
materials to produce two-dimensional (2D) and 3D structures (Figure 1-9A) [245, 246]. 
There is difficulty, however, in control of the size and the flow continuity of the ink droplets 
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[247, 248]. Hydrodynamics need to be considered here. Currently, inkjet bioprinting mainly 
includes thermal inkjets and piezoelectric inkjets [249], which use thermal or piezo 
technology to prompt the liquid droplets through the pre-settled 3D structure. The ink in the 
cartridge is replaced with biological materials including cells, cell culture fluid or gel 
precursors. The development of inkjet printing technology has resulted in the achievement of 
a relatively suitable quality at a low cost that affords broad application prospects in 3D cell 
printing. The technology can be used in high-throughput bioprinting but it is difficult to 
achieve control over single cells [250].  
1.5.1.2 Microextrusion bioprinting 
Microextrusion bioprinting is the most common 3D printing system, in addition to being 
more affordable. Unlike inkjet printers, which generate droplets, the microextrusion printer’s 
materials are deposited onto a substrate (Figure 1-9B). Directed by CAD software, small 
beads of materials are deposited into two dimensions where the deposited layer serves as a 
foundation for the subsequent layer while the stage or microextrusion head moves along the 
z-axis hence forming a 3D structure. The most common way to extrude biological materials 
for 3D bioprinting is through the use of pneumatic [251-253] or mechanical (piston or screw) 
systems [254]. The cell survival rate decreases with increasing extrusion pressure and nozzle 
gauge [255]. This observed decrease in cell viability is mainly due to the shear stresses 
inflicted on cells in viscous fluids. Although cell viability can be increased by using low 
pressures and large nozzle sizes, this also results in decreased resolution and printing speed. 
1.5.1.3 Laser-assisted 3D bioprinting 
Laser-assisted bioprinting uses the laser optical tweezers effect of trace substances sink and 
thermal shock to deposit droplets containing cells (Figure 1-9 C) [243]. After several decades 
of development, as a non-contact, sterile technology with high precision and high accuracy, 
the significance of laser treatment in cell therapy has finally been recognised. According to 
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the principles adopted by cell deposition, laser printing can be divided into two distinct 
technologies: laser-induced direct writing (laser-guided direct writing, LGDW) and laser-
induced metastasis (Laser induced forward transfer, LIFT)  
LGDW was proposed by Renn et al. in 1999 [237]. The laser beam may be in a parallel or 
perpendicular orientation to generate a force in a direction so that the cells will move in 
horizontal or vertical directions. When the force of the laser beam on the cells is greater than 
10pN, the cells may move within the range of several tens of micrometres to several 
millimetres, which then will be deposited on the surface of the selected object.  
LIFT utilizes laser-ablated materials as the basis of the ink. When the laser beam is directed 
through the transparent substrate onto the interface of the thin film (transferred material) and 
matrix, causing an interaction between the laser and the material to be transferred (cell 
suspension film and material liquid), a trace amount of thin material is forced away from the 
base body and deposited on the bottom of the substrate-receiving layer[256].  
 
 
Figure 1-9 Three types of 3D bioprinting technology for depositing cells 
A Direct inkjet 3D bioprinting. B Microextrusion 3D bioprinting. C Laser-mediated 3D 
bioprinting. 
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1.5.2 The process of 3D bioprinting 
To construct organs using 3D bioprinting, the first step is imaging and modeling. The most 
common medical imaging technologies are computed tomography (CT) and magnetic 
resonance imaging (MRI), for which CAD combines the mathematical format to assist with 
the modeling [15, 246, 257].  
For printing preparation, there is a need to use a bioink that is compatible with various types 
of cells and a matrix which can support proliferation and functionalization of cells. The 
material selection is based on the material’s bioactivity, physical properties, biocompatibility, 
toxic degradation and printability. Presently, scientists can successfully extract cells from 
donors’ bone marrow, adipose or some other tissues and then these cells can be expanded into 
sufficient numbers for the preparation of printing. Through layer-by-layer deposition from 
vertical or horizontal, it is possible to complete the organ’s construction [258]. Finally, the 
materials should be chosen in accordance with the organ’s properties.  
After modeling and material selection, there is a need to encourage tissue fusion, remodeling 
and acceleration of tissue maturation. As organs are composed of different types of tissues, 
there is a requirement to develop a vascular tree for the organs including capillaries and 
microvessels. In vitro, bioreactors can be used to maintain tissues and provide maturation-
promoting factors. Once the organ is mature, it is ready for transplantation. The process is 
outlined in Figure 1-10 [259, 260]. 
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Figure 1-10 The process for 3D bioprinting. 
Step 1: Imaging and model designing. 
Step 2: Selection of cells (up) and materials (bottom). 
Step 3: Printing 3D structure and application 
 
1.5.3 Biomaterials for 3D bioprinting 
Initially, 3D printing technology was designed for rapid prototyping using earlier materials 
such as metals, ceramics and thermo-plastic polymers that generally used organic solvents, 
high temperatures or non-biocompatible crosslinking [15]. Characterization of the physical 
properties (i.e. porosity, elastic modulus, degradation, and water-swelling) and cell response 
parameters (i.e. cell viability, proliferation, differentiation and spreading) is fundamental to 
determining the suitability of these polymers for different tissue engineering applications 
[261]; hence the variety of biomaterials used in tissue engineering. This section summarizes 
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the biomaterials used for solid scaffolds and hydrogels, the two main forms used for 3D 
printing. 
Solid scaffolds are the earliest scaffolds used in tissue engineering, especially in bone 
substitution [4]. To date, solid scaffolds have been studied and used for the regeneration of 
various tissues in vitro or vivo. Since the invention of stereolithography, scaffolds can be 
printed from inks and cured to support cell culture after printing [14]. However, the potential 
risks and regulatory requirements should be fully understood before the use of solid scaffolds 
in clinical applications. Although raw materials such as PLA, PEG and PCL have been 
approved by the FDA, the processing unit for the industrial devices must be optimized and 
tested for FDA approval [261].  
Hydrogels are hydrophilic polymeric network groups that have been used as artificial ECM to 
encapsulate cells. Some biomaterials could be formed into hydrogels as shown in Table 1-6. 
Due to their high absorption properties, hydrogels have received significant attention for cell 
biology and tissue engineering applications [262]. Furthermore, hydrogels possess excellent 
biocompatibility and possible bioactive molecule motifs encoded in their chemical structures. 
Hydrogels are widely used for different biomedical applications, such as regeneration, drug 
delivery, and tissue adhesives [263]. Their features can allow cells to travel in the space of 
hydrogels and provide room for cell growth and migration. The easier diffusion of nutrients 
and wastes could avoid cell starvation and cell damage in the absence of vascularization 
[264].  
1.5.4 3D bioprinting for regenerative medicine 
The goal of regenerative medicine is to develop new ways of restoring the function of 
damaged and abnormal tissues. It is difficult for traditional methods to construct tissues 
comprising the many typical features of biological tissues, such as the complex organization 
of various cell types, complex ECMs and microvasculatures. Nevertheless, 3D bioprinting 
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can print constructs containing a variety of ECMs, and these biological materials could be 
organized into uniform or non-uniform layers at different loci of the printed structure to 
mimic the native tissues[219]. In recent years, advances in the 3D fabrication of biological 
structures include the fabrication of artificial bladders [265], skin [121], tracheas[266] and 
heart valves [5] for clinical applications. These examples relied on thin, biodegradable 
scaffolds which were filled with autologous cells from patients, hence there were no allograft 
rejections in the patients, and thus alleviated the need for organ transplantation to an extent. 
In the near future, 3D bioprinting will potentially play a wider role in regenerative medicine 
because its advantages could contribute to thick tissue construction with complicated 
structure, which has been described above. 
1.6 Stem cells and biomaterials for tissue engineering 
Stem cells attract great attention for tissue engineering because of their ability to rejuvenate 
damaged tissues and to be specialized into functional cell types[267]. At the initial stage, 
PSCs have been studied for differentiation into embryoid bodies (EBs) which contain the cell 
types representing three germ layers. Furthermore, the PSCs could develop into neurospheres 
comprised of neural precursors through suspension cultures of differentiated EBs[268]. 
Through modification of the culture system, there was self-organized cortical tissue 
formation from human ESCs [269]. It is exciting to note that a three-dimensional organoid 
culture system has been developed for cerebral tissue generation from human PSCs, aiming 
to model the human brain [270]. Now, complete lenses could be produced using endogenous 
stem cells in a petri dish in vitro for patients [271]. The aforementioned tissues (Figure 
1-11A-D) have promoted the application of stem cells. However, the tissues are simple or 
contain just a few cell layers. It is difficult to generate tissues with blood vessels using 
conventional methods. Therefore, biomaterials and advanced technologies such as 3D 
printing are helping tissue engineering. Figure 1-11E, F show an entire liver produced from 
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Figure 1-11 The development of tissue regeneration from stem cells.  
A) EB and neurosphere formation from human iPSCs, Bars, 100 µm. B Cortical tissues from 
human ESCs on day 46 post-differentiation with cortical plate marker Bf1, TuJ and Ctip2 
expression[269]. Bars, 100 µm. C) Cerebral tissues from human PSCs with Reelin expression 
indicating the presence of Cajal–Retzius cells which are important for cortical plate 
generation[270]. Bars, 200 and 100 for the left and right panel respectively. D) Left, phase-
contrast of a lentoid body from lens epithelial stem/progenitor cells (LECs) on the day 30 
post-differentiation. Right, a lentoid body demonstrating magnifying properties[271]. Bars, 
100 µm. E) Left, matrix from decellularized whole liver. Right, liver from recellularization of 
the matrix with about 50 million hepatocytes [273]. Bars, 200 µm. F) Vascularized tissue 
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from 3D printing with a hUVEC-lined (red) vascular network supporting HNDF laden (green) 
matrix on the 45 days of perfusion[272]. Bars, 100 µm. 
 
Biomaterials are increasingly being used in tissue engineering. Polymeric scaffolds have been 
widely used in tissue regeneration/restoration through permanent or temporary replacement 
of the damaged tissues[274]. Scaffolds including PGA, PLLA, PU and PLA have been 
widely used clinically [275]. However, the tissue types supported are limited falling short of 
complex tissues with high bioactivity. Therefore, hydrogel-based scaffolds have received 
considerable interest in tissue engineering because of their high bioactivity and the possibility 
of creating vascularized tissues[276]. Here, Table 1-8 summarizes the application of these 
materials in tissue engineering.  
Table 1-8 Biomaterials used for tissue engineering 
Materials Types Application description 
Polymer synthetic polymer PGA as scaffolds for bone internal fixation devices 
[277], PLLA as fibres for blood vessel conduits 
[278], PLGA as meshes for skin graft [279] 
Alginate natural polymer scaffolds with amniotic stem cells for bone [280], 
alginate encapsulating chondrocytes for the ear [281], 
encapsulating porcine aortic valve interstitial cells 
(PAVIC) and work with PEG-DA scaffolds for the 
aortic valve [282] 
Chitosan natural polymer scaffolds as skin substitute [283] 
Gelatin natural protein encapsulating BMSCs for osteochondral tissue [163], 
magnesium calcium phosphate gelatin scaffolds for 
bone[284], gelatin sponge for trachea[285], 
Collagen natural protein Alginate/collagen scaffolds encapsulated with 
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Materials Types Application description 
amniotic stem cells for bone[280], ear[286], skin [38, 
287], scaffolds loaded with endometrium-like cells 
for uterus regeneration [288] 
Fibrin natural protein scaffolds for cardiac tissue engineering [289], 
encapsulating cardiomyocytes for cardiac tissue 
[172], work with bioglass as scaffolds for the repair 
of osteoporotic defects [290], 
HA natural 
polysaccharide 
scaffolds for skin [291], carriers as corneal 
endothelial cell (CEC) sheets for cornea [292], 
scaffolds for central neural tissue [293] 
Multilaterals hybrid polymer gelMA  encapsulating MSCs with PCL, PVA and 
alginate as scaffolds for anatomically shaped 
constructs [240], fibrin-collagen encapsulating 
chondrocytes with PCL as scaffolds for cartilage 
[294], methacrylated hyaluronic acid (Me-HA) and 
methacrylated gelatin (Me-Gel) hydrogel 
encapsulating human aortic valvular interstitial cells 
(HAVIC) for heart valve [295], alginate, chitosan, 
fibrin and gelatin encapsulating ADSCs for liver 
[167], gelatin and HA patches encapsulating 
hCMPCs for preservation from myocardial infarction 
[165]  
 
Figure 1-12 also presents examples of biomaterials application in tissue engineering to 
describe the development of the field. Biomaterials have been developed from scaffolds for 
cell culture for the fabrication of one entire organ, with the combination of stem cells and the 
assistance of rapid prototyping (RP) technologies. With the involvement of stem cells, 
wanted tissue would be generated in vivo [280]. 3D printing technology has been improved as 
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a powerful tool for tissue engineering [296]. It could be used to distribute cells precisely and 
to print  tissue with high resolution [281]. Successful 3D printed tissues have been used in 
vivo from hCMPCs and HA/gelatin based matrices [165]. 
 
Figure 1-12 Biomaterials for tissue engineering. 
A) Human iPSCs in 3D collagen scaffolds [82]. B) The bones formed from implanted 
constructs with amniotic fluid–derived stem (AFS) cells, diamond, scaffolds seeded with 
AFS cells, triangle, scaffolds without AFS[280]. C) Left, tissue-engineered trachea from 
gelatin sponge. Right, the scaffold implanted into the dorsal subcutaneous spaces of nude 
mice [285]. D) Human skin equivalents reconstructed from human TERT-immortalized 
keratinocytes and fibroblasts (right panel) with the native skin (left panel) and primary human 
skin equivalent (middle panel) as control. Hematoxylin and eosin (H&E) staining was used 
for histological appearance and vimentin staining was used for fibroblasts [297]. E) 
Fabrication of HA-CEC sheet constructs. Left, cell sheet (asterisk) attached to HA scaffold. 
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Middle, Hoechst 33258 staining showed the cross-section of the construct with large and fine 
arrows pointing large and small pores on the carrier respectively, asterisk, cell sheet, bars, 
200 μm. Right, cornea implanted with HA carriers (up) and HA+cell sheets (bottom), bars, 5 
mm [292]. F) Visible transplanted hCMPC scaffold as a patch on the infarcted area of the 
ventricular wall on 1 (left) and 4 (middle) weeks with Troponin I (TnI) staining for CMPC 
and human-specific Lamin A/C expression[165]. G) 3D printed bionic ear (left, bars, 1 cm) 
with coil antenna (right up, bars, 5 mm) contacting the neocartilaginous tissue with viability 
(right bottom, bars, 50 μm) [281]. 
 
1.7 3D printing used for tissue repair 
An ideal 3D bioprinting system is shown schematically in Figure 1-10. Firstly, accurate 
information on tissues and organs should be collected for designing the model. Secondly, the 
server should be able to convert the information into electrical signals to control the printer to 
print the tissues, and the printer should be able to maintain the cell viability during the 
fabrication process. Usually, tissue is composed of many types of cells and the cells will be 
mixed with some substances to be better fused [298-300]. At present, some hard tissues can 
be fabricated with bionic materials by a 3D printer [301], and these have been used in clinical 
trials. A 3D printer cannot construct a complicated tissue at present. In the future, a 3D bio-
printer could be used to print organs for repairing damaged body parts or to simulate some 
functional tissues for research, therapy and drug screening. Furthermore, 3D bioprinting can 
be used for personalized therapy with reduced costs. Biocompatible and biodegradable 
materials can be combined with 3D bioprinting to reduce the incompatibilities caused by 
materials [299, 302]. The sections below will detail the application of 3D bioprinting in tissue 
engineering. 
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1.7.1 Hard tissue repair 
Hard tissue is mainly composed of solids such as collagen and substituted hydroxyapatite 
with ceramic [303]. Therefore, acellular tissues such as bone and teeth could be repaired 
using biomaterials more easily than the cellular tissues could be repaired.  
Infections, external force, abnormal bone development and other bone defects caused by 
diseases have serious impacts on patients’ daily lives. Advances in bone tissue engineering 
for treating bone defects provide new ways to take advantage of the rapid prototyping 
technology [304, 305]. Injuries occur uniquely and high resolution is required for the 
interlinkage. Therefore, it is difficult to replace and repair damaged tissues using traditionally 
fabricated scaffolds. To overcome this issue 3D printing, a highly personalized technology, 
has been initiated to create a precise bone mold for individual patients [305]. A cancer patient, 
Erig Moger, most of whose face was removed surgically initially relied on a feeding tube in 
order to eat[306]. Later, his doctor used CT and facial scanning technology to scan the 
patient’s skull, followed by a construction of a normal 3D face model using 3D printing and 
nylon plastic. The screws for the artificial face were also created with a 3D printer. After 
combining this with autologous bone, 3D printing was used to treat orbital floor fractures as 
one cost-effective technique [307]. The successful surgery, incorporating of the new artificial 
hard tissues enhanced the quality of life of the patient greatly by enabling the patient to eat, 
drink and see normally and renewed his life prospects. Similar to human bones, the structure 
and morphology of teeth are complex with diverse organizational structures. Dental growth 
and development in adapting to the alveolar structure are also complex. Therefore, traditional 
tissue engineering technology for tooth regeneration has encountered several complexities 
[308]. At present, growth factors and autologous cells have been considered for use in hard 
tissue printing to enhance tissue bioactivity [309]. One particular study showed that one 
thermosensitive microparticulate material could be combined with cells to print strong 
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constructs for bone repair [310]. These results will facilitate future cell-based hard tissue 
printing.  
As 3D bioprinting technology is a computer-assisted modeling technology designed to meet 
an individual’s needs, the technology also has great potential in stomatology surgery. 
1.7.2 Soft tissue repair 
Soft tissue connects, supports or surrounds all structures or organs in the body. Traumatic 
injury or tumour resections often require a large amount of soft tissue reconstruction. From 
the aesthetic or cosmetic point of view, soft tissue reconstruction is also important for the 
patients to maintain a good quality of life [311]. This section will review the soft tissues in 
skin, nervous and vascular systems, which are the three main research foci in soft tissue 
regenerative medicine. Many studies have been conducted to reconstruct these tissues [15]. 
Skin is the largest organ of the human body. Skin losses due to wounds or burns require a 
transplant to protect the wound, which can be difficult due to the lack of autologous or 
allosome skin [312]. Over the past four decades, industry and academia have invested in and 
designed the engineering of human skin [313-315]. Initial efforts focussed on the 
development of a skin graft for wounds and obtained significant results. Following on from 
that, the research focus progressed to the development of a skin model in vitro and the 
permeability of drugs and excipients [316, 317]. However, the typical approach to 
engineering skin begins by simplifying its complexity, and this cannot render it as the normal 
layered structure. Tissue engineering has a high potential for the production of new skin. 
Several skin substitutes like Integra® and Matriderm® have already been used in clinical 
settings as supplements of autologous split-thickness skin grafts [318-320]. Nevertheless, the 
main difficulty still lies in the reconstruction of the subcutaneous microvascular network and 
sweat glands. However, 3D bioprinting may be able to solve the problem and pattern cells as 
for the native tissue[321]. The structure of human skin has been printed using fibroblasts and 
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keratinocytes [322, 323], however the development and functional factors involved need 
further investigation [324]. Neural tissue is the main component of the central and peripheral 
nervous systems, known for its difficulty in spontaneous recovery [325]. Biological 
substitutes such as conductive polymers and biomaterials for the maintenance, restoration or 
improvement of neural tissue function have been indispensable to neural regenerative 
medicine [326, 327]. Moreover, the interaction between cells and biomaterials plays an 
important role in tissue fabrication because it improves cell proliferation and 
functionalization, which has been described in the previous sections. Initially, efforts were 
put into the binding of the small functional molecules to scaffolds for the promotion of nerve 
regeneration and the results in animal models were encouraging [328]. Furthermore, cells co-
cultured with biomaterials, a novel technology combination, have been used in peripheral 
nerve and brain injury repair [329]. A novel polysaccharide-based hydrogel for neural stem 
cell printing has recently been developed which included functional mini-neural tissue 
construct formation [88]. To mimic the ceramal cortex structure, hand-held printing methods 
were used to print primary neuronal cells in addition to which there was neuronal network 
observation [212].  
The blood vascular system is the main mode of transport in tissue. The main challenge in 
tissue engineering is limited mass transfer [330]. Some simplex and thin tissues (i.e. skin [38], 
cartilage [294]) have been preliminarily established. However, due to the size of tissue 
engineering, the vascular system needs to be incorporated into the tissue structure for the 
supply of nutrients and oxygen to cells. To this end, a 3D inkjet bioprinting system was used 
with NIH 3T3 mouse fibroblasts in tubes, which resulted in an overhang structure with post-
printing cell viability of over 82% [331]. A microvascular device was developed comprising 
cylindrical microchannels with medium flow and endothelial cells attached on the side 
walls[332]. Then, a large network of blood vessels located in a microvascular perfusion unit 
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was used to support the self-assembly and connection to an existing network [333]. 
Previously, fibroblasts and umbilical vein endothelial cells combined with material scaffolds 
were used for blood vessel regeneration [334]. Currently, there are also novel computer aided 
algorithms and methods developed for 3D bioprinting of scaffold-free biomimetic 
macrovascular structures (self-supported model) [40]. To supply nutrients and transport the 
waste from the thick tissues and organs, sacrificial materials such as pluronic F-127 were 
used in initial 3D printing, which were later removed by dissolving them with fluids. The 
constructs retained the tube shapes needed for medium perfusion [272, 335]. 
Many challenges in 3D bioprinting concerning tissues and organs need to be addressed. 
However, the preparation time for the bioink before printing is dependent on the time it takes 
to obtain a sufficient amount of cells which is usually lengthy when using conventional cell 
culture methods, and is also dependent on the cell type [40]. In addition, materials such as 
synthetic or bio-based polymers are required for an extremely precise development to match 
with the natural tissue. The tear strength, bursting strength, mechanical and biological 
properties, blood compatibility and long-term stability are the primary limiting factors in 
creating large structures; as there is no single material that meets these requirements. 
Therefore, researchers are turning their attention to combining several materials to obtain a 
well-rounded biomaterial for 3D printing and tissue culture, or to the exploration of new 
functional materials [336]. 
1.7.3 Complicated tissue fabrication in vitro 
3D printed prosthetics [337], jaw bones and tracheas [338, 339] have been used in clinical 
settings with good functionality. Moreover, 3D cell spheroids or hepatocytes are being used 
to build a liver model and support artificial devices [340]. Unfortunately, there is still no solid 
organ that can be used for clinical transplantation although organ models have been 
constructed for surgical stimulation in vitro with structures exactly mirroring true organs. To 
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print organs with essential vascular networks for nutrient and waste transportation, several 
studies have successfully constructed a vascular tree into the printed organ [341]. 
Nonetheless, many challenges must be met, as described above, before a truly functional 
artificial tissue or tissue analogs can be generated.  
52 
1.8 Reference 
[1] Y. Shimazono, The state of the international organ trade: a provisional picture based on 
integration of available information, Bulletin of the World Health Organization 85(12) (2007) 
955-962. 
[2] C. Mason, E. Manzotti, Regenerative medicine cell therapies: numbers of units 
manufactured and patients treated between 1988 and 2010, Regenerative Medicine 5(3) (2010) 
307. 
[3] Y.M. Bello, A.F. Falabella, W.H. Eaglstein, Tissue-engineered skin, American Journal of 
Clinical Dermatology 2(5) (2001) 305-313. 
[4] G. Daculsi, Biphasic calcium phosphate concept applied to artificial bone, implant coating 
and injectable bone substitute, Biomaterials 19(16) (1998) 1473-1478. 
[5] H.-H. Sievers, Artificial heart valve, Google Patents, U.S., 2006. 
[6] A.R. Nectow, K.G. Marra, D.L. Kaplan, Biomaterials for the development of peripheral 
nerve guidance conduits, Tissue Engineerig Part B 18(1) (2012) 40-50. 
[7] S.S. Blume, Histories of cochlear implantation, Social Science & Medicine 49(9) (1999) 
1257-1268. 
[8] A. Sifferlin, FDA approves first bionic eye, CNN. TIME. Avalaible online at: cnn. com, 
Retrieved 10 (2013). 
[9] E. Ford, Bionic heart breakthrough: Scientists transplant device into sheep, hope for 
clinical trials. <http://www.abc.net.au/news/2015-03-07/bionic-heart-breakthrough-scientists-
transplant-device-in-sheep/6288126>, 2015). 
[10] S.N. Jayasinghe, Biomaterials and bioengineering tomorrow's healthcare, Biomaterials 
3(3) (2013) e25887. 
[11] O.V. Horst, M.G. Chavez, A.H. Jheon, T. Desai, O.D. Klein, Stem cell and biomaterials 
research in dental tissue engineering and regeneration, Dental clinics of North America 56(3) 
(2012) 495-520. 
[12] Z. Ruszczak, Effect of collagen matrices on dermal wound healing, Advanced drug 
delivery reviews 55(12) (2003) 1595-611. 
[13] G. Bao, S. Suresh, Cell and molecular mechanics of biological materials, Nature 
materials 2(11) (2003) 715-25. 
[14] E. Sachs, M. Cima, P. Williams, D. Brancazio, J. Cornie, Three dimensional printing: 
rapid tooling and prototypes directly from a CAD model, Journal of Manufacturing Science 
and Engineering 114(4) (1992) 481-488. 
53 
[15] S.V. Murphy, A. Atala, 3D bioprinting of tissues and organs, Nature Biotechnology 32(8) 
(2014) 773-785. 
[16] C. Mason, P. Dunnill, A brief definition of regenerative medicine, Regenerative 
Medicine 3(1) (2008) 1-5. 
[17] A. Atala, Engineering organs, Curr Opin Biotech 20(5) (2009) 575-92. 
[18] K. Muneoka, C.H. Allan, X. Yang, J. Lee, M. Han, Mammalian regeneration and 
regenerative medicine, Birth Defects Research. Part C Embryo Today 84(4) (2008) 265-80. 
[19] C.L. Stoick-Cooper, R.T. Moon, G. Weidinger, Advances in signaling in vertebrate 
regeneration as a prelude to regenerative medicine, Genes & Development 21(11) (2007) 
1292-1315. 
[20] A. Heidary Rouchi, M. Mahdavi-Mazdeh, Regenerative Medicine in Organ and Tissue 
Transplantation: Shortly and Practically Achievable?, International Journal of Organ 
Transplantation Medicine 6(3) (2015) 93-8. 
[21] A. Atala, Tissue engineering and regenerative medicine: concepts for clinical application, 
Rejuvenation Research 7(1) (2004) 15-31. 
[22] M. Geiser, P. Gerber, I. Maye, V. Im Hof, P. Gehr, Retention of Teflon particles in 
hamster lungs: a stereological study, J Aerosol Med 13(1) (2000) 43-55. 
[23] P.-H. Kim, J.-Y. Cho, Myocardial tissue engineering using electrospun nanofiber 
composites, BMB Reports 49(1) (2016) 26. 
[24] A. Bansiddhi, T.D. Sargeant, S.I. Stupp, D.C. Dunand, Porous NiTi for bone implants: a 
review, Acta Biomater 4(4) (2008) 773-82. 
[25] F.J. O'Brien, Biomaterials & scaffolds for tissue engineering, Materials Today 14(3) 
(2011) 88-95. 
[26] Y. Li, J. Rodrigues, H. Tomas, Injectable and biodegradable hydrogels: gelation, 
biodegradation and biomedical applications, Chemical Society Reviews 41(6) (2012) 2193-
2221. 
[27] J.L. Olson, A. Atala, J.J. Yoo, Tissue engineering: current strategies and future 
directions, Chonnam Medical Journal 47(1) (2011) 1-13. 
[28] B.S. Kim, D.J. Mooney, Development of biocompatible synthetic extracellular matrices 
for tissue engineering, Trends Biotechnol 16(5) (1998) 224-30. 
[29] T.R. Heathman, A.W. Nienow, M.J. McCall, K. Coopman, B. Kara, C.J. Hewitt, The 
translation of cell-based therapies: clinical landscape and manufacturing challenges, 
Regenerative Medicine 10(1) (2015) 49-64. 
54 
[30] J.A. Thomson, J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. 
Marshall, J.M. Jones, Embryonic stem cell lines derived from human blastocysts, Science 
282(5391) (1998) 1145-7. 
[31] K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, S. Yamanaka, 
Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell 
131(5) (2007) 861-72. 
[32] A. Trounson, C. McDonald, Stem Cell Therapies in Clinical Trials: Progress and 
Challenges, Cell Stem Cell 17(1) (2015) 11-22. 
[33] J. Lebkowski, GRNOPC1: the world’s first embryonic stem cell-derived therapy, 
Regenerative Medicine 6(6s) (2011) 11-13. 
[34] S.D. Schwartz, C.D. Regillo, B.L. Lam, D. Eliott, P.J. Rosenfeld, N.Z. Gregori, J.P. 
Hubschman, J.L. Davis, G. Heilwell, M. Spirn, J. Maguire, R. Gay, J. Bateman, R.M. Ostrick, 
D. Morris, M. Vincent, E. Anglade, L.V. Del Priore, R. Lanza, Human embryonic stem cell-
derived retinal pigment epithelium in patients with age-related macular degeneration and 
Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies, Lancet 
385(9967) (2015) 509-16. 
[35] W.K. Song, K.-M. Park, H.-J. Kim, J.H. Lee, J. Choi, S.Y. Chong, S.H. Shim, L.V. Del 
Priore, R. Lanza, Treatment of macular degeneration using embryonic stem cell-derived 
retinal pigment epithelium: preliminary results in Asian patients, Stem Cell Reports 4(5) 
(2015) 860-872. 
[36] P. Orth, A. Rey-Rico, J.K. Venkatesan, H. Madry, M. Cucchiarini, Current perspectives 
in stem cell research for knee cartilage repair, Stem Cells Cloning 7 (2014) 1-17. 
[37] H. Tian, S. Bharadwaj, Y. Liu, H. Ma, P.X. Ma, A. Atala, Y. Zhang, Myogenic 
differentiation of human bone marrow mesenchymal stem cells on a 3D nano fibrous scaffold 
for bladder tissue engineering, Biomaterials 31(5) (2010) 870-7. 
[38] V. Lee, G. Singh, J.P. Trasatti, C. Bjornsson, X. Xu, T.N. Tran, S.S. Yoo, G. Dai, P. 
Karande, Design and fabrication of human skin by three-dimensional bioprinting, Tissue Eng 
Part C Methods 20(6) (2014) 473-84. 
[39] M. Georgiou, J.P. Golding, A.J. Loughlin, P.J. Kingham, J.B. Phillips, Engineered 
neural tissue with aligned, differentiated adipose-derived stem cells promotes peripheral 
nerve regeneration across a critical sized defect in rat sciatic nerve, Biomaterials 37 (2015) 
242-51. 
55 
[40] C. Kucukgul, S.B. Ozler, I. Inci, E. Karakas, S. Irmak, D. Gozuacik, A. Taralp, B. Koc, 
3D bioprinting of biomimetic aortic vascular constructs with self-supporting cells, 
Biotechnology and Bioengineering 112(4) (2015) 811-21. 
[41] W.L. Murphy, T.C. McDevitt, A.J. Engler, Materials as stem cell regulators, Nature 
materials 13(6) (2014) 547-557. 
[42] D.W. Green, Tissue bionics: examples in biomimetic tissue engineering, Biomedical 
Materials 3(3) (2008) 034010. 
[43] K. Lingaraj, Y.H. Teo, N. Bergman, The management of severe acetabular bone defects 
in revision hip arthroplasty using modular porous metal components, Journal of Bone and 
Joint Surgery 91(12) (2009) 1555-60. 
[44] R. Zhou, S.J. Gao, The application of post-core-metal fused ceramic crowns in esthetic 
restoration of the anterior teeth, Shanghai Kou Qiang Yi Xue 3(2) (1994) 104-5. 
[45] L.A. Sewon, A.L. Keistinen, Review of the use of bioceramic implants in periodontal 
treatment, Journal - Alabama Dental Association 74(1) (1990) 13-22. 
[46] J. Osborn, T. Weiss, Hydroxylapatite ceramics--a bone-like biomaterial. Preliminary 
report, Schweizerische Monatsschrift fur Zahnheilkunde= Revue Mensuelle Suisse d'odonto-
stomatologie 88(10) (1978) 1166. 
[47] M. Cannas, E. Indemini, A. Krajewski, A. Ravaglioli, S. Contoli, In vitro observations of 
iron-doped bioactive glasses, Biomaterials 11(4) (1990) 281-5. 
[48] L.L. Hench, Bioactive materials: the potential for tissue regeneration, Journal of 
Biomedical Materials Research 41(4) (1998) 511-8. 
[49] L.L. Hench, J.M. Polak, Third-generation biomedical materials, Science 295(5557) 
(2002) 1014-7. 
[50] N.A. Peppas, J.R. Clegg, The challenge to improve the response of biomaterials to the 
physiological environment, Regenerative biomaterials 3(2) (2016) 67-71. 
[51] R.L. Juliano, S. Haskill, Signal transduction from the extracellular matrix, Journal of 
Cell Biology 120 (1993) 577-577. 
[52] The extracellular matrix of animals, in: B. Alberts, A. Johnson, J. Lewis, M. Raff, K. 
Roberts, P. Walter (Eds.), Molecular Biology of the Cell, 4th edition, Garland Science, New 
York, 2002. 
[53] P. Singh, C. Carraher, J.E. Schwarzbauer, Assembly of fibronectin extracellular matrix, 
Annual Review of Cell and Developmental Biology 26 (2010) 397. 
[54] J. Xu, D. Mosher, Fibronectin and other adhesive glycoproteins, The extracellular matrix: 
an overview, Springer 2011, pp. 41-75. 
56 
[55] P. Handford, Fibrillin-1, a calcium binding protein of extracellular matrix, Biochimica et 
Biophysica Acta (BBA)-Molecular Cell Research 1498(2) (2000) 84-90. 
[56] R. Timpl, H. Rohde, P.G. Robey, S.I. Rennard, J.-M. Foidart, G.R. Martin, Laminin--a 
glycoprotein from basement membranes, Journal of Biological Chemistry 254(19) (1979) 
9933-9937. 
[57] M. Aumailley, L. Bruckner-Tuderman, W.G. Carter, R. Deutzmann, D. Edgar, P. 
Ekblom, J. Engel, E. Engvall, E. Hohenester, J.C. Jones, H.K. Kleinman, M.P. Marinkovich, 
G.R. Martin, U. Mayer, G. Meneguzzi, J.H. Miner, K. Miyazaki, M. Patarroyo, M. Paulsson, 
V. Quaranta, J.R. Sanes, T. Sasaki, K. Sekiguchi, L.M. Sorokin, J.F. Talts, K. Tryggvason, J. 
Uitto, I. Virtanen, K. von der Mark, U.M. Wewer, Y. Yamada, P.D. Yurchenco, A simplified 
laminin nomenclature, Matrix Biology 24(5) (2005) 326-32. 
[58] V. Iorio, L.D. Troughton, K.J. Hamill, Laminins: Roles and Utility in Wound Repair, 
Advanced Wound Care (New Rochelle) 4(4) (2015) 250-263. 
[59] A.D. Lander, S.B. Selleck, The elusive functions of proteoglycans: in vivo veritas, 
Journal of Cell Biology 148(2) (2000) 227-32. 
[60] H. Kresse, E. Schönherr, Proteoglycans of the extracellular matrix and growth control, 
Journal of Cellular Physiology 189(3) (2001) 266-274. 
[61] U.G. Wegst, H. Bai, E. Saiz, A.P. Tomsia, R.O. Ritchie, Bioinspired structural materials, 
Nature materials  (2014) 23–36. 
[62] M. Hosseinkhani, R. Shirazi, F. Rajaei, M. Mahmoudi, N. Mohammadi, M. Abbasi, 
Engineering of the embryonic and adult stem cell niches, Iranian Red Crescent Medical 
Journal 15(2) (2013) 83. 
[63] D.A. Brafman, Constructing stem cell microenvironments using bioengineering 
approaches, Physiological Genomics 45(23) (2013) 1123-1135. 
[64] L.B. Hazeltine, J.A. Selekman, S.P. Palecek, Engineering the human pluripotent stem 
cell microenvironment to direct cell fate, Biotechnology Advances 31(7) (2013) 1002-1019. 
[65] L. Yan, M. Yang, H. Guo, L. Yang, J. Wu, R. Li, P. Liu, Y. Lian, X. Zheng, J. Yan, J. 
Huang, M. Li, X. Wu, L. Wen, K. Lao, J. Qiao, F. Tang, Single-cell RNA-Seq profiling of 
human preimplantation embryos and embryonic stem cells, Nature Structural & Molecular 
biology 20(9) (2013) 1131-9. 
[66] F. Guharay, F. Sachs, Stretch-activated single ion channel currents in tissue-cultured 
embryonic chick skeletal muscle, The Journal of Physiology 352(1) (1984) 685-701. 
[67] N.S. Cook, The pharmacology of potassium channels and their therapeutic potential, 
Trends in Pharmacological Sciences 9(1) (1988) 21-28. 
57 
[68] A. Curtis, J. Forrester, C. McInnes, F. Lawrie, Adhesion of cells to polystyrene surfaces, 
The Journal of Cell Biology 97(5) (1983) 1500-1506. 
[69] P. Van Wachem, T. Beugeling, J. Feijen, A. Bantjes, J. Detmers, W. Van Aken, 
Interaction of cultured human endothelial cells with polymeric surfaces of different 
wettabilities, Biomaterials 6(6) (1985) 403-408. 
[70] R. Edmondson, J.J. Broglie, A.F. Adcock, L. Yang, Three-dimensional cell culture 
systems and their applications in drug discovery and cell-based biosensors, Assay and Drug 
Development Technologies 12(4) (2014) 207-218. 
[71] T.B. Puschmann, Y. de Pablo, C. Zandén, J. Liu, M. Pekny, A Novel Method for Three-
Dimensional Culture of Central Nervous System Neurons, Tissue Engineering Part C: 
Methods 20(6) (2014) 485-492. 
[72] J.E. Dixon, D.A. Shah, C. Rogers, S. Hall, N. Weston, C.D. Parmenter, D. McNally, C. 
Denning, K.M. Shakesheff, Combined hydrogels that switch human pluripotent stem cells 
from self-renewal to differentiation, Proceedings of the National Academy of Sciences 
111(15) (2014) 5580-5585. 
[73] J.W. Haycock, 3D cell culture: a review of current approaches and techniques, 3D Cell 
Culture, Springer2011, pp. 1-15. 
[74] C. Cunha, S. Panseri, O. Villa, D. Silva, F. Gelain, 3D culture of adult mouse neural 
stem cells within functionalized self-assembling peptide scaffolds, Int J Nanomedicine 6 
(2011) 943-955. 
[75] J. Sottile, D.C. Hocking, Fibronectin polymerization regulates the composition and 
stability of extracellular matrix fibrils and cell-matrix adhesions, Molecular Biology of the 
Cell 13(10) (2002) 3546-3559. 
[76] W.P. Daley, S.B. Peters, M. Larsen, Extracellular matrix dynamics in development and 
regenerative medicine, Journal of Cell Science 121(3) (2008) 255-264. 
[77] S. Li, D. Edgar, R. Fässler, W. Wadsworth, P.D. Yurchenco, The role of laminin in 
embryonic cell polarization and tissue organization, Developmental Cell 4(5) (2003) 613-624. 
[78] S.J. Florczyk, F.M. Kievit, K. Wang, A.E. Erickson, R.G. Ellenbogen, M. Zhang, 3D 
porous chitosan–alginate scaffolds promote proliferation and enrichment of cancer stem-like 
cells, Journal of Materials Chemistry B 4(38) (2016) 6326-6334. 
[79] B.B. Mandal, S.C. Kundu, Cell proliferation and migration in silk fibroin 3D scaffolds, 
Biomaterials 30(15) (2009) 2956-65. 
58 
[80] J. Li, R. Tao, W. Wu, H. Cao, J. Xin, J. Li, J. Guo, L. Jiang, C. Gao, A.A. Demetriou, 
3D PLGA Scaffolds Improve Differentiation and Function of Bone Marrow Mesenchymal 
Stem Cell–Derived Hepatocytes, Stem Cells and Development 19(9) (2010) 1427-1436. 
[81] C.B. Machado, J.M. Ventura, A.F. Lemos, J.M. Ferreira, M.F. Leite, A.M. Goes, 3D 
chitosan-gelatin-chondroitin porous scaffold improves osteogenic differentiation of 
mesenchymal stem cells, Biomedical Materials 2(2) (2007) 124-31. 
[82] Q. Gu, H. Zhu, L. Chen, L. Shuai, J. Fang, J. Wu, L. Liu, W. Li, J. Dai, J. Hao, Q. Zhou, 
Three dimensional collagen scaffolds promote iPSC induction with higher pluripotency, 
Protein Cell 7(11) (2016) 844-848. 
[83] M. Caiazzo, Y. Okawa, A. Ranga, A. Piersigilli, Y. Tabata, M.P. Lutolf, Defined three-
dimensional microenvironments boost induction of pluripotency, Nature materials 15 (2016) 
344–352. 
[84] F. Pampaloni, E.G. Reynaud, E.H. Stelzer, The third dimension bridges the gap between 
cell culture and live tissue, Nature Reviews Molecular Cell Biology 8(10) (2007) 839-845. 
[85] H. Huang, Y. Ding, X.S. Sun, T.A. Nguyen, Peptide hydrogelation and cell 
encapsulation for 3D culture of MCF-7 breast cancer cells, PLoS One 8(3) (2013) e59482. 
[86] L. Chen, Z. Xiao, Y. Meng, Y. Zhao, J. Han, G. Su, B. Chen, J. Dai, The enhancement 
of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer 
and anti-cancer drugs, Biomaterials 33(5) (2012) 1437-44. 
[87] S. Ortinau, J. Schmich, S. Block, A. Liedmann, L. Jonas, D.G. Weiss, C.A. Helm, A. 
Rolfs, M.J. Frech, Effect of 3D-scaffold formation on differentiation and survival in human 
neural progenitor cells, Biomedical engineering online 9 (2010) 70. 
[88] Q. Gu, E. Tomaskovic-Crook, R. Lozano, Y. Chen, R.M. Kapsa, Q. Zhou, G.G. Wallace, 
J.M. Crook, Functional 3D Neural Mini-Tissues from Printed Gel-Based Bioink and Human 
Neural Stem Cells, Advanced Healthcare Materials 5(12) (2016) 1429-38. 
[89] Y.R. Lou, L. Kanninen, B. Kaehr, J.L. Townson, J. Niklander, R. Harjumaki, C. Jeffrey 
Brinker, M. Yliperttula, Silica bioreplication preserves three-dimensional spheroid structures 
of human pluripotent stem cells and HepG2 cells, Scientific reports 5 (2015) 13635. 
[90] H. Ali, S. Dixit, D. Ali, A.A. Alkahtane, S. Alarifi, B.A. Ali, S. Alkahtani, Isolation and 
evaluation of biological efficacy of quercetol in human hepatic carcinoma cells, Drug design, 
development and therapy 10 (2016) 155-62. 
[91] X. Li, X. Zhang, S. Zhao, J. Wang, G. Liu, Y. Du, Micro-scaffold array chip for 
upgrading cell-based high-throughput drug testing to 3D using benchtop equipment, Lab on a 
Chip 14(3) (2014) 471-481. 
59 
[92] A.L. Carlson, C.A. Florek, J.J. Kim, T. Neubauer, J.C. Moore, R.I. Cohen, J. Kohn, M. 
Grumet, P.V. Moghe, Microfibrous substrate geometry as a critical trigger for organization, 
self-renewal, and differentiation of human embryonic stem cells within synthetic 3-
dimensional microenvironments, The FASEB Journal 26(8) (2012) 3240-3251. 
[93] N. Gomez, C.E. Schmidt, Nerve growth factor‐immobilized polypyrrole: Bioactive 
electrically conducting polymer for enhanced neurite extension, Journal of Biomedical 
Materials Research Part A 81(1) (2007) 135-149. 
[94] X. Li, R. Cui, W. Liu, L. Sun, B. Yu, Y. Fan, Q. Feng, F. Cui, F. Watari, The Use of 
Nanoscaled Fibers or Tubes to Improve Biocompatibility and Bioactivity of Biomedical 
Materials, Journal of Nanomaterials 2013 (2013) Article ID 728130, 16 pages. 
[95] N.O. Dhoot, C.A. Tobias, I. Fischer, M.A. Wheatley, Peptide‐modified alginate surfaces 
as a growth permissive substrate for neurite outgrowth, Journal of Biomedical Materials 
Research Part A 71(2) (2004) 191-200. 
[96] P.K. Kreeger, T.K. Woodruff, L.D. Shea, Murine granulosa cell morphology and 
function are regulated by a synthetic Arg–Gly–Asp matrix, Molecular and Cellular 
Endocrinology 205(1) (2003) 1-10. 
[97] X. Yao, R. Peng, J. Ding, Cell–Material Interactions Revealed Via Material Techniques 
of Surface Patterning, Advanced Materials 25(37) (2013) 5257-5286. 
[98] Bones: structure and mechanics, Princeton university press, New Jersey, 2002. 
[99] D.W. Thompson, On growth and form, Cambridge University Press, Cambridge, 
England, 1942. 
[100] S. Han, Y. Zhao, Z. Xiao, J. Han, B. Chen, L. Chen, J. Dai, The three-dimensional 
collagen scaffold improves the stemness of rat bone marrow mesenchymal stem cells, Journal 
of Genetics and Genomics 39(12) (2012) 633–641. 
[101] Z. Ma, C. Gao, Y. Gong, J. Shen, Cartilage tissue engineering PLLA scaffold with 
surface immobilized collagen and basic fibroblast growth factor, Biomaterials 26(11) (2005) 
1253-1259. 
[102] C. Gaudet, W.A. Marganski, S. Kim, C.T. Brown, V. Gunderia, M. Dembo, J.Y. Wong, 
Influence of type I collagen surface density on fibroblast spreading, motility, and contractility, 
Biophysical Journal 85(5) (2003) 3329-3335. 
[103] B. Trappmann, J.E. Gautrot, J.T. Connelly, D.G.T. Strange, Y. Li, M.L. Oyen, M.A.C. 
Stuart, H. Boehm, B.J. Li, V. Vogel, J.P. Spatz, F.M. Watt, W.T.S. Huck, Extracellular-
matrix tethering regulates stem-cell fate, Nature materials 11(7) (2012) 642-649. 
60 
[104] J.S. Harunaga, K.M. Yamada, Cell-matrix adhesions in 3D, Matrix Biology 30(7-8) 
(2011) 363-8. 
[105] K. Takahashi, K. Okita, M. Nakagawa, S. Yamanaka, Induction of pluripotent stem 
cells from fibroblast cultures, Nature Protocols 2(12) (2007) 3081-9. 
[106] V. Marin, G. Kaplanski, S. Gres, C. Farnarier, P. Bongrand, Endothelial cell culture: 
protocol to obtain and cultivate human umbilical endothelial cells, Journal of immunological 
methods 254(1) (2001) 183-190. 
[107] B. Weng, R.L. Shepherd, K. Crowley, A.J. Killard, G.G. Wallace, Printing conducting 
polymers, Analyst 135(11) (2010) 2779-2789. 
[108] C. Zamora-Ledezma, N. Puech, C. Zakri, E. Grelet, S.E. Moulton, G.G. Wallace, S. 
Gambhir, C. Blanc, E. Anglaret, P. Poulin, Liquid Crystallinity and Dimensions of 
Surfactant-Stabilized Sheets of Reduced Graphene Oxide, Journal of Physical Chemistry 
Letters 3(17) (2012) 2425-2430. 
[109] X.J. Li, Z.W. Du, E.D. Zarnowska, M. Pankratz, L.O. Hansen, R.A. Pearce, S.C. Zhang, 
Specification of motoneurons from human embryonic stem cells, Nature Biotechnology 23(2) 
(2005) 215-21. 
[110] S.M. Pollard, L. Conti, Y. Sun, D. Goffredo, A. Smith, Adherent neural stem (NS) cells 
from fetal and adult forebrain, Cerebral Cortex 16 Suppl 1 (2006) i112-20. 
[111] P. Pimton, S. Sarkar, N. Sheth, A. Perets, C. Marcinkiewicz, P. Lazarovici, P.I. Lelkes, 
Fibronectin-mediated upregulation of α5β1 integrin and cell adhesion during differentiation 
of mouse embryonic stem cells, Cell Adhesion & Migration 5(1) (2011) 73-82. 
[112] M. Amit, C. Shariki, V. Margulets, J. Itskovitz-Eldor, Feeder layer-and serum-free 
culture of human embryonic stem cells, Biology of Reproduction 70(3) (2004) 837-845. 
[113] D. Zhang, W. Jiang, M. Liu, X. Sui, X. Yin, S. Chen, Y. Shi, H. Deng, Highly efficient 
differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells, 
Cell Research 19(4) (2009) 429-38. 
[114] N. Sun, N.J. Panetta, D.M. Gupta, K.D. Wilson, A. Lee, F. Jia, S. Hu, A.M. Cherry, 
R.C. Robbins, M.T. Longaker, J.C. Wu, Feeder-free derivation of induced pluripotent stem 
cells from adult human adipose stem cells, Proceedings of the National Academy of Sciences 
106(37) (2009) 15720-5. 
[115] S.R. Braam, L. Zeinstra, S. Litjens, D. Ward‐van Oostwaard, S. van den Brink, L. van 
Laake, F. Lebrin, P. Kats, R. Hochstenbach, R. Passier, Recombinant Vitronectin Is a 
Functionally Defined Substrate That Supports Human Embryonic Stem Cell Self‐Renewal 
via αVβ5 Integrin, Stem Cells 26(9) (2008) 2257-2265. 
61 
[116] G. Chen, D.R. Gulbranson, Z. Hou, J.M. Bolin, V. Ruotti, M.D. Probasco, K. Smuga-
Otto, S.E. Howden, N.R. Diol, N.E. Propson, Chemically defined conditions for human iPSC 
derivation and culture, Nature Methods 8(5) (2011) 424-429. 
[117] Z. Melkoumian, J.L. Weber, D.M. Weber, A.G. Fadeev, Y. Zhou, P. Dolley-Sonneville, 
J. Yang, L. Qiu, C.A. Priest, C. Shogbon, Synthetic peptide-acrylate surfaces for long-term 
self-renewal and cardiomyocyte differentiation of human embryonic stem cells, Nature 
Biotechnology 28(6) (2010) 606-610. 
[118] L.G. Villa-Diaz, H. Nandivada, J. Ding, N.C. Nogueira-de-Souza, P.H. Krebsbach, K.S. 
O'Shea, J. Lahann, G.D. Smith, Synthetic polymer coatings for long-term growth of human 
embryonic stem cells, Nature Biotechnology 28(6) (2010) 581-583. 
[119] J.R. Klim, L. Li, P.J. Wrighton, M.S. Piekarczyk, L.L. Kiessling, A defined 
glycosaminoglycan-binding substratum for human pluripotent stem cells, Nature Methods 
7(12) (2010) 989-994. 
[120] Y. Mei, K. Saha, S.R. Bogatyrev, J. Yang, A.L. Hook, Z.I. Kalcioglu, S.-W. Cho, M. 
Mitalipova, N. Pyzocha, F. Rojas, Combinatorial development of biomaterials for clonal 
growth of human pluripotent stem cells, Nature materials 9(9) (2010) 768-778. 
[121] M.K. Carpenter, J. Frey-Vasconcells, M.S. Rao, Developing safe therapies from human 
pluripotent stem cells, Nature Biotechnology 27(7) (2009) 606-13. 
[122] F. Grinnell, Fibroblast biology in three-dimensional collagen matrices, Trends in Cell 
Biology 13(5) (2003) 264-269. 
[123] F. Grinnell, Fibroblast–collagen-matrix contraction: growth-factor signalling and 
mechanical loading, Trends in Cell Biology 10(9) (2000) 362-365. 
[124] R.M. Salasznyk, W.A. Williams, A. Boskey, A. Batorsky, G.E. Plopper, Adhesion to 
vitronectin and collagen I promotes osteogenic differentiation of human mesenchymal stem 
cells, BioMed Research International 2004(1) (2004) 24-34. 
[125] J.-S. Chun, M.-J. Ha, B.S. Jacobson, Differential translocation of protein kinase C ϵ 
during HeLa cell adhesion to a gelatin substratum, Journal of Biological Chemistry 271(22) 
(1996) 13008-13012. 
[126] S. Rodin, A. Domogatskaya, S. Ström, E.M. Hansson, K.R. Chien, J. Inzunza, O. 
Hovatta, K. Tryggvason, Long-term self-renewal of human pluripotent stem cells on human 
recombinant laminin-511, Nature Biotechnology 28(6) (2010) 611-615. 
[127] S.I. Jeong, S.H. Kim, Y.H. Kim, Y. Jung, J.H. Kwon, B.-S. Kim, Y.M. Lee, 
Manufacture of elastic biodegradable PLCL scaffolds for mechano-active vascular tissue 
engineering, Journal of Biomaterials Science, Polymer Edition 15(5) (2004) 645-660. 
62 
[128] W.Y. Yeong, N. Sudarmadji, H.Y. Yu, C.K. Chua, K.F. Leong, S.S. Venkatraman, Y.C. 
Boey, L.P. Tan, Porous polycaprolactone scaffold for cardiac tissue engineering fabricated by 
selective laser sintering, Acta Biomaterialia 6(6) (2010) 2028-34. 
[129] T. Cao, K.H. Ho, S.H. Teoh, Scaffold design and in vitro study of osteochondral 
coculture in a three-dimensional porous polycaprolactone scaffold fabricated by fused 
deposition modeling, Tissue Engineering 9 Suppl 1 (2003) S103-12. 
[130] A. Salerno, D. Guarnieri, M. Iannone, S. Zeppetelli, P.A. Netti, Effect of Micro-and 
Macroporosity of Bone Tissue Three-Dimensional-Poly (ɛ-Caprolactone) Scaffold on Human 
Mesenchymal Stem Cells Invasion, Proliferation, and Differentiation In Vitro, Tissue Eng Pt 
A 16(8) (2010) 2661-2673. 
[131] E.M. Ahmed, Hydrogel: Preparation, characterization, and applications, Journal of 
Advanced Research 6(2) (2013) 105–121. 
[132] H. Park, J.S. Temenoff, Y. Tabata, A.I. Caplan, A.G. Mikos, Injectable biodegradable 
hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for 
cartilage tissue engineering, Biomaterials 28(21) (2007) 3217-3227. 
[133] H. Li, A. Wijekoon, N.D. Leipzig, 3D Differentiation of Neural Stem Cells in 
Macroporous Photopolymerizable Hydrogel Scaffolds, PLoS ONE 7(11) (2012) e48824. 
[134] A.E. Aitken, E.T. Morgan, Gene-specific effects of inflammatory cytokines on 
cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes, Drug Metabolism 
and Disposition 35(9) (2007) 1687-1693. 
[135] W. Cui, D.-H. Kim, M. Imamura, S.-H. Hyon, K. Inoue, Tissue-engineered pancreatic 
islets: culturing rat islets in the chitosan sponge, Cell Transplantation 10(4-5) (2001) 4-5. 
[136] L. He, B. Liu, G. Xipeng, G. Xie, S. Liao, D. Quan, D. Cai, J. Lu, S. Ramakrishna, 
Microstructure and properties of nano-fibrous PCL-b-PLLA scaffolds for cartilage tissue 
engineering, European Cells & Materials 18 (2009) 63-74. 
[137] H.L. Holtorf, J.A. Jansen, A.G. Mikos, Ectopic bone formation in rat marrow stromal 
cell/titanium fiber mesh scaffold constructs: effect of initial cell phenotype, Biomaterials 
26(31) (2005) 6208-6216. 
[138] L. Ma, C. Gao, Z. Mao, J. Zhou, J. Shen, X. Hu, C. Han, Collagen/chitosan porous 
scaffolds with improved biostability for skin tissue engineering, Biomaterials 24(26) (2003) 
4833-4841. 
[139] S.H. Oh, S.G. Kang, E.S. Kim, S.H. Cho, J.H. Lee, Fabrication and characterization of 
hydrophilic poly (lactic-< i> co</i>-glycolic acid)/poly (vinyl alcohol) blend cell scaffolds by 
melt-molding particulate-leaching method, Biomaterials 24(22) (2003) 4011-4021. 
63 
[140] D.G. Cruz, V. Sardinha, J.E. Ivirico, J. Mano, J.G. Ribelles, Gelatin microparticles 
aggregates as three-dimensional scaffolding system in cartilage engineering, Journal of 
Materials Science: Materials in Medicine 24(2) (2013) 503-513. 
[141] M. Yuan, K.W. Leong, B.P. Chan, Three-dimensional culture of rabbit nucleus 
pulposus cells in collagen microspheres, The Spine Journal 11(10) (2011) 947-960. 
[142] M. Mitra, C. Mohanty, A. Harilal, U.K. Maheswari, S.K. Sahoo, S. Krishnakumar, A 
novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs, 
Molecular vision 18 (2012) 1361. 
[143] J.T. Schantz, A. Brandwood, D.W. Hutmacher, H.L. Khor, K. Bittner, Osteogenic 
differentiation of mesenchymal progenitor cells in computer designed fibrin-polymer-ceramic 
scaffolds manufactured by fused deposition modeling, Journal of materials science. Materials 
in medicine 16(9) (2005) 807-19. 
[144] W. Lee, V. Lee, S. Polio, P. Keegan, J.H. Lee, K. Fischer, J.K. Park, S.S. Yoo, On-
demand three-dimensional freeform fabrication of multi-layered hydrogel scaffold with 
fluidic channels, Biotechnology and Bioengineering 105(6) (2010) 1178-86. 
[145] T. Billiet, E. Gevaert, T. De Schryver, M. Cornelissen, P. Dubruel, The 3D printing of 
gelatin methacrylamide cell-laden tissue-engineered constructs with high cell viability, 
Biomaterials 35(1) (2013) 49–62. 
[146] V. Gupta, G. Davis, A. Gordon, A.M. Altman, G.P. Reece, P.R. Gascoyne, A.B. 
Mathur, Endothelial and stem cell interactions on dielectrophoretically aligned fibrous silk 
fibroin‐chitosan scaffolds, Journal of Biomedical Materials Research Part A 94(2) (2010) 
515-523. 
[147] S. Wu, Y. Liu, S. Bharadwaj, A. Atala, Y. Zhang, Human urine-derived stem cells 
seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue 
engineering, Biomaterials 32(5) (2011) 1317-1326. 
[148] L.N. Sierad, A. Simionescu, C. Albers, J. Chen, J. Maivelett, M.E. Tedder, J. Liao, D.T. 
Simionescu, Design and testing of a pulsatile conditioning system for dynamic 
endothelialization of polyphenol-stabilized tissue engineered heart valves, Cardiovascular 
Engineering and Technology 1(2) (2010) 138-153. 
[149] D. Marolt, I.M. Campos, S. Bhumiratana, A. Koren, P. Petridis, G. Zhang, P.F. 
Spitalnik, W.L. Grayson, G. Vunjak-Novakovic, Engineering bone tissue from human 
embryonic stem cells, Proceedings of the National Academy of Sciences 109(22) (2012) 
8705-8709. 
64 
[150] J. Zhu, R.E. Marchant, Design properties of hydrogel tissue-engineering scaffolds, 
Expert Review of Medical Devices 8(5) (2011) 607-626. 
[151] S.H. Ahn, H.J. Lee, J.S. Lee, H. Yoon, W. Chun, G.H. Kim, A novel cell-printing 
method and its application to hepatogenic differentiation of human adipose stem cell-
embedded mesh structures, Scientific reports 5 (2015) 13427. 
[152] L. Baruch, M. Machluf, Alginate-chitosan complex coacervation for cell encapsulation: 
effect on mechanical properties and on long-term viability, Biopolymers 82(6) (2006) 570-9. 
[153] A. Khademhosseini, G. Eng, J. Yeh, J. Fukuda, J. Blumling, R. Langer, J.A. Burdick, 
Micromolding of photocrosslinkable hyaluronic acid for cell encapsulation and entrapment, 
Journal of Biomedical Materials Research Part A 79(3) (2006) 522-532. 
[154] Y.-J. Eun, A.S. Utada, M.F. Copeland, S. Takeuchi, D.B. Weibel, Encapsulating 
bacteria in agarose microparticles using microfluidics for high-throughput cell analysis and 
isolation, ACS Chemical Biology 6(3) (2010) 260-266. 
[155] A. Batorsky, J. Liao, A.W. Lund, G.E. Plopper, J.P. Stegemann, Encapsulation of adult 
human mesenchymal stem cells within collagen‐agarose microenvironments, Biotechnology 
and Bioengineering 92(4) (2005) 492-500. 
[156] T. Richardson, P.N. Kumta, I. Banerjee, Alginate Encapsulation of Human Embryonic 
Stem Cells to Enhance Directed Differentiation to Pancreatic Islet-like cells, Tissue Eng Pt A 
20(23-24) (2014) 3198-3211. 
[157] S. Khalil, W. Sun, Bioprinting endothelial cells with alginate for 3D tissue constructs, 
Journal of biomechanical engineering 131(11) (2009) 111002-111002. 
[158] L. Li, A.E. Davidovich, J.M. Schloss, U. Chippada, R.R. Schloss, N.A. Langrana, M.L. 
Yarmush, Neural lineage differentiation of embryonic stem cells within alginate microbeads, 
Biomaterials 32(20) (2011) 4489-4497. 
[159] A. Bozza, E.E. Coates, T. Incitti, K.M. Ferlin, A. Messina, E. Menna, Y. Bozzi, J.P. 
Fisher, S. Casarosa, Neural differentiation of pluripotent cells in 3D alginate-based cultures, 
Biomaterials 35(16) (2014) 4636-45. 
[160] M. Westhrin, M. Xie, M.O. Olderoy, P. Sikorski, B.L. Strand, T. Standal, Osteogenic 
differentiation of human mesenchymal stem cells in mineralized alginate matrices, PLoS One 
10(3) (2015) e0120374. 
[161] T. Yoshioka, R. Hirano, T. Shioya, M. Kako, Encapsulation of mammalian cell with 
chitosan-CMC capsule, Biotechnology and Bioengineering 35(1) (1990) 66-72. 
65 
[162] H. Li, A. Wijekoon, N.D. Leipzig, Encapsulated neural stem cell neuronal 
differentiation in fluorinated methacrylamide chitosan hydrogels, Annals of Biomedical 
Engineering 42(7) (2014) 1456-69. 
[163] T. Mazaki, Y. Shiozaki, K. Yamane, A. Yoshida, M. Nakamura, Y. Yoshida, D. Zhou, 
T. Kitajima, M. Tanaka, Y. Ito, T. Ozaki, A. Matsukawa, A novel, visible light-induced, 
rapidly cross-linkable gelatin scaffold for osteochondral tissue engineering, Scientific reports 
4 (2014) 4457. 
[164] W. Schuurman, P.A. Levett, M.W. Pot, P.R. van Weeren, W.J. Dhert, D.W. Hutmacher, 
F.P. Melchels, T.J. Klein, J. Malda, Gelatin-methacrylamide hydrogels as potential 
biomaterials for fabrication of tissue-engineered cartilage constructs, Macromol Biosci 13(5) 
(2013) 551-61. 
[165] R. Gaetani, D.A. Feyen, V. Verhage, R. Slaats, E. Messina, K.L. Christman, A. 
Giacomello, P.A. Doevendans, J.P. Sluijter, Epicardial application of cardiac progenitor cells 
in a 3D-printed gelatin/hyaluronic acid patch preserves cardiac function after myocardial 
infarction, Biomaterials 61 (2015) 339-48. 
[166] J.H.Y. Chung, S. Naficy, Z.L. Yue, R. Kapsa, A. Quigley, S.E. Moulton, G.G. Wallace, 
Bio-ink properties and printability for extrusion printing living cells, Biomaterials Science 
1(7) (2013) 763-773. 
[167] L. Shengjie, X. Zhuo, W. Xiaohong, Y. Yongnian, L. Haixia, Z. Renji, Direct 
Fabrication of a Hybrid Cell/Hydrogel Construct by a Double-nozzle Assembling 
Technology, Journal of Bioactive and Compatible Polymers 24(3) (2009) 249-265. 
[168] K. Baysal, A.Z. Aroguz, Z. Adiguzel, B.M. Baysal, Chitosan/alginate crosslinked 
hydrogels: preparation, characterization and application for cell growth purposes, 
International journal of biological macromolecules 59 (2013) 342-8. 
[169] B.P. Chan, T.Y. Hui, M.Y. Wong, K.H. Yip, G.C. Chan, Mesenchymal stem cell-
encapsulated collagen microspheres for bone tissue engineering, Tissue Engineering Part C: 
Methods 16(2) (2010) 225-35. 
[170] R.P. Meier, R. Mahou, P. Morel, J. Meyer, E. Montanari, Y.D. Muller, P. 
Christofilopoulos, C. Wandrey, C. Gonelle-Gispert, L.H. Buhler, Microencapsulated human 
mesenchymal stem cells decrease liver fibrosis in mice, Journal of Hepatology 62(3) (2015) 
634-41. 
[171] K. Watanabe, M. Nakamura, H. Okano, Y. Toyama, Establishment of three-
dimensional culture of neural stem/progenitor cells in collagen Type-1 Gel, Restorative 
Neurology and Neuroscience 25(2) (2007) 109-17. 
66 
[172] K. Yuan Ye, K.E. Sullivan, L.D. Black, Encapsulation of cardiomyocytes in a fibrin 
hydrogel for cardiac tissue engineering, Journal of Visualized Experiments (55) (2011) 3251. 
[173] T.A. Ahmed, M.T. Hincke, Fibrin for encapsulation of human mesenchymal stem cells 
for chondrogenic differentiation, in: M.A. Hayat (Ed.), Stem Cells and Cancer Stem Cells, 
Volume 10, Springer Netherlands2013, pp. 59-69. 
[174] J. Liu, H.H. Xu, H. Zhou, M.D. Weir, Q. Chen, C.A. Trotman, Human umbilical cord 
stem cell encapsulation in novel macroporous and injectable fibrin for muscle tissue 
engineering, Acta Biomaterialia 9(1) (2013) 4688-4697. 
[175] S. Gerecht, J.A. Burdick, L.S. Ferreira, S.A. Townsend, R. Langer, G. Vunjak-
Novakovic, Hyaluronic acid hydrogel for controlled self-renewal and differentiation of 
human embryonic stem cells, Proceedings of the National Academy of Sciences 104(27) 
(2007) 11298-303. 
[176] K.H. Bae, J.J. Yoon, T.G. Park, Fabrication of hyaluronic acid hydrogel beads for cell 
encapsulation, Biotechnology Progress 22(1) (2006) 297-302. 
[177] W. Hassan, Y. Dong, W. Wang, Encapsulation and 3D culture of human adipose-
derived stem cells in an in-situ crosslinked hybrid hydrogel composed of PEG-based 
hyperbranched copolymer and hyaluronic acid, Stem cell research & therapy 4(2) (2013) 32. 
[178] A.L. Rutz, K.E. Hyland, A.E. Jakus, W.R. Burghardt, R.N. Shah, A Multimaterial 
Bioink Method for 3D Printing Tunable, Cell‐Compatible Hydrogels, Advanced Materials 
27(9) (2015) 1607–1614. 
[179] P. Schumann, D. Lindhorst, C. von See, N. Menzel, A. Kampmann, F. Tavassol, H. 
Kokemüller, M. Rana, N.C. Gellrich, M. Rücker, Accelerating the early angiogenesis of 
tissue engineering constructs in vivo by the use of stem cells cultured in matrigel, Journal of 
Biomedical Materials Research Part A 102(6) (2014) 1652-1662. 
[180] R. Gaetani, P.A. Doevendans, C.H. Metz, J. Alblas, E. Messina, A. Giacomello, J.P. 
Sluijter, Cardiac tissue engineering using tissue printing technology and human cardiac 
progenitor cells, Biomaterials 33(6) (2012) 1782-90. 
[181] J.A. DeQuach, S.H. Yuan, L.S. Goldstein, K.L. Christman, Decellularized porcine 
brain matrix for cell culture and tissue engineering scaffolds, Tissue Eng Pt A 17(21-22) 
(2011) 2583-92. 
[182] F. Pati, J. Jang, D.H. Ha, S. Won Kim, J.W. Rhie, J.H. Shim, D.H. Kim, D.W. Cho, 
Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink, 
Nature Communications 5 (2014) 3935. 
67 
[183] Y. Lei, D.V. Schaffer, A fully defined and scalable 3D culture system for human 
pluripotent stem cell expansion and differentiation, Proceedings of the National Academy of 
Sciences 110(52) (2013) E5039-48. 
[184] A.L. Barnes, P.G. Genever, S. Rimmer, M.C. Coles, Collagen-Poly(N-
isopropylacrylamide) Hydrogels with Tunable Properties, Biomacromolecules 17(3) (2016) 
723-34. 
[185] Z. Pan, C. Yan, R. Peng, Y. Zhao, Y. He, J. Ding, Control of cell nucleus shapes via 
micropillar patterns, Biomaterials 33(6) (2012) 1730-5. 
[186] P.M. Davidson, H. Özçelik, V. Hasirci, G. Reiter, K. Anselme, Microstructured 
Surfaces Cause Severe but Non‐Detrimental Deformation of the Cell Nucleus, Advanced 
Materials 21(35) (2009) 3586-3590. 
[187] X. Liu, S. Wang, Three-dimensional nano-biointerface as a new platform for guiding 
cell fate, Chemical Society Reviews  (2014). 
[188] M.P. Prabhakaran, J. Venugopal, C.K. Chan, S. Ramakrishna, Surface modified 
electrospun nanofibrous scaffolds for nerve tissue engineering, Nanotechnology 19(45) (2008) 
455102. 
[189] T. Cohen-Karni, K.J. Jeong, J.H. Tsui, G. Reznor, M. Mustata, M. Wanunu, A. Graham, 
C. Marks, D.C. Bell, R. Langer, Nanocomposite Gold-Silk Nanofibers, Nano letters 12(10) 
(2012) 5403-5406. 
[190] D. Bae, S.-H. Moon, B.G. Park, S.-J. Park, T. Jung, J.S. Kim, K.B. Lee, H.-M. Chung, 
Nanotopographical control for maintaining undifferentiated human embryonic stem cell 
colonies in feeder free conditions, Biomaterials 35(3) (2014) 916-928. 
[191] E.K. Yim, S.W. Pang, K.W. Leong, Synthetic nanostructures inducing differentiation 
of human mesenchymal stem cells into neuronal lineage, Experimental Cell Research 313(9) 
(2007) 1820-1829. 
[192] S. Oh, K.S. Brammer, Y.J. Li, D. Teng, A.J. Engler, S. Chien, S. Jin, Stem cell fate 
dictated solely by altered nanotube dimension, Proceedings of the National Academy of 
Sciences 106(7) (2009) 2130-2135. 
[193] J. Wu, Z. Mao, H. Tan, L. Han, T. Ren, C. Gao, Gradient biomaterials and their 
influences on cell migration, Interface Focus 2(3) (2012) 337-355. 
[194] S.Y. Jang, V. Seshadri, M.S. Khil, A. Kumar, M. Marquez, P.T. Mather, G.A. Sotzing, 
Welded electrochromic conductive polymer nanofibers by electrostatic spinning, Advanced 
Materials 17(18) (2005) 2177-2180. 
68 
[195] D.G. Coblas, A. Fatu, A. Maoui, M. Hajjam, Manufacturing textured surfaces: State of 
art and recent developments, Proceedings of the Institution of Mechanical Engineers, Part J: 
Journal of Engineering Tribology 229(1) (2015) 3-29. 
[196] A. Mata, E.J. Kim, C.A. Boehm, A.J. Fleischman, G.F. Muschler, S. Roy, A three-
dimensional scaffold with precise micro-architecture and surface micro-textures, 
Biomaterials 30(27) (2009) 4610-4617. 
[197] X. Le, G.E.J. Poinern, N. Ali, C.M. Berry, D. Fawcett, Engineering a biocompatible 
scaffold with either micrometre or nanometre scale surface topography for promoting protein 
adsorption and cellular response, International Journal of Biomaterials 2013 (2013) Article 
ID 782549, 16 pages. 
[198] F. Chowdhury, S. Na, D. Li, Y.-C. Poh, T.S. Tanaka, F. Wang, N. Wang, Material 
properties of the cell dictate stress-induced spreading and differentiation in embryonic stem 
cells, Nature materials 9(1) (2009) 82-88. 
[199] A. Banerjee, M. Arha, S. Choudhary, R.S. Ashton, S.R. Bhatia, D.V. Schaffer, R.S. 
Kane, The influence of hydrogel modulus on the proliferation and differentiation of 
encapsulated neural stem cells, Biomaterials 30(27) (2009) 4695-4699. 
[200] A.J. Engler, S. Sen, H.L. Sweeney, D.E. Discher, Matrix elasticity directs stem cell 
lineage specification, Cell 126(4) (2006) 677-89. 
[201] H.B. Schiller, R. Fässler, Mechanosensitivity and compositional dynamics of cell–
matrix adhesions, EMBO Reports 14(6) (2013) 509-519. 
[202] A.J. Engler, L. Richert, J.Y. Wong, C. Picart, D.E. Discher, Surface probe 
measurements of the elasticity of sectioned tissue, thin gels and polyelectrolyte multilayer 
films: correlations between substrate stiffness and cell adhesion, Surface Science 570(1) 
(2004) 142-154. 
[203] C.P. Johnson, H.Y. Tang, C. Carag, D.W. Speicher, D.E. Discher, Forced unfolding of 
proteins within cells, Science 317(5838) (2007) 663-666. 
[204] A.J. Engler, C. Carag-Krieger, C.P. Johnson, M. Raab, H.-Y. Tang, D.W. Speicher, 
J.W. Sanger, J.M. Sanger, D.E. Discher, Embryonic cardiomyocytes beat best on a matrix 
with heart-like elasticity: scar-like rigidity inhibits beating, Journal of Cell Science 121(22) 
(2008) 3794-3802. 
[205] A.I. Orza, C. Mihu, O. Soritau, M. Diudea, A. Florea, H. Matei, S. Balici, T. Mudalige, 
G.K. Kanarpardy, A.S. Biris, Multistructural biomimetic substrates for controlled cellular 
differentiation, Nanotechnology 25(6) (2014) 065102. 
69 
[206] A. Buxboim, I.L. Ivanovska, D.E. Discher, Matrix elasticity, cytoskeletal forces and 
physics of the nucleus: how deeply do cells ‘feel’outside and in?, Journal of Cell Science 
123(3) (2010) 297-308. 
[207] E. Yim, M.P. Sheetz, Force-dependent cell signaling in stem cell differentiation, Stem 
cell research & therapy 3(41). 
[208] D.E. Discher, P. Janmey, Y.-l. Wang, Tissue cells feel and respond to the stiffness of 
their substrate, Science 310(5751) (2005) 1139-1143. 
[209] I. Sandvig, K. Karstensen, A.M. Rokstad, F.L. Aachmann, K. Formo, A. Sandvig, G. 
Skjak-Braek, B.L. Strand, RGD-peptide modified alginate by a chemoenzymatic strategy for 
tissue engineering applications, Journal of Biomedical Materials Research Part A 103(3) 
(2015) 896-906. 
[210] J.Y. Lee, Y.S. Choi, S.J. Lee, C.P. Chung, Y.J. Park, Bioactive peptide-modified 
biomaterials for bone regeneration, Current Pharmaceutical Design 17(25) (2011) 2663-76. 
[211] J.A. Burdick, K.S. Anseth, Photoencapsulation of osteoblasts in injectable RGD-
modified PEG hydrogels for bone tissue engineering, Biomaterials 23(22) (2002) 4315-23. 
[212] R. Lozano, L. Stevens, B.C. Thompson, K.J. Gilmore, R. Gorkin, E.M. Stewart, M. in 
het Panhuis, M. Romero-Ortega, G.G. Wallace, 3D printing of layered brain-like structures 
using peptide modified gellan gum substrates, Biomaterials 67 (2015) 264-273. 
[213] O.D. Krishna, K.L. Kiick, Protein- and peptide-modified synthetic polymeric 
biomaterials, Biopolymers 94(1) (2010) 32-48. 
[214] Q.L. Loh, C. Choong, Three-dimensional scaffolds for tissue engineering applications: 
role of porosity and pore size, Tissue Engineering Part B: Reviews 19(6) (2013) 485-502. 
[215] P.C. Sherrell, B.C. Thompson, J.K. Wassei, A.A. Gelmi, M.J. Higgins, R.B. Kaner, 
G.G. Wallace, Maintaining Cytocompatibility of Biopolymers Through a Graphene Layer for 
Electrical Stimulation of Nerve Cells, Advanced Functional Materials 24(6) (2013) 769-776. 
[216] X. Liu, J. Chen, K.J. Gilmore, M.J. Higgins, Y. Liu, G.G. Wallace, Guidance of neurite 
outgrowth on aligned electrospun polypyrrole/poly(styrene-beta-isobutylene-beta-styrene) 
fiber platforms, Journal of Biomedical Materials Research Part A 94A(4) (2010) 1004-1011. 
[217] W. Zheng, J.M. Razal, P.G. Whitten, R. Ovalle-Robles, G.G. Wallace, R.H. Baughman, 
G.M. Spinks, Artificial Muscles Based on Polypyrrole/Carbon Nanotube Laminates, 
Advanced Materials 23(26) (2011) 2966–2970. 
[218] B. Yue, C. Wang, X. Ding, G.G. Wallace, Polypyrrole coated nylon lycra fabric as 
stretchable electrode for supercapacitor applications, Electrochimica Acta 68 (2012) 18-24. 
70 
[219] C. Mandrycky, Z. Wang, K. Kim, D.H. Kim, 3D bioprinting for engineering complex 
tissues, Biotechnology Advances 34(4) (2016) 422-34. 
[220] A.V. Do, B. Khorsand, S.M. Geary, A.K. Salem, 3D Printing of Scaffolds for Tissue 
Regeneration Applications, Advanced Healthcare Materials 4(12) (2015) 1742-62. 
[221] J. Horvath, A brief history of 3D printing, Mastering 3D Printing, Springer2014, pp. 3-
10. 
[222] L. Setar, M. MacFarland, Top 10 fastest-growing industries,  (2012). 
[223] C. Dieckmann, R. Renner, L. Milkova, J.C. Simon, Regenerative medicine in 
dermatology: biomaterials, tissue engineering, stem cells, gene transfer and beyond, 
Experimental dermatology 19(8) (2010) 697-706. 
[224] T. Xu, W. Zhao, J.M. Zhu, M.Z. Albanna, J.J. Yoo, A. Atala, Complex heterogeneous 
tissue constructs containing multiple cell types prepared by inkjet printing technology, 
Biomaterials 34(1) (2013) 130-9. 
[225] T. Xu, J. Jin, C. Gregory, J.J. Hickman, T. Boland, Inkjet printing of viable mammalian 
cells, Biomaterials 26(1) (2005) 93-99. 
[226] D.L. Cohen, E. Malone, H. Lipson, L.J. Bonassar, Direct freeform fabrication of seeded 
hydrogels in arbitrary geometries, Tissue engineering 12(5) (2006) 1325-35. 
[227] L. Shor, S. Guceri, R. Chang, J. Gordon, Q. Kang, L. Hartsock, Y. An, W. Sun, 
Precision extruding deposition (PED) fabrication of polycaprolactone (PCL) scaffolds for 
bone tissue engineering, Biofabrication 1(1) (2009) 015003. 
[228] B. Guillotin, A. Souquet, S. Catros, M. Duocastella, B. Pippenger, S. Bellance, R. 
Bareille, M. Remy, L. Bordenave, J. Amedee, F. Guillemot, Laser assisted bioprinting of 
engineered tissue with high cell density and microscale organization, Biomaterials 31(28) 
(2010) 7250-6. 
[229] F. Guillemot, A. Souquet, S. Catros, B. Guillotin, J. Lopez, M. Faucon, B. Pippenger, R. 
Bareille, M. Rémy, S. Bellance, High-throughput laser printing of cells and biomaterials for 
tissue engineering, Acta Biomaterialia 6(7) (2010) 2494-2500. 
[230] C.S. Chen, M. Mrksich, S. Huang, G.M. Whitesides, D.E. Ingber, Micropatterned 
surfaces for control of cell shape, position, and function, Biotechnology progress 14(3) (1998) 
356-63. 
[231] D.F. Duarte Campos, A. Blaeser, M. Weber, J. Jakel, S. Neuss, W. Jahnen-Dechent, H. 
Fischer, Three-dimensional printing of stem cell-laden hydrogels submerged in a 
hydrophobic high-density fluid, Biofabrication 5(1) (2013) 015003. 
71 
[232] N.A. Raof, N.R. Schiele, Y. Xie, D.B. Chrisey, D.T. Corr, The maintenance of 
pluripotency following laser direct-write of mouse embryonic stem cells, Biomaterials 32(7) 
(2011) 1802-8. 
[233] J.A. Barron, R. Rosen, J. Jones-Meehan, B.J. Spargo, S. Belkin, B.R. Ringeisen, 
Biological laser printing of genetically modified Escherichia coli for biosensor applications, 
Biosensors & bioelectronics 20(2) (2004) 246-52. 
[234] R. Gaebel, N. Ma, J. Liu, J.J. Guan, L. Koch, C. Klopsch, M. Gruene, A. Toelk, W.W. 
Wang, P. Mark, F. Wang, B. Chichkov, W.Z. Li, G. Steinhoff, Patterning human stem cells 
and endothelial cells with laser printing for cardiac regeneration, Biomaterials 32(35) (2011) 
9218-9230. 
[235] A.D. Dias, D.M. Kingsley, D.T. Corr, Recent advances in bioprinting and applications 
for biosensing, Biosensors 4(2) (2014) 111-36. 
[236] T.A. Gruen, A. Sarmiento, Key references in biomaterials: bone/biomaterial interface 
in orthopedic joint implants, Journal of biomedical materials research 18(5) (1984) 577-99. 
[237] D.J. Odde, M.J. Renn, Laser-guided direct writing for applications in biotechnology, 
Trends in Biotechnology 17(10) (1999) 385-9. 
[238] T. Xu, C.A. Gregory, P. Molnar, X. Cui, S. Jalota, S.B. Bhaduri, T. Boland, Viability 
and electrophysiology of neural cell structures generated by the inkjet printing method, 
Biomaterials 27(19) (2006) 3580-8. 
[239] T. Xu, W. Zhao, J.-M. Zhu, M.Z. Albanna, J.J. Yoo, A. Atala, Complex heterogeneous 
tissue constructs containing multiple cell types prepared by inkjet printing technology, 
Biomaterials 34(1) (2013) 130-139. 
[240] J. Visser, B. Peters, T.J. Burger, J. Boomstra, W.J. Dhert, F.P. Melchels, J. Malda, 
Biofabrication of multi-material anatomically shaped tissue constructs, Biofabrication 5(3) 
(2013) 035007. 
[241] N. Jones, Science in three dimensions: the print revolution, Nature 487(7405) (2012) 
22-3. 
[242] N.R. Schiele, D.T. Corr, Y. Huang, N.A. Raof, Y. Xie, D.B. Chrisey, Laser-based 
direct-write techniques for cell printing, Biofabrication 2(3) (2010) 032001. 
[243] A. Ovsianikov, M. Gruene, M. Pflaum, L. Koch, F. Maiorana, M. Wilhelmi, A. 
Haverich, B. Chichkov, Laser printing of cells into 3D scaffolds, Biofabrication 2(1) (2010) 
014104. 
72 
[244] M. Gruene, A. Deiwick, L. Koch, S. Schlie, C. Unger, N. Hofmann, I. Bernemann, B. 
Glasmacher, B. Chichkov, Laser printing of stem cells for biofabrication of scaffold-free 
autologous grafts, Tissue engineering. Part C, Methods 17(1) (2011) 79-87. 
[245] V. Mironov, V. Kasyanov, R.R. Markwald, Organ printing: from bioprinter to organ 
biofabrication line, Current opinion in biotechnology 22(5) (2011) 667-73. 
[246] Y.-J. Seol, T.-Y. Kang, D.-W. Cho, Solid freeform fabrication technology applied to 
tissue engineering with various biomaterials, Soft Matter 8(6) (2012) 1730-1735. 
[247] W.Y. Yeong, C.K. Chua, K.F. Leong, M. Chandrasekaran, M.W. Lee, Indirect 
fabrication of collagen scaffold based on inkjet printing technique, Rapid Prototyping Journal 
12(4) (2006) 229-237. 
[248] B. Weng, X. Liu, R. Shepherd, G.G. Wallace, Inkjet printed polypyrrole/collagen 
scaffold: A combination of spatial control and electrical stimulation of PC12 cells, Synthetic 
Metals 162(15-16) (2012) 1375-1380. 
[249] T. Boland, T. Xu, B. Damon, X. Cui, Application of inkjet printing to tissue 
engineering, Biotechnology journal 1(9) (2006) 910-7. 
[250] M. Nakamura, A. Kobayashi, F. Takagi, A. Watanabe, Y. Hiruma, K. Ohuchi, Y. 
Iwasaki, M. Horie, I. Morita, S. Takatani, Biocompatible inkjet printing technique for 
designed seeding of individual living cells, Tissue Engineering 11(11-12) (2005) 1658-66. 
[251] N.E. Fedorovich, I. Swennen, J. Girones, L. Moroni, C.A. van Blitterswijk, E. Schacht, 
J. Alblas, W.J. Dhert, Evaluation of photocrosslinked Lutrol hydrogel for tissue printing 
applications, Biomacromolecules 10(7) (2009) 1689-96. 
[252] R. Chang, J. Nam, W. Sun, Effects of dispensing pressure and nozzle diameter on cell 
survival from solid freeform fabrication-based direct cell writing, Tissue engineering. Part A 
14(1) (2008) 41-8. 
[253] C.C. Chang, E.D. Boland, S.K. Williams, J.B. Hoying, Direct‐write bioprinting three‐
dimensional biohybrid systems for future regenerative therapies, Journal of Biomedical 
Materials Research Part B: Applied Biomaterials 98(1) (2011) 160-170. 
[254] K. Jakab, B. Damon, A. Neagu, A. Kachurin, G. Forgacs, Three-dimensional tissue 
constructs built by bioprinting, Biorheology 43(3-4) (2006) 509-13. 
[255] C.M. Smith, A.L. Stone, R.L. Parkhill, R.L. Stewart, M.W. Simpkins, A.M. Kachurin, 
W.L. Warren, S.K. Williams, Three-dimensional bioassembly tool for generating viable 
tissue-engineered constructs, Tissue engineering 10(9-10) (2004) 1566-76. 
73 
[256] M. Colina, M. Duocastella, J.M. Fernández-Pradas, P. Serra, J.L. Morenza, Laser-
induced forward transfer of liquids: Study of the droplet ejection process, Journal of Applied 
Physics 99(8) (2006) 084909. 
[257] Y.J. Seol, H.W. Kang, S.J. Lee, A. Atala, J.J. Yoo, Bioprinting technology and its 
applications, European journal of cardio-thoracic surgery : official journal of the European 
Association for Cardio-thoracic Surgery 46(3) (2014) 342-8. 
[258] A. Blaeser, D.F. Duarte Campos, M. Weber, S. Neuss, B. Theek, H. Fischer, W. 
Jahnen-Dechent, Biofabrication under fluorocarbon: a novel freeform fabrication technique to 
generate high aspect ratio tissue-engineered constructs, BioResearch open access 2(5) (2013) 
374-84. 
[259] J.S. Lee, J.M. Hong, J.W. Jung, J.H. Shim, J.H. Oh, D.W. Cho, 3D printing of 
composite tissue with complex shape applied to ear regeneration, Biofabrication 6(2) (2014) 
024103. 
[260] Y.J. Seol, T.Y. Kang, D.W. Cho, Solid freeform fabrication technology applied to 
tissue engineering with various biomaterials, Soft Matter 8(6) (2012) 1730-1735. 
[261] W.L. Stoppel, C.E. Ghezzi, S.L. McNamara, L.D. Black, 3rd, D.L. Kaplan, Clinical 
applications of naturally derived biopolymer-based scaffolds for regenerative medicine, 
Annals of Biomedical Engineering 43(3) (2015) 657-80. 
[262] M.W. Tibbitt, K.S. Anseth, Hydrogels as extracellular matrix mimics for 3D cell 
culture, Biotechnology and Bioengineering 103(4) (2009) 655-663. 
[263] J. Thiele, Y. Ma, S.M. Bruekers, S. Ma, W.T. Huck, 25th anniversary article: Designer 
hydrogels for cell cultures: a materials selection guide, Advanced materials 26(1) (2014) 125-
47. 
[264] B. Guillotin, F. Guillemot, Cell patterning technologies for organotypic tissue 
fabrication, Trends in biotechnology 29(4) (2011) 183-90. 
[265] A. Atala, S.B. Bauer, S. Soker, J.J. Yoo, A.B. Retik, Tissue-engineered autologous 
bladders for patients needing cystoplasty, Lancet 367(9518) (2006) 1241-6. 
[266] S. Llames, E. Garcia, V. Garcia, M. del Rio, F. Larcher, J.L. Jorcano, E. Lopez, P. 
Holguin, F. Miralles, J. Otero, A. Meana, Clinical results of an autologous engineered skin, 
Cell and tissue banking 7(1) (2006) 47-53. 
[267] P. Bianco, P.G. Robey, Stem cells in tissue engineering, Nature 414(6859) (2001) 118-
21. 
[268] B.Y. Hu, S.C. Zhang, Differentiation of spinal motor neurons from pluripotent human 
stem cells, Nature Protocols 4(9) (2009) 1295-304. 
74 
[269] M. Eiraku, K. Watanabe, M. Matsuo-Takasaki, M. Kawada, S. Yonemura, M. 
Matsumura, T. Wataya, A. Nishiyama, K. Muguruma, Y. Sasai, Self-organized formation of 
polarized cortical tissues from ESCs and its active manipulation by extrinsic signals, Cell 
Stem Cell 3(5) (2008) 519-532. 
[270] M.A. Lancaster, M. Renner, C.A. Martin, D. Wenzel, L.S. Bicknell, M.E. Hurles, T. 
Homfray, J.M. Penninger, A.P. Jackson, J.A. Knoblich, Cerebral organoids model human 
brain development and microcephaly, Nature 501(7467) (2013) 373-9. 
[271] H. Lin, H. Ouyang, J. Zhu, S. Huang, Z. Liu, S. Chen, G. Cao, G. Li, R.A. Signer, Y. 
Xu, Lens regeneration using endogenous stem cells with gain of visual function, Nature 
531(7594) (2016) 323-328. 
[272] D.B. Kolesky, K.A. Homan, M.A. Skylar-Scott, J.A. Lewis, Three-dimensional 
bioprinting of thick vascularized tissues, Proceedings of the National Academy of Sciences 
113(12) (2016) 3179–3184. 
[273] B.E. Uygun, A. Soto-Gutierrez, H. Yagi, M.-L. Izamis, M.A. Guzzardi, C. Shulman, J. 
Milwid, N. Kobayashi, A. Tilles, F. Berthiaume, Organ reengineering through development 
of a transplantable recellularized liver graft using decellularized liver matrix, Nature 
Medicine 16(7) (2010) 814-820. 
[274] E.S. Place, J.H. George, C.K. Williams, M.M. Stevens, Synthetic polymer scaffolds for 
tissue engineering, Chemical Society Reviews 38(4) (2009) 1139-1151. 
[275] B. Dhandayuthapani, Y. Yoshida, T. Maekawa, D.S. Kumar, Polymeric scaffolds in 
tissue engineering application: a review, International Journal of Polymer Science 2011 (2011) 
Article ID 290602, 19 pages. 
[276] I.M. El-Sherbiny, M.H. Yacoub, Hydrogel scaffolds for tissue engineering: Progress 
and challenges, Global cardiology science & practice 2013(3) (2013) 316-42. 
[277] P.B. Maurus, C.C. Kaeding, Bioabsorbable implant material review, Operative 
Techniques in Sports Medicine 12(3) (2004) 158-160. 
[278] M. Zilberman, K.D. Nelson, R.C. Eberhart, Mechanical properties and in vitro 
degradation of bioresorbable fibers and expandable fiber‐based stents, Journal of Biomedical 
Materials Research Part B: Applied Biomaterials 74(2) (2005) 792-799. 
[279] S. Leinonen, E. Suokas, M. Veiranto, P. Törmälä, T. Waris, N. Ashammakhi, Holding 
power of bioabsorbable ciprofloxacin-containing self-reinforced poly-L/DL-lactide 70/30 
bioactive glass 13 miniscrews in human cadaver bone, Journal of Craniofacial Surgery 13(2) 
(2002) 212-218. 
75 
[280] P. De Coppi, G. Bartsch, Jr., M.M. Siddiqui, T. Xu, C.C. Santos, L. Perin, G. 
Mostoslavsky, A.C. Serre, E.Y. Snyder, J.J. Yoo, M.E. Furth, S. Soker, A. Atala, Isolation of 
amniotic stem cell lines with potential for therapy, Nature Biotechnology 25(1) (2007) 100-6. 
[281] M.S. Mannoor, Z. Jiang, T. James, Y.L. Kong, K.A. Malatesta, W.O. Soboyejo, N. 
Verma, D.H. Gracias, M.C. McAlpine, 3D printed bionic ears, Nano Letters 13(6) (2013) 
2634-9. 
[282] L.A. Hockaday, K.H. Kang, N.W. Colangelo, P.Y. Cheung, B. Duan, E. Malone, J. Wu, 
L.N. Girardi, L.J. Bonassar, H. Lipson, C.C. Chu, J.T. Butcher, Rapid 3D printing of 
anatomically accurate and mechanically heterogeneous aortic valve hydrogel scaffolds, 
Biofabrication 4(3) (2012) 035005. 
[283] H.-Y. Lin, S.-H. Chen, S.-H. Chang, S.-T. Huang, Tri-layered chitosan scaffold as a 
potential skin substitute, Journal of Biomaterials Science, Polymer Edition 26(13) (2015) 
855-867. 
[284] A. Hussain, K. Takahashi, J. Sonobe, Y. Tabata, K. Bessho, Bone regeneration of rat 
calvarial defect by magnesium calcium phosphate gelatin scaffolds with or without bone 
morphogenetic protein-2, Journal of Maxillofacial and Oral Surgery 13(1) (2014) 29-35. 
[285] J.H. Park, J.M. Hong, Y.M. Ju, J.W. Jung, H.W. Kang, S.J. Lee, J.J. Yoo, S.W. Kim, 
S.H. Kim, D.W. Cho, A novel tissue-engineered trachea with a mechanical behavior similar 
to native trachea, Biomaterials 62 (2015) 106-15. 
[286] Alyssa J. Reiffel, Concepcion Kafka, Karina A. Hernandez, Samantha Popa, Justin L. 
Perez, Sherry Zhou, Satadru Pramanik, Bryan N. Brown, Won Seuk Ryu, Lawrence J. 
Bonassar, J.A. Spector, High-Fidelity Tissue Engineering of Patient-Specific Auricles for 
Reconstruction of Pediatric Microtia and Other Auricular Deformities, PLoS One 8(2) (2013) 
8. 
[287] L. Koch, A. Deiwick, S. Schlie, S. Michael, M. Gruene, V. Coger, D. Zychlinski, A. 
Schambach, K. Reimers, P.M. Vogt, B. Chichkov, Skin tissue generation by laser cell 
printing, Biotechnology and bioengineering 109(7) (2012) 1855-63. 
[288] T. Song, X. Zhao, H. Sun, X.a. Li, N. Lin, L. Ding, J. Dai, Y. Hu, Regeneration of 
uterine horns in rats using collagen scaffolds loaded with human embryonic stem cell-derived 
endometrium-like cells, Tissue Eng Pt A 21(1-2) (2014) 353-361. 
[289] K.S. Thomson, F.S. Korte, C.M. Giachelli, B.D. Ratner, M. Regnier, M. Scatena, 
Prevascularized microtemplated fibrin scaffolds for cardiac tissue engineering applications, 
Tissue engineering. Part A 19(7-8) (2013) 967-77. 
76 
[290] Y. Zhang, N. Cheng, R. Miron, B. Shi, X. Cheng, Delivery of PDGF-B and BMP-7 by 
mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects, Biomaterials 
33(28) (2012) 6698-708. 
[291] I.P. Monteiro, A. Shukla, A.P. Marques, R.L. Reis, P.T. Hammond, Spray-assisted 
layer-by-layer assembly on hyaluronic acid scaffolds for skin tissue engineering, Journal of 
biomedical materials research. Part A 103(1) (2015) 330-40. 
[292] J.Y. Lai, H.Y. Cheng, D.H. Ma, Investigation of Overrun-Processed Porous Hyaluronic 
Acid Carriers in Corneal Endothelial Tissue Engineering, PLoS One 10(8) (2015) e0136067. 
[293] X. Wang, J. He, Y. Wang, F.Z. Cui, Hyaluronic acid-based scaffold for central neural 
tissue engineering, Interface Focus 2(3) (2012) 278-91. 
[294] T. Xu, K.W. Binder, M.Z. Albanna, D. Dice, W. Zhao, J.J. Yoo, A. Atala, Hybrid 
printing of mechanically and biologically improved constructs for cartilage tissue engineering 
applications, Biofabrication 5(1) (2013) 015001. 
[295] B. Duan, E. Kapetanovic, L.A. Hockaday, J.T. Butcher, Three-dimensional printed 
trileaflet valve conduits using biological hydrogels and human valve interstitial cells, Acta 
Biomaterialia 10(5) (2014) 1836-1846. 
[296] Y. Yan, X. Wang, Y. Pan, H. Liu, J. Cheng, Z. Xiong, F. Lin, R. Wu, R. Zhang, Q. Lu, 
Fabrication of viable tissue-engineered constructs with 3D cell-assembly technique, 
Biomaterials 26(29) (2005) 5864-71. 
[297] C.M. Reijnders, A. van Lier, S. Roffel, D. Kramer, R.J. Scheper, S. Gibbs, 
Development of a Full-Thickness Human Skin Equivalent In Vitro Model Derived from 
TERT-Immortalized Keratinocytes and Fibroblasts, Tissue Eng Pt A 21(17-18) (2015) 2448-
59. 
[298] K. Jakab, C. Norotte, F. Marga, K. Murphy, G. Vunjak-Novakovic, G. Forgacs, Tissue 
engineering by self-assembly and bio-printing of living cells, Biofabrication 2(2) (2010) 
022001. 
[299] V. Mironov, R.P. Visconti, V. Kasyanov, G. Forgacs, C.J. Drake, R.R. Markwald, 
Organ printing: Tissue spheroids as building blocks, Biomaterials 30(12) (2009) 2164-2174. 
[300] B. Derby, Printing and Prototyping of Tissues and Scaffolds, Science 338(6109) (2012) 
921-926. 
[301] J.L. Ricci, E.A. Clark, A. Murriky, J.E. Smay, Three-dimensional printing of bone 
repair and replacement materials: impact on craniofacial surgery, Journal of Craniofacial 
Surgery 23(1) (2012) 304-8. 
77 
[302] T. Billiet, M. Vandenhaute, J. Schelfhout, S. Van Vlierberghe, P. Dubruel, A review of 
trends and limitations in hydrogel-rapid prototyping for tissue engineering, Biomaterials 
33(26) (2012) 6020-41. 
[303] D.A. Wahl, J.T. Czernuszka, Collagen-hydroxyapatite composites for hard tissue repair, 
European cells & materials 11 (2006) 43-56. 
[304] N.E. Fedorovich, J.R. De Wijn, A.J. Verbout, J. Alblas, W.J. Dhert, Three-dimensional 
fiber deposition of cell-laden, viable, patterned constructs for bone tissue printing, Tissue Eng 
Pt A 14(1) (2008) 127-33. 
[305] C. Szpalski, M. Wetterau, J. Barr, S.M. Warren, Bone tissue engineering: current 
strategies and techniques--part I: Scaffolds, Tissue engineering. Part B, Reviews 18(4) (2012) 
246-57. 
[306] Dailymail, Cancer left Eric with half his face missing and unable to eat or drink. Now 
surgeons have made him a new face using a 3D PRINTER. 
<http://www.dailymail.co.uk/health/article-2304637/Surgeon-uses-3D-printing-technology-
make-cancer-patient-new-face.html#ixzz3qEaaB3yz >, 2013). 
[307] M. Vehmeijer, M. van Eijnatten, N. Liberton, J. Wolff, A Novel Method of Orbital 
Floor Reconstruction Using Virtual Planning, 3-Dimensional Printing, and Autologous Bone, 
Journal of Oral and Maxillofacial Surgery 74(8) (2016) 1608–1612. 
[308] K. Kim, C.H. Lee, B.K. Kim, J.J. Mao, Anatomically shaped tooth and periodontal 
regeneration by cell homing, Journal of dental research 89(8) (2010) 842-7. 
[309] S. Bose, S. Vahabzadeh, A. Bandyopadhyay, Bone tissue engineering using 3D printing, 
Materials Today 16(12) (2013) 496-504. 
[310] M.J. Sawkins, P. Mistry, B.N. Brown, K.M. Shakesheff, L.J. Bonassar, J. Yang, Cell 
and protein compatible 3D bioprinting of mechanically strong constructs for bone repair, 
Biofabrication 7(3) (2015) 035004. 
[311] C.M. Hwang, B. Ay, D.L. Kaplan, J.P. Rubin, K.G. Marra, A. Atala, J.J. Yoo, S.J. Lee, 
Assessments of injectable alginate particle-embedded fibrin hydrogels for soft tissue 
reconstruction, Biomedical materials 8(1) (2013) 014105. 
[312] A.D. Metcalfe, M.W. Ferguson, Bioengineering skin using mechanisms of regeneration 
and repair, Biomaterials 28(34) (2007) 5100-5113. 
[313] R.V. Shevchenko, S.L. James, S.E. James, A review of tissue-engineered skin 
bioconstructs available for skin reconstruction, Journal of the Royal Society, Interface / the 
Royal Society 7(43) (2010) 229-58. 
78 
[314] F.M. Wood, M.L. Kolybaba, P. Allen, The use of cultured epithelial autograft in the 
treatment of major burn wounds: eleven years of clinical experience, Burns : journal of the 
International Society for Burn Injuries 32(5) (2006) 538-44. 
[315] S. MacNeil, Progress and opportunities for tissue-engineered skin, Nature 445(7130) 
(2007) 874-80. 
[316] F. Netzlaff, M. Kaca, U. Bock, E. Haltner-Ukomadu, P. Meiers, C.-M. Lehr, U.F. 
Schaefer, Permeability of the reconstructed human epidermis model Episkin® in comparison 
to various human skin preparations, European Journal of Pharmaceutics and 
Biopharmaceutics 66(1) (2007) 127-134. 
[317] F. Netzlaff, C.-M. Lehr, P. Wertz, U. Schaefer, The human epidermis models EpiSkin®, 
SkinEthic® and EpiDerm®: an evaluation of morphology and their suitability for testing 
phototoxicity, irritancy, corrosivity, and substance transport, European Journal of 
Pharmaceutics and Biopharmaceutics 60(2) (2005) 167-178. 
[318] P.M. Vogt, P. Kolokythas, A. Niederbichler, K. Knobloch, K. Reimers, C.Y. Choi, 
[Innovative wound therapy and skin substitutes for burns], Der Chirurg; Zeitschrift fur alle 
Gebiete der operativen Medizen 78(4) (2007) 335-42. 
[319] D.M. Supp, S.T. Boyce, Engineered skin substitutes: practices and potentials, Clinics in 
dermatology 23(4) (2005) 403-12. 
[320] A.J. Singer, R.A. Clark, Cutaneous wound healing, The New England journal of 
medicine 341(10) (1999) 738-46. 
[321] I.T. Ozbolat, Bioprinting scale-up tissue and organ constructs for transplantation, 
Trends in Biotechnology 33(7) (2015) 395-400. 
[322] W. Lee, J.C. Debasitis, V.K. Lee, J.-H. Lee, K. Fischer, K. Edminster, J.-K. Park, S.-S. 
Yoo, Multi-layered culture of human skin fibroblasts and keratinocytes through three-
dimensional freeform fabrication, Biomaterials 30(8) (2009) 1587-1595. 
[323] M. Rimann, E. Bono, H. Annaheim, M. Bleisch, U. Graf-Hausner, Standardized 3D 
Bioprinting of Soft Tissue Models with Human Primary Cells, Journal of laboratory 
automation 21(4) (2015) 496-509. 
[324] A. Vultur, T. Schanstra, M. Herlyn, The promise of 3D skin and melanoma cell 
bioprinting, Melanoma research 26(2) (2016) 205-6. 
[325] E.A. Huebner, S.M. Strittmatter, Axon regeneration in the peripheral and central 
nervous systems, Results and problems in cell differentiation 48 (2009) 339-51. 
79 
[326] D.F. Emerich, G. Orive, C. Thanos, J. Tornoe, L.U. Wahlberg, Encapsulated cell 
therapy for neurodegenerative diseases: from promise to product, Advanced drug delivery 
reviews 67-68 (2014) 131-41. 
[327] A. Williamson, J. Rivnay, L. Kergoat, A. Jonsson, S. Inal, I. Uguz, M. Ferro, A. Ivanov, 
T.A. Sjostrom, D.T. Simon, M. Berggren, G.G. Malliaras, C. Bernard, Controlling 
epileptiform activity with organic electronic ion pumps, Advanced Materials 27(20) (2015) 
3138-44. 
[328] J. Cao, C. Sun, H. Zhao, Z. Xiao, B. Chen, J. Gao, T. Zheng, W. Wu, S. Wu, J. Wang, J. 
Dai, The use of laminin modified linear ordered collagen scaffolds loaded with laminin-
binding ciliary neurotrophic factor for sciatic nerve regeneration in rats, Biomaterials 32(16) 
(2011) 3939-48. 
[329] X. Han, W. Zhang, J. Gu, H. Zhao, L. Ni, J. Han, Y. Zhou, Y. Gu, X. Zhu, J. Sun, X. 
Hou, H. Yang, J. Dai, Q. Shi, Accelerated postero-lateral spinal fusion by collagen scaffolds 
modified with engineered collagen-binding human bone morphogenetic protein-2 in rats, 
PLoS One 9(5) (2014) e98480. 
[330] M. Lovett, K. Lee, A. Edwards, D.L. Kaplan, Vascularization strategies for tissue 
engineering, Tissue engineering. Part B, Reviews 15(3) (2009) 353-70. 
[331] C. Xu, W. Chai, Y. Huang, R.R. Markwald, Scaffold-free inkjet printing of three-
dimensional zigzag cellular tubes, Biotechnology and bioengineering 109(12) (2012) 3152-60. 
[332] D. Tsvirkun, A. Grichine, A. Duperray, C. Misbah, L. Bureau, Microvasculature on a 
chip: study of the Endothelial Surface Layer and the flow structure of Red Blood Cells, 
Scientific reports 7 (2017) 45036. 
[333] K. Jakab, C. Norotte, F. Marga, K. Murphy, G. Vunjak-Novakovic, G. Forgacs, Tissue 
engineering by self-assembly and bio-printing of living cells, Biofabrication 2(2) (2010) 
022001. 
[334] D.B. Kolesky, R.L. Truby, A. Gladman, T.A. Busbee, K.A. Homan, J.A. Lewis, 3D 
Bioprinting of Vascularized, Heterogeneous Cell‐Laden Tissue Constructs, Advanced 
Materials 26(19) (2014) 3124-3130. 
[335] H.W. Kang, S.J. Lee, I.K. Ko, C. Kengla, J.J. Yoo, A. Atala, A 3D bioprinting system 
to produce human-scale tissue constructs with structural integrity, Nature Biotechnology 34 
(2016) 312–319. 
[336] Q. Gu, J. Hao, Y. Lu, L. Wang, G.G. Wallace, Q. Zhou, Three-dimensional bio-
printing, Science China Life Sciences 58(5) (2015) 411-419. 
80 
[337] R.E. Alcaide-Aguirre, D.C. Morgenroth, D.P. Ferris, Motor control and learning with 
lower-limb myoelectric control in amputees, Journal of rehabilitation research and 
development 50(5) (2013) 687-98. 
[338] BBC, Transplant jaw made by 3D printer <http://www.bbc.com/news/technology-
16907104>, 2012). 
[339] B. Krassenstein, 3D Printing Helps Create Upper Jaw Prosthetic For Cancer Patient. 
<http://3dprint.com/19617/osteo3d-3d-print-mouth/>, 2014). 
[340] S.N. Bhatia, G.H. Underhill, K.S. Zaret, I.J. Fox, Cell and tissue engineering for liver 
disease, Science Translational Medicine 6(245) (2014) 245sr2. 
[341] R.P. Visconti, V. Kasyanov, C. Gentile, J. Zhang, R.R. Markwald, V. Mironov, 
Towards organ printing: engineering an intra-organ branched vascular tree, Expert opinion on 












2.1 INTRODUCTION ........................................................................................................... 83 
2.2 REAGENTS AND MATERIALS ...................................................................................... 83 
2.3 SYNTHESIS OF HYDROGELS AND CONDUCTIVE POLYMERS .......................................... 88 
2.3.1 Al-CMC-Ag preparation ........................................................................................ 88 
2.3.2 Synthesis of the PPy-DBS conductive polymer ...................................................... 90 
2.4 STEM CELL CULTURE AND DIFFERENTIATION ............................................................. 91 
2.4.1 Human NSC culture and differentiation ................................................................ 92 
2.4.2 Human iPSC culture and differentiation ............................................................... 93 
2.5 3D PRINTING STEM CELLS AND STIMULATION OF HUMAN IPSCS ................................ 94 
2.5.1 3D printing human NSCs ....................................................................................... 95 
2.5.2 3D printing human iPSCs ...................................................................................... 96 
2.6 PHYSICAL CHARACTERIZATION .................................................................................. 97 
2.6.1 Mechanical measurement ...................................................................................... 97 
2.6.2 Scanning electron microscopy (SEM) ................................................................. 100 
2.6.3 Weight loss experiment ........................................................................................ 100 
2.6.4 Hydrogel swelling ratio ....................................................................................... 100 
2.6.5 Diffusion experiment............................................................................................ 101 
2.7 ELECTROCHEMICAL CHARACTERIZATION ................................................................. 102 
2.7.1 Cyclic voltammetry .............................................................................................. 102 
2.7.2 Electrical stimulation .......................................................................................... 103 
2.8 CELL ANALYSES ....................................................................................................... 105 
2.8.1 Human NSC and human iPSC viability assay ..................................................... 105 
2.8.2 Cell proliferation analysis in the 3D printed gels ............................................... 105 
2.8.3 Cell Immunophenotyping ..................................................................................... 105 
2.8.4 Live cell calcium imaging .................................................................................... 106 
83 
2.8.5 Reverse transcription-quantitative PCR (RT-qPCR) .......................................... 106 
2.9 REFERENCE .............................................................................................................. 107 
2 GENERAL EXPERIMENTAL 
2.1 Introduction 
This section details the general materials, instrumentation and procedures used in this thesis. 
It primarily deals with bioink development, characterization, 3D bioprinting and stimulation. 
Also included are details on the culture of human NSCs and human iPSCs in the 3D printed 
hydrogels. More detailed information on specific procedures is presented in the experimental 
sections of relevant chapters. 
2.2 Reagents and Materials 
Reagent name  Source Cat NO 
Alginic acid sodium salt (Alginate, 
Al) 
Sigma A2033 
Carboxymethyl chitosan (CMC) Santa Cruz sc-358091A 
Agarose (Ag) Biochemicals BIOD0012 
Calcium chloride Ajax FineChem 128 
PBS tablet Sigma P3813 
Pyrrole (Py) Sigma 577030 
Dodecylbenzenesulfonate (DBS) Sigma 289957 
Poly(3,4-ethylenedioxythiophene) 
polystyrene sulfonate (PEDOT:PSS) 
Sigma 483095 
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Reagent name  Source Cat NO 
Ethylene glycol Sigma 324558 
Knockout Dulbecco's modified 
Eagle medium (KO-DMEM) 
Invitrogen 10829018 
Gibco™ Dulbecco's Modified Eagle 
Medium: Nutrient Mixture F-12 
(DMEM/F-12) 
Invitrogen 11330-032 
NeuroCult® NS-A Basal Medium 
(Human) 









Stem Cell Technologies 05753 
Heparin Sigma H3149 
Epidermal growth factor (EGF) PeproTech AF-100-15 
Basic fibroblast growth factor 
(bFGF) 
PeproTech AF-100-18B 
Nerve Growth Factor Invitrogen 13290-010 
Brain-derived neurotrophic factor PeproTech 450-02 
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Reagent name  Source Cat NO 
(BDNF) 
Penicillin/Streptomycin Gibco 15140122 
β-mercaptoethanol Gibco 21985023 
Laminin Sigma L6274 
TypLE(1X) Gibco 17100017 
StemPro® Neural Supplement Invitrogen A1050801 
N-2 supplement Invitrogen 17502048 
Matrigel® Corning Life Sciences 354277 
mTeSR1 Stem Cell Technologies 05850 
Y27632 Merck Millipore 688000 
Calcein AM Invitrogen C3099 
Propidium iodide (PI) Invitrogen P3566 
Paraformaldehyde (PFA, 3.7% 
solution in PBS) 
Fluka 76240 
Triton X-100 Sigma T8532 
Donkey serum Merck S30 
Goat serum Sigma G9023 
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Reagent name  Source Cat NO 
PrestoBlue™ Invitrogen A13262 
Donkey anti-Rabbit igG(H+L) 
Secondary antibody, Alexa Fluor 
647  
Invitrogen A31573 
Goat anti-Mouse IgG (H+L) Highly 
Cross-Adsorbed Secondary 
Antibody, Alexa Fluor Plus 488 
Invitrogen A32723 
Goat anti-Rabbit IgG (H+L) Highly 
Cross-Adsorbed Secondary 
Antibody, Alexa Fluor Plus 488 
Invitrogen A32731 
Donkey anti-Mouse IgG (H+L) 
Highly Cross-Adsorbed Secondary 





Prolong Diamond antifade Invitrogen P36965 
Bicuculline Sigma 14340 
Fluo-4 Invitrogen 23917 
Ethylenediaminetetraacetic acid 
(EDTA) 
Ajax FineChem 180 
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Reagent name  Source Cat NO 
Trizol Invitrogen 15596018 
Conjugated antibody 
Glial fibrillary acidic protein 
(GFAP; mouse)  
 
Cell Signalling Technology 3656 
Microtubule-associated protein 2 
(MAP2; mouse) 
Millipore MAB3418X 
SRY (sex determining region Y)-box 
2 (SOX2; rabbit) 
Cell Signalling Technology 5049 
Vimentin (rabbit) Cell Signalling Technology 9856 
Oligodendrocyte lineage 
transcription factor 2 (OLIGO2; 
mouse) 
Millipore MABN50A4 
KI67 (mouse) Invitrogen 334711 
Neuron-specific class III β-tubulin 
(TUJ1; mouse) 
Abcam ab169556 
Unconjugated primary antibody 
Nestin (mouse) Invitrogen  
Synaptophysin (rabbit) Millipore AB9272 
Gamma-aminobutyric acid (GABA; Sigma A2052 
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Reagent name  Source Cat NO 
rabbit) 
Glutamic acid decarboxylase (GAD; 
mouse) 
Millipore MAB351 
Octamer-binding transcription factor 
4 (OCT4; mouse) 
STEMCELL Technologies 60093 
SSEA4 (mouse) STEMCELL Technologies 60062 
TRA-1-60 (mouse) STEMCELL Technologies 60064 
PAX6 (rabbit) Sigma HPA030775 
TUJ1 (Chicken) Millipore AB9354 
 
2.3 Synthesis of hydrogels and conductive polymers 
2.3.1 Al-CMC-Ag preparation 
Alginate (Al), also called alginic acid or algin, is a type of polysaccharide, a linear copolymer 
with homopolymeric blocks composed of (1-4)-linked uronate residues (Figure 2-1). Al 
obtained from brown algae is afforded, in different types, with different viscosities; one of 
which with a viscosity of 100–300 cP was chosen [1]. Chitin is a homopolymer (poly[β-(1→
4)-2-acetamido-2-deoxy-D-glucopyranose]) produced from the shells of marine animals. The 
idealized structure is shown in Figure 2-2. Chitosan is a copolymer (poly [β-(1→4)-2-amino-
2-deoxy-D-glucopyranose-2-acetamide-2-deoxy-D-glucopyranose]) which is derived from 
chitin by deacetylation with alkali. The process is schematically shown in Figure 2-3 [2]. 
One serious problem with chitosan is its poor solubility in neutral solutions. Carboxymethyl 
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chitosan (CMC) is obtained from the carboxymethylation of chitosan, which can be divided 
into O- and N-carboxymethylation, with the latter chosen for this work because it is a well-
defined derivate[3]. Agarose (Ag) is also extracted from seaweed and is a purified linear 
galactan. Due to the structure of agarose containing D-galactose and 3,6-anhydro-L-
galactopyronose, agarose is thermosensitive (Figure 2-4)[4].  
 
 
Figure 2-1 Molecular structure of alginate 
 
 
Figure 2-2 Molecular structure of chitin 
 
 
Figure 2-3 Molecular structure of chitosan 
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Figure 2-4 Molecular structure of agarose 
 
Ag was dissolved in sterile PBS by micro-waving for several seconds. The vials were then 
placed on a stirrer, 5% (w/v) Al was added and stirred at 60 °C for 30 min, followed by the 
addition of 5% (w/v) CMC and another stirring step at 60 °C for 1 h. The final solutions were 
allowed to cool to RT. The solutions can be stored in the refrigerator for up to 3 weeks.  
2.3.2 Synthesis of the PPy-DBS conductive polymer 
The pyrrole monomer and DBS were purchased from Sigma. The pyrrole monomer was 
distilled before use and stored at -20○C, aliquots of which were taken immediately before 
they were required. The monomer formula is C4H5N with a molecular weight of 67.09g/mol. 
The structures of the monomer and polymer are shown in Figure 2-5. The synthesis of PPy-
DBS was achieved through the oxidative polymerization of pyrrole at an anode. Aqueous 
monomer solutions were prepared with distilled and deionized water (ddH2O, Milli-Q) with 
0.05 M DBS. Gold-coated mylar (Solutia Performance Films), where the oxidative 
polymerization occurred was sterilised with isopropanol followed by drying under a N2 
stream. The aqueous solution was degassed using N2 before PPy-DBS films were grown on 
mylar films. The traditional two electrode electrochemical cell was used for the oxidation 
galvanostatically at 0.1 mA/cm2 for 10 mins on the platform eDAQ EA161 potentiostat 
(eDAQ Pty Ltd, Australia) (Figure 2-6). The area for deposition needed to be determined 
prior to the synthesis for calculation of the constant current to be applied; using knowledge of 
the height of the solution and the width of the working electrode.  
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Figure 2-5 Primary structure of pyrrole (A) and polypyrrole (B). 
 
 
Figure 2-6 Two electrode electrochemical cell for polypyrrole synthesis. 
The system contains four principle components: working electrode, counter electrode, EDAQ 
software and the polymerisation solution. 
2.4 Stem cell culture and differentiation 
Human NSCs are the precursors of various types of neuronal and glial cells. Human iPSCs 
are one type of pluripotent stem cell with the potential to generate any type of cell of the body. 
Both were used to test the bioactivity of hydrogels and the synthetics that were generated in 
the work. 
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2.4.1 Human NSC culture and differentiation 
The human NSC cell line used was purchased from Millipore (SCC007). The human NSC 
culture medium was prepared by mixing NeuroCult® NS-A Basal Medium (Human) 
supplemented with heparin (2 μg/mL), epidermal growth factor (EGF, 20 ng/mL), and basic 
fibroblast growth factor (bFGF, 20 ng/mL). The human NSC cryogenic vials were removed 
from the liquid nitrogen storage container, allowed to thaw in the water bath at 37°C. Human 
NSCs were seeded at a density of 2-3 x 106 cells per well of a low attachment six-well plate 
(Corning) with two mL human NSC culture medium per well. During culture, the human 
NSCs formed into neurospheres spontaneously. Following five to seven days of culture, the 
medium containing spontaneously formed neurospheres was collected for digestion with 
TrypLE (pre-warmed to 37°C), which could then be used for bioprinting. If cells were to be 
further subcultured, the cells were seeded on low-attachment plates. The normal neural 
spheres are shown in Figure 2-7. 
 
 
Figure 2-7 Neurosphere formation during culture of human NSCs. 
The photomicrograph shows human NSCs following 3 days of subculture. 
Human NSCs were differentiated in a human NSC differentiation medium containing two 
parts DMEM/F-12 and one part neurobasal medium supplemented with 2% StemPro, 0.5% 
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N2, and brain-derived neurotrophic factor (BDNF; 50 ng/mL). NSCs were incubated on the 
laminin (20 μg/mL) coated plates for differentiation and the medium was refreshed with the 
differentiation medium every three days. The differentiated human NSCs are shown in 
Figure 2-8.  
 
 
Figure 2-8 SEM image of differentiated human NSCs. 
The differentiated human NSCs exhibit long neurite extensions. 
2.4.2 Human iPSC culture and differentiation 
Working stocks of human iPSCs were maintained as 2D cultures in 5% CO2 at 37°C, 
mTeSR™1 on Matrigel® basement membrane matrix in 6-well plates (Greiner Bio-One). 
Cells were passaged when colony centres became dense by incubation with 0.02% EDTA for 
3 min and fluxing with a pipette, followed by a 1:4-1:6 split. To form EBs, iPSC colonies 
were extracted non-enzymatically and transferred to fresh culture plates for non-adherent 
suspension culture in the medium without bFGF. 
For 3D printed human iPSC culture and differentiation, mTeSR™1 was again used for 
human iPSC expansion, and the KOSR medium (DMEM/F12 supplemented with 20% 
KnockOut™ Serum Replacement, 1×MEM non-essential amino acids solution (NEAA; 100x 
stock) and 55 µM β-mercaptoethanol) without bFGF was used for induction of EBs. The 
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initial culture medium was supplemented with 5 µM rock inhibitor Y27632 for the first 3 
days of culture, while for EB formation, the medium was changed to bFGF-free medium on 
the 5th day post-printing. Figure 2-9 shows the conventional colonies of human iPSCs.  
 
 
Figure 2-9 A colony of human iPSCs. 
The colony is flatted with a distinct boarder.  
 
2.5 3D printing stem cells and stimulation of human iPSCs 
Before the current study, there had not been any report on 3D bioprinting for human NSCs 
and human iPSCs. This section will describe human NSC and human iPSC culture and 
differentiation under two different conditions including 2D and 3D environments, as well as 
under electrical stimulation. The platform used for 3D bioprinting was the 3D-Bioplotter by 




Figure 2-10 The bioprinter used for 3D printing stem cells 
The 3D printer is a commercial system manufactured by EnvisionTEC. 
 
2.5.1 3D printing human NSCs  
Prior to printing, the ink and cells were prepared. The human NSCs were collected as 
described in the section on stem cell culture (2.4). 5x106 cells were suspended in 0.5 mL 
bioink. The samples were loaded into a 55cc syringe barrel (Nordson) and centrifuged at 300 
g for 1 min to remove air bubbles. The design of the 3D model (eg. 10 mm x 10 mm x 2 mm) 
was accomplished using Blender™ software and saved as a STL type file. The STL file could 
be converted to a bp format file using Bioplotter® RP software. The bp file was then opened 
to establish a new protocol for the 3D printing. The applied pressure for bioink printing was 
set at 1.5-2.0 bar, and the temperature of the barrel and platform was set at 15 °C on the 
Bioplotter® RP software according to the manual. Stainless steel dispensing tips (Nordon, 
7018333) were used for dispersion. After printing, the printed scaffolds were immersed in 2 % 
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w/v calcium chloride for 10 min for crosslinking. After crosslinking, the scaffolds (Figure 
2-11) were immediately washed using culture medium three times for 1 min each, followed 
by two 10 min washes. Then the scaffolds were incubated for one h in the medium prior to 
conducting extended tissue culture. 
Each construct was incubated in one well of a 6-well plate with NSC differentiation medium 
at 37 oC for a minimum of 10 days post-printing, with half-volume medium changes 
performed every 2-3 days. 
 
 
Figure 2-11 Printed Al-CMC-Ag with human NSCs. 
 
2.5.2 3D printing human iPSCs 
The process of 3D printing human iPSCs is similar to that of NSC printing. 2x107 cells were 
collected and then suspended in 0.5 mL gel to comprise the bioink. After mixing the 
biomaterials with the cells, the bioink was introduced into 55cc Syringe Barrels (Nordson) 
with stainless steel dispensing tips (Nordon, 7018333) for 3D printing. After printing and 
gelation, the constructs needed to be rinsed using culture medium three times, followed by 
two 10 min washes and equilibration in culture medium for 1hour to remove excess calcium 
ions. To differentiate iPSCs into neurons in the 3D printed structure, the medium was 
changed to neural induction medium (comprising DMEM/F12 supplemented with 1×N2 
supplement, 2 µg/mL heparin and 1×MEM non-essential amino acids solution (100x stock)) 
97 
on the 5th day after printing. Two weeks later, the medium was changed to a neuronal 
differentiation medium containing 2 parts DMEM/F-12: 1 part Neurobasal medium 
supplemented with 2% StemPro, 0.5% N2 and 50 ng/mL brain-derived neurotrophic factor 
(BDNF) for culture up to 3 weeks. Additionally, all the media for 3D printed constructs 
contained penicillin (100U/mL) and streptomycin (100 µg/mL) to prevent contamination. The 
culture medium was supplemented with five µM rock inhibitor Y27632 for the first three 
days of culture to improve the recovery of human iPSCs [5]. 
2.6 Physical characterization 
2.6.1 Mechanical measurement  
The indentation, compression modulus and consistency are crucial to ink printability. They 
were measured on an EZ-S mechanical tester (Shimadzu, Japan). Modulus was determined 
using both compression and indentation tests as previously described[6]. The hydrogel 
solutions were cast in custom-made molds (cylindrical, 10 mm ID, 4 mm in thickness). After 
crosslinking, the samples were placed on an EZ-S mechanical tester, then the 10 N load cell 
was used to compress the sample with a strain rate of 2 mm/min (Figure 2-12). The 
compression modulus (Ecomp) could be calculated from the strain-stress curve using 








Figure 2-12 Schematic diagram of the mechanical test using compression mode. 
During compression of the hydrogel the electrical value increased up to the point of the gel 
splitting. 
 
Indentation testing was performed using a flat stainless steel indenter (1 mm in diameter) 
with a 2 N load cell to indent the samples at a rate of 0.1 mm/min. The indentation modulus 
(Eind) can be calculated from the recorded force (F), indentation depth (d), indenter radius (a) 
and the reduced modulus (Er) (Figure 2-13). The derivation process is as below [7]: 
𝐹𝐹 = 2𝑎𝑎𝐸𝐸𝑟𝑟𝑎𝑎 
2-2 
Because Er can also be expressed by the indenter modulus (E1) and the substrate modulus (E2) 
[8],  
𝐸𝐸𝑟𝑟−1 = (1 − 𝑣𝑣12)𝐸𝐸1−1 + (1 − 𝑣𝑣22)𝐸𝐸2−1 
2-3 
where ν1 and ν2 are the Poisson’s ratios of the indenter and the substrate and the value of (1- 
ν22)E2-1 was insignificant when the steel indenter was much stiffer compared to the hydrogel 






Figure 2-13 Indentation mode for the hydrogel mechanical test. 
 
Bioink consistency was measured using previously described method [6, 9]. The scheme of 
the consistency test is shown in Figure 2-14. The gel was prepared without crosslinking and 
then loaded into the syringe and the plunger was connected to the upper clamp of the tester. 
The data was collected during extrusion of the ink.  
 
 
Figure 2-14 Ink consistency measurement 
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2.6.2 Scanning electron microscopy (SEM) 
In this study, there were two instruments used in the SEM tests: a JSM-7500FA LV Scanning 
Electron Microscope (JEOL Ltd, USA) and a JSM-6490 LV Scanning Electron Microscope 
(JEOL Ltd, USA). Prior to SEM imaging, the gels were fixed with 3.7% paraformaldehyde 
(PFA) for 30 min. Then gels were freeze-fractured by immersion in liquid nitrogen for 60 
seconds followed by fracturing using a cold razor blade. Fractured gels were examined with 
magnifications of 200, 500 and 1000× on a JSM-6490 LV Scanning Electron Microscope. To 
analyse the surface morphology, the gels were freeze-dried overnight. After depositing 20 nm 
gold coating to avoid charge accumulation, the morphology of the samples was examined 
using a field emission scanning electron microscope, JSM-7500FA LV Scanning Electron 
Microscope. 
2.6.3 Weight loss experiment 
This experiment was conducted to determine the change in weight over time. The samples 
were prepared as mentioned above and then vacuum freeze-dried overnight. The weight of 
the dried sample was determined as W0. The dried samples were soaked in a culture medium 
and incubated in a humid incubator at 37°C and 5% CO2 for two days. The weights of the 
dried samples in the determination process were repeated and determined (We). The weight 
loss (%) of hydrogels after the two day culture can be described according to the equation[10] 
below: 
𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊ℎ𝑡𝑡 𝑙𝑙𝐸𝐸𝑙𝑙𝑙𝑙 (%) = (𝑊𝑊0 −𝑊𝑊𝑒𝑒)/𝑊𝑊0 × 100 
2-5 
2.6.4 Hydrogel swelling ratio 
Swelling is one important property of the hydrogel which can be used for absorption[11]. For 
the swelling studies, the hydrogels were prepared in the same manner as would be used for 
cell printing. The initial hydrogel without crosslinking was weighed (Wi) and then 
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crosslinked. Monitoring of the time during crosslinking was initiated and there were three 
time points chosen for the tests: 15 min, 60 min, and 180 min, at which times the gels were 






2.6.5 Diffusion experiment 
Diffusion of solute into and out of the gels was characterized by using a similar method to 
that applied by Lozano R [12]. Three cylindrical hydrogels of 2 cm x 0.35 cm diameter were 
soaked in solutions containing fluorescently labelled bovine serum albumin (FITC-BSA, 
Sigma), then the uptake and release of the protein was calculated by collecting the solution 
and measuring the loss of solute over time (0, 0.5 h, 1 h, 2 h, 4 h, 6 h, 8 h, 10 h, 12 h, and 14 
h) until the equilibrium was reached. We determined the FITC-BSA concentration using a 
micro-plate reader (Fluostar Omega, BMG Labtech). Concentrations of BSA were calculated 
from a standard curve. The hydrogels were kept at a constant temperature of 37 ºC in a 
shaking water bath. The release was calculated after the gel reached equilibrium by soaking 
the gels in fresh PBS, and taking fluorescence measurements over time. Diffusion 
coefficients of FITC-BSA in the gels were calculated using a nonlinear regression method, 














Ct is concentration of BSA in the bath at time t (g/cm3) 
C∞ is concentration of BSA in the bath at equilibrium (g/cm3) 
α is K×(bath solution volume)/(gel solution volume) 
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K is the equilibrium partition coefficient, = 𝐶𝐶∞
𝑔𝑔𝑒𝑒𝑔𝑔/𝐶𝐶∞𝑏𝑏𝑏𝑏𝑡𝑡ℎ 
D is the diffusion coefficient of BSA in the gels (cm2/s) 
r is the radius of the gel cylinder (cm) 
qn is the positive, nonzero roots of the equation αqnJn(qn)+2J1(qn)=0, where the Jn are Bessel 
functions of nth order. 
2.7 Electrochemical characterization 
2.7.1 Cyclic voltammetry 
Cyclic voltammetry (CV) is a potentiodynamic electrochemical technique to probe the nature 
of electrochemical redox processes. An electrochemical cell with three electrodes consisting 
of a reference electrode, working electrode and counter electrode, was setup as shown in 
Figure 2-15. The baisc principle is that the redox reaction at the working electrode induces 
the current between the working and counter electrodes. The potential at the working 
electrode is applied by a potentiostat between an initial value and a final value (generally -
0.6V to +0.8V vs. reference electrode) at a fixed scan rate. The current at the working 
electrode was monitored and a plot of current versus the applied potential was recorded and 





Figure 2-15 Three electrode electrochemical cell for cyclic voltammetric measurement. 
 
2.7.2 Electrical stimulation 
Electrical stimulation was performed on custom-made Plexiglas chambers which were 
attached to the PPy-DBS films as the working electrode with non-toxic silicone adhesive 
(Flowable silicone sealer, ITW Permatx Inc, USA) and the counter electrode was the custom 
plastic cover with auxiliary platinum mesh (Figure 2-16). The device was immersed in 
distilled water overnight and then sterilized by immersion into 70% ethanol for 5 min 
followed by drying in the hood. The whole system used for stimulation is shown in Figure 
2-17. Digital Stimulator, DS8000 generated the biphasic waveform, and an A365 Isolator 
(World Precision Instruments) was used for the current control interfaced with the eDAQ 
system to record the signal. 
104 
 
Figure 2-16 Custom two electrode setup for stem cell stimulation. 
The module comprised a PPy coated gold working electrode and a platinum mesh counter 
electrode. 
 
Figure 2-17 The stimulation system components 
Cell chamber connected to an isolator and parameters for stimulating set using the stimulator. 
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2.8 Cell analyses 
2.8.1 Human NSC and human iPSC viability assay 
Viability assay could be used to display cell dispersion in the gels. Calcein AM is one cell 
permeant dye which reacts with intracellular esterases in the live cells to be converted into 
green-fluorescent calcein. Propidium iodide (PI) is a membrane impermeant dye which binds 
to the double stranded DNA. The samples were treated with calcein AM at 37 ºC for 10 min 
followed by PI for 1 min. The 3D constructs were mounted onto glass slides and a coverslip 
placed over the slide-mounted construct using glue. Finally, the slides were reversed and then 
observed on a confocal microscope (Leica TSC SP5 II). ImageJ can calculate the number of 
the live and dead cells. 
2.8.2 Cell proliferation analysis in the 3D printed gels 
PrestoBlue® is one resazurin-based cell viability test reagent, which is reduced to resorufin 
by NADPH, FADH, FMNH, NADH and cytochromes in viable cells and the reduction 
process will induce fluorescent forms [16]. In the current study, the samples were first 
incubated with the reagent, then the supernatant was collected into a 96-well plate and 
screened by a microplate reader (POLARstar Omega) to obtain the fluorescent intensity. The 
gels without cells were used as the blank control. 
2.8.3 Cell Immunophenotyping 
Cell immunophenotyping is one immunohistochemistry reaction for determination of protein 
expression. Samples were fixed using a 3.7 % paraformaldehyde (PFA; Fluka) solution in 
phosphate-buffered saline (PBS; pH 7.4). The samples were blocked and permeabilized 
overnight at 4 ºC with 5% (v/v) donkey serum in PBS containing 0.3% (v/v) Triton X-100. 
Constructs were incubated with conjugated antibodies (in the dark) or unconjugated primary 
antibodies at 4 ºC overnight. Constructs incubated with unconjugated primary antibodies 
were immersed in 0.1% Triton X-100 in PBS three times followed by incubation for one hour 
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at 37 ºC with an Alexa Fluor-conjugated secondary antibody. Staining was performed with 
DAPI at RT for 10 min followed by treatment with an antifade reagent. Then the constructs 
were mounted onto glass coverslips and imaged for qualitative analysis with a confocal 
microscope.  
2.8.4 Live cell calcium imaging 
Intracellular calcium signals generated by calcium ions regulate many cell functions such as 
muscle cell contraction and neurotransmitter-containing synaptic vesicles [17]. Calcium 
imaging is one important method for analyzing neuronal function/activity. In this study, Fluo-
4 was used to detect calcium flux. Constructs were incubated with Fluo-4 (2 µM) in a fresh 
culture medium for 30 min at 37 ºC, rinsed in Tyrode’s solution, and mounted on coverslips 
for the observation of spontaneous intracellular calcium release on a confocal microscope; 
ideally while immersed in Tyrode’s solution. Bicuculline, a GABA(A) receptor antagonist, 
was added to induce intracellular calcium release and the image was immediately acquired 
through a confocal microscope. Leica AF software can be used to quantify the signal 
intensity. 
2.8.5 Reverse transcription-quantitative PCR (RT-qPCR) 
RT-qPCR is used to detect and quantify the gene expression at the RNA level. It contains two 
steps: one is to reverse the mRNA into cDNA; the other is to quantify the cDNA. For RT-
qPCR, a trizol reagent was used to isolate the total RNA of the samples, with the purity of 
RNA defined by NanoDrop™. RNA is transcribed to cDNA with random primers in the 
RNAse-free system and qPCR was performed with a Gotaq 2-step RT-qPCR system 
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3 Bioink development for stem cell printing 
3.1 Introduction 
The strategy of encapsulating cells in biodegradable materials offers many advantages 
including ease of handling, mimicking the in vivo tissue-like environments and processability 
of delivering the materials into sites of interest [1]. High water-content hydrogels are widely 
used in this strategy [2]. A wide range of hydrogels have been used to encapsulate cells for 
3D bioprinting as described in Section 1.1. At present, alginate, chitosan, gelatin and 
hyaluronic acid (HA) etc. have been used for cell encapsulation culture [3]. To permit 
immediate seeding and uniform cell distribution, 3D printing technology is used in 
combination with hydrogels for cell patterning, which is known as bioprinting [4-6]. Another 
advantage of bioprinting is that this technology can pattern the “ink” in precise geometries. 
During processing of cell-hydrogel mixtures, the hydrogel must support cell viability while 
maintaining printable properties. Gelatin-methacrylamide (gelMA, a protein-based hydrogel 
modified from gelatin) has been used for 3D bioprinting of several cancer cell lines [7]. To 
improve the viscosity, HA and various other components can be added[8]. Importantly, a 
simple polymer cannot satisfy all the requirements for cell compatibility and printing. Also, a 
cell’s survival is dependent on attachment through adhesion sites. Although there has been 
considerable research relating to cell attachment under 2D conditions, there are few reports 
relating to 3D printable materials.  
Initial studies within this PhD relate to the use of a novel 3D polysaccharide-based bioink 
comprising alginate (Al), carboxymethyl-chitosan (CMC) and agarose (Ag) for printing and 
encapsulation of human stem cells. Al is a natural polysaccharide derived from brown algae 
and linear copolymers containing (1,4)-linked β-D-mannuronate (M) acid and α-L-guluronic 
acid (G) residues[9]. Only the G blocks of adjacent polymer chains are believed to be cross-
linked with multivalent cations (e.g., Ca2+ or Ba2+) through intermolecular actions with 
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carboxylic groups to form hydrogels[10]. So the combination of the polymers and variations 
in the solidifying time will determine the mechanical properties of the gel and then influence 
the cell growth. The Al property is suitable for the 3D bioprinting process. Chitosan is 
derived from the deacetylation of chitin and has been used in pharmaceutical and non-
pharmaceutical fields, but its limited solubility has been a hurdle to its applications[11, 12]. 
Carboxymethylation is one method which can improve its water solubility [13]. The 
carboxymethyl group was the biological group chosen because ester and hydrocarbon have 
been reported to play roles in stem cell growth [14, 15]. Agarose is also a polysaccharide 
derived from seaweed and is soluble in water when the temperature is above 65oC. Agarose 
gels are stable and do not swell until heated to 65oC [16]. So during the construction of 
scaffolds, it can supply support and be used widely for nucleic acid separation [17]. Previous 
reports have described the concentration of alginate used for 3D printing [18], therefore this 
chapter is focussed on the optimization of the Al concentration and CMC and Ag for 
bioprinting. 
3.2 Experimental 
3.2.1 Bioink synthesis 
The general process of developing bioink from Al-CMC-Ag was described in Section 2.3.1. 
Here, Al-CMC-Ag was prepared with different concentrations of Ag. Different 
concentrations of Ag solution (including 0.5, 1.5 or 2.5% w/v) in vials were prepared in 
phosphate-buffered saline (PBS; pH7.4) by heating in a microwave oven, with agitation every 
5 sec. This agitation was carried out 11-14 times for the 2.5% and 3-5 times and 5-8 times for 
the 0.5% and 1.5% respectively. When the agarose was completely dissolved, 5% (w/v) 
alginate was added into the agarose medium and stirred at 60°C for half an hour. Finally, 
CMC with different concentrations (w/v) were prepared in the above Al-Ag medium with a 
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magnetic stirrer at 60°C for an hour. Then the solutions were ready to be used for printing and 
mechanical testing. 
3.2.2 Consistency and mechanical measurement 
The experimental procedures have been described in detail in Sections 2.6.1. Briefly, 
compression and indentation tests can indicate the modulus of Al, Al-Ag and Al-CMC-Ag. 
Solutions were cast in custom-made moulds (cylindrical, 10 mm ID, 4 mm in thickness). 
After preparation of the samples, the Al-CMC-Ag solutions were loaded into a 1 mL syringe 
and measured on an EZ-S mechanical tester (Shimadzu, Japan) with a 10 N load cell at a 0.2 
mm s−1constant strain.  
For compression, there was no culture and each sample was mounted on an EZ-S mechanical 
tester. Then the 10 N load cell was used to compress the sample with a strain rate of 2 
mm/min. At least three different samples represented one group of the materials. The 
compression modulus (Ecomp) could be calculated from the strain-stress curve, Ecomp= 
F/(pi*r2). Here, r equalled 5 mm. 
Indentation tests were also performed on the EZ-S mechanical tester but a flat stainless-steel 
indenter (1 mm in diameter) with a 2 N load cell was used to indent the samples at a rate of 
0.1 mm/min. The indentation modulus (Eind) can be calculated from the recorded force (F), 
indentation depth (d) indenter radius (a) and the reduced modulus (Er). 
3.2.3 Integrity test 
The samples with different concentrations of the CMC were prepared in custom-made 
moulds (cylindrical, 10 mm ID, 4 mm in thickness). After a washing process, the samples 
were cultured in the medium without cells. Then, on the second day, the morphology of the 
hydrogel was observed on a Leica stereo-microscope. 
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3.2.4 Weight loss experiment 
The general method for this experiment has been described in Section 2.6.3. Here, the 
samples of Al-CMC-Ag with different CMC concentrations (0, 1.5%, 2.5%, 3.5% and 5%) 
were prepared as detailed in Section 3.2.1. The weight of the dried samples was determined 
as W0. The dried samples were soaked in a culture medium and incubated in a humid 
incubator at 37°C and 5% CO2 for 2 days. The weight of the dried samples determination was 
repeated and the mean value determined as We. The weight loss (%) of hydrogel can be 
calculated according to Equation 2-5. 
3.2.5 SEM of 3D samples 
General processes were described in Section 2.6.2. For surface porosity studies, samples were 
submerged in human NSC culture media for 24 hr, freeze-dried overnight using a Christ 
Alpha 2-4 LD Freeze Dryer, then coated with 20 nm gold using an Edwards sputter coater, 
and kept desiccated until analysed.  SEM was performed using a JSM-7500FA LV Scanning 
Electron Microscope. For studies of internal porosity with and without cells, samples were 
fixed with 3.7% paraformaldehyde (PFA, Fluka) for 30 min, immersed in liquid nitrogen for 
60 seconds, and then freeze-fractured using a cold razor blade. The fractured samples were 
immediately observed on the JSM-6490 LV Scanning Electron Microscope.  
3.2.6 3D encapsulation culture of human NSCs 
The Al-CMC-Ag materials with different CMC concentration were prepared as described in 
Section 3.2.1. 5x106 cells were suspended in 0.5 mL bioink and then crosslinked with 2% 
calcium for ten minutes followed by rinsing to reduce the high concentration of calcium as 
follows: 3 rinses with culture medium every minute after crosslinking, a fourth and fifth rinse 
with culture medium after 10 and 20 mins and a final rinse with culture media 60 mins after 
crosslinking. 2D culture of human NSCs has been described in Section 2.4.1. The same 
media employed for 2D and 3D human NSC culture.  
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3.2.7 Statistical Analyses 
Statistical analyses were performed in OriginPro 2015 (Version b9.2.272) using one-way 
analysis of variance (ANOVA) with Bonferroni multiple comparison post hoc test or two-
way ANOVA with Bonferroni post hoc test. Homogeneity of variance tests was performed to 
confirm that statistical assumptions were met for ANOVA.  Statistical significance was set at 
P < 0.05.  
3.3 Results and discussion 
3.3.1 Synthesis of Al-CMC-Ag 
In this study, Al, CMC and Ag were used for synthesizing bioink (Figure 3-1). Al is a 
polysaccharide derived from algae which can be crosslinked through exposure to divalent 
cations. Many studies have demonstrated the utilization of alginate for the entrapment of 
mammalian cells [10]. Recently, there have been reports that the mechanical stability and 
elastic modulus of alginate can be modified to support neural lineage survival and 
differentiation [19]. CMC is a derivation of chitosan. Without CMC, after culture, there were 
cracks on the surface of the hydrogel of Al and Al-Ag (Figure 3-2). The cracks were 
generated because air bubbles could not escape and there were also some factors from 
swelling. Ag concentrations were varied but the printing test with the lower and higher 
viscosities resulted in poorly defined scaffold structures at the same pressure, so 1.5 percent 
was chosen (Figure 3-3).  
 
 
Figure 3-1 The chemical structure of Al, CMC and Ag 
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Figure 3-2 The integrity of Al, Al-Ag and Al-CMC-Ag.  
The left panel represents the hydrogel immediately after crosslinking and the right panel 




Figure 3-3 Agarose could improve the printability of materials.  
Three concentrations of Ag (0.5%, 1.5% and 2.5%) were used for the 3D printing test. 
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3.3.2 CMC is used to improve human NSC viability 
Different concentrations of CMC were tested. The indentation experiment was used to test a 
localised part of the sample surface. Noticeably, a decrease in modulus was observed with the 
increase of CMC. But, there was no apparent difference between Al and Al-Ag samples. 
After 1-4 days culture in cell culture medium, all samples showed a sharp drop in modulus. 
Al-CMC (5%)-Ag demonstrated an obvious decrease in modulus compared with the other 
two Al-CMC-Ag samples from 4 days culture (Figure 3-4).  
Initial studies of human NSC survival and proliferation within the printed gel construct 
showed CMC content of the gel influenced human NSC viability, with 5% w/v associated 
with greater cell loading (indicated by area measurements of individual cells and cell 
aggregates) compared with lower concentrations (F (3, 580) = 22.77, P < 0.0001). 
Furthermore, there was a significant difference in the effect of CMC content with increasing 
days of culture (F (11, 580) = 13.82, P < 0.0001). Following 9 days culture of 5% w/v CMC-
gel constructs, Bonferroni post hoc analysis revealed that cell support was significantly 
greater than gel constructs with lower CMC content at any time during culture (P < 0.0001; 
Figure 3-5, Figure 3-6). However, support by gel constructs with 5% and 3.5% w/v CMC 
content at day 5 culture was greater than Al-Ag alone (ie. no CMC) at day 9 of culture (P < 
0.01 and P < 0.05 respectively; Figure 3-5, Figure 3-6). Whereas cell loading of 5% w/v 
CMC gel increased for the duration of culture (indicative of human NSC proliferation), 
loading decreased from the time of printing for gels with no or 2% w/v CMC, while 3.5% 
w/v CMC gel supported an initial increase up to day 5 with subsequent reduced cell loading 
apparent by day 9 post-printing (Figure 3-5, Figure 3-6). Area measurements of viable cells 
and aggregates in the gels comprised a wide range of values (manifested as large standard 
deviations, Levene’s Test (Absolute deviations), F (11, 580) = 7.59, P < 0.0001), indicative 
of a large range of human NSC aggregate sizes (Figure 3-6). Importantly, the population 
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variances were not significantly different according to Levene’s Test (Squared deviations; P 




Figure 3-4 Indentation modulus of Al, Al-Ag and Al-CMC-Ag. 
Al-CMC-Ag contained different concentrations of CMC. All the materials were maintained 
in cell culture medium for over 13 days. Data represents mean ± S.D.  
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Figure 3-5 Survival of printed human NSCs with different percent of CMC.  
Live (Calcein AM) and dead (Propidium iodide; PI) human NSC staining at specific time 
points following direct-printing in gels with different concentrations of CMC. Human NSCs 
are visible as single cells and aggregates of cells. 
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Figure 3-6 Comparative assessment of viable human NSC content of constructs. 
The constructs depicted in Figure 3-5 including single cells and aggregates of cells were 
measured by the area of Calcein AM staining within constructs. Mean ± S.D.; n = 3. Two-
way ANOVA with Bonferroni multiple comparison post hoc test. *P < 0.05 (3.5% w/v CMC 
day 5, vs Al-Ag day 9); **P < 0.01 (5% w/v CMC day 5, vs Al-Ag day 9); ***P < 0.0001 (5% 
w/v CMC day 9 vs all comparisons). 
 
3.3.3 Further characterization of Al-CMC-Ag 
After confirmation of the cell viability in Al-CMC-Ag, it is essential to define why the 5% 
CMC group had higher cell viability compared with the others. There was a small difference, 
where the modulus decreased when comparing Al-CMC-Ag with Al and Al-Ag (Figure 3-7). 
This could be due to the addition of the CMC. Furthermore, the weight loss experiment 
demonstrated that, 5% CMC led to the increased weight loss of hydrogel from 1.5% to 9% 
(Figure 3-8). To further define a suitable crosslinking for the new hydrogel Al-CMC-Ag, the 
compression modulus of the materials was tested for different periods of crosslinking on day 
0 and day 4 post cultures, which supported the choice of 10 min crosslinking (Figure 3-9). 
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The weight swelling ratio showed that the weight of Al-CMC-Ag attained equilibrium after 
3h of crosslinking when there would be 40% weight swelling (Figure 3-10), which differed 
from the swelling ratio of Alginate which could reach more than 200% [20].  
 
Figure 3-7  Compression measurements of Al, Al-Ag and Al-CMC-Ag. 
The samples were tested by compression and data represents mean ± S.D. with at least three 
repeats. 
 
Figure 3-8 Weight loss of different materials after one day degradation in PBS. 
a, b mean significant difference at P<0.05.  
122 
























Figure 3-9 The time course of indentation modulus of Al-CMC (5%)-Ag. 
Samples with different crosslinking time were tested at day 0 and day 4 after culture in the 
medium. Mean ± S.D.; n = 3. 
 
 
Figure 3-10 Swelling properties of Al-CMC-Ag. 




3.3.4 The mechanism of CMC (5%) improvement of cell viability 
To correspond with the weight loss experiments, gel porosity was examined in the absence of 
cells by low vacuum scanning electron microscopy (SEM), with freeze fracturing for internal 
analysis. Surface scanning of gels comprising different concentrations of CMC indicated 
variable porosity, with 5% and 3.5% w/v CMC associated with a highly and sparsely porous 
surface respectively, and 2% or less w/v CMC gels associated with negligible to no pores 
(Figure 3-11A). SEM of the gel interior revealed an assembly of polyhedral pores throughout 
regardless of CMC content, although a range of pore diameters was observed (Figure 3-11B). 
The alginate gel (Al) displayed a homogeneous porosity which progressed to closed (isolated) 
porosity as agarose was added to the alginate (Al-Ag); the internal structure (porosity) was 
changed by increasing pores sizes, as observed. On initial addition of CMC, Al-CMC(0.5%)-
Ag and Al-CMC(2%)-Ag, no effect on the porous structure was observed. However, as 
higher concentrations of CMC were added, such as Al-CMC(3.5%)-Ag and Al-CMC(5%)-Ag, 
an immediate effect on the internal structures was observed; it seemed to have resulted in a 
wider pore size distribution together with the appearance of more connected, tunnel-like 
structures, which has been related to better gas, liquid and nutrients accessibility to cells [21]. 
Therefore, gels with 5% and 3.5 % w/v CMC comprised a network of larger and smaller 
sized pores, with the smaller pores often connecting the larger pores. In contrast, gels with 2% 
or less w/v CMC principally comprised larger pores, with relatively few small pores. A 
possible model was presented for the Al-CMC-Ag (Figure 3-12). During culture, CMC could 
be deposited into the medium and the nutrients and oxygen could enter the structure while the 
whole scaffold was completely retained. 
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Figure 3-11 Characterization of porosity of gels. 
A) SEM showing surface porosity of gels with different concentrations of CMC. B) SEM 
showing internal porosity of gels with different concentrations of CMC. 
 
 
Figure 3-12 A model diagram showing the Al-CMC(5%)-Ag structure during culture. 
The figure indicates some of the CMC dispersed into the culture medium and some remained 
in the structure during culture. 
 
3.4  Conclusion 
In conclusion, optimizations of the concentration of agarose and carboxymethyl chitosan 
were carried out to produce printable and bioactive bioink. The mechanical properties were 
evaluated and the best combination was 5% alginate with 5% carboxymethlychitosan and 1.5% 
agarose. The use of CMC improved cell viability and distribution. The proposed mechanism 
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was that some part of the CMC dispersed into the medium during culture, which could then 
contribute to freedom of transport of the nutrients and waste. Further work in this thesis will 
detail the diffusion property of the material and its application in the 3D printing of human 
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4 Functional 3D neural mini-tissues from printed gel-based bioink and 
human NSCs 
4.1 Introduction 
3D bioprinting to generate functional tissues has been made possible by recent advances in 
printing technology, materials science and stem cell science. Also known as additive 
biofabrication, 3D bioprinting has provided a paradigm shift in in vitro tissue engineering, as 
a potential remedy to limited supply of functional tissues for modelling development and 
disease, and transplantation therapy[1]. Bioprinting enables specification of extracellular 
features and cell organisation for increased control of 3D tissue fabrication. Compared with 
traditional 2D methods of cell culture in monolayers, 3D printed cultures better recapitulate 
the natural cell environment and cell-cell interaction for more authentic, reliable and 
clinically relevant tissue generation. Key features of a printed construct include porosity for 
diffusion of oxygen and nutrients, and correct mechanochemistry of component biomaterials 
to promote cell adhesion, survival, networking and function [2].   
Strategies for additive tissue fabrication include printing of biomaterial scaffolds that are 
seeded with cells following printing [3], or concomitant (co-) printing of biomaterials and 
cells resulting in encapsulated cell constructs[3-9]. The strategy of co-printing offers many 
advantages including immediate integration of cells with printed biomaterials, more rapid 
production of a construct, and more authentic simulation of the in vivo tissue environment 
whereby cells are completely surrounded by and in direct contact with extracellular 
components and other cells. These features serve to provide a simpler, more automated and 
defined approach to biomaterial-cell interfacing for reproducible, robust and germane 
construct development.   
Here we report a well-defined and reproducible method for making a novel 3D neural mini-
tissue construct (nMTC) by microextrusion bioprinting frontal cortical human NSCs with a 
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supporting bioink followed by in situ differentiation to functional neurons and supporting 
neuroglia. The bioink comprises polysaccharides Al, CMC and Ag, which form a gel by 
chemical crosslinking following extrusion with human NSC encapsulation. Al and Ag 
provide structural support for the construct, with Al enabling gelation in the presence of 
cations after printing and Ag conferring suitable bioink viscosity during printing prior to 
gelation. CMC is a water-soluble derivative of chitosan and conducive to cell survival within 
the construct. Human NSCs can be maintained as self-renewing cells following printing, 
continuing to proliferate in situ for approximately 10 days. Differentiation of human NSCs 
principally results in GABAergic neurons, together with glial cells expressing astrocyte and 
oligodendrocyte lineage markers. Importantly, neurons are spontaneously active and show a 
bicuculline-induced increased calcium response, indicative of the presence of receptors for 
GABA and therefore GABA responsive neurons, and consistent with the occurrence of 
aforesaid GABAergic neurons. Finally, the method will enable interrogation of neural 
development, function and disease and may be adaptable for generating other neuronal and 
non-neuronal MTCs in vitro. Moreover, the MTCs have the potential to be used to develop 
larger macro-tissue constructs by either “rational design”, “autonomous assembly” or both[1]. 
4.2 Experimental 
4.2.1 Human NSC culture and differentiation 
2D culture methods have been described in Section 2.4.1. For 3D human NSC culture and 
differentiation, the same media employed for 2D culture and differentiation were used, 
however, washing of printed constructs was performed immediately after printing and 
gelation (see Bioprinting below). Washing was performed by rinsing constructs for 1 min 
three times in 37oC culture medium followed by two 10 min washes and 1 h incubation in 
media before ongoing culture with 100 U/mL penicillin and 100 µg/mL streptomycin (Life 
Technologies) under 5% CO2 at 37°C.  
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Cells used in this study are approved for use by the University of Wollongong’s Human 
Research Ethics Committee (HE14/049), and regularly tested and maintained mycoplasma 
free.  
4.2.2 Bioink preparation  
The detailed information of bioink synthesis has been described in the Section 2.3.1. Here, 
we used the optimal material which was described in the Section 3. The 1.5% w/v of Ag 
solution was prepared in PBS; by heating in a microwave oven, with agitation every 5 sec. Al 
was added to give 5% w/v and stirred at 60 °C for 30 min. Finally, CMC was added to give 
3.5 or 5% w/v and stirred at 60 °C for 1 h. The final solutions were subsequently cooled to 
RT, in readiness for combining with human NSCs and direct-write printing.  
4.2.3 Bioprinting for human NSCs 
Samples were extrusion printed into a cubic construct (10mm x 10mm x 10mm) using a 3D-
Bioplotter® System (EnvisionTEC GmbH). hNSC-laden bioink samples comprised 5x106 
cells suspended in 0.5 mL bioink. Samples were loaded into a 55cc barrel (Nordson Australia 
Pty Ltd), centrifuged at 1000rpm and 15 oC for 1 min to remove air bubbles, placed in the 
printing magazine, and fitted with a 200 µm printing nozzle (Nordson Australia Pty Ltd). 
Blender™ open source software was employed to design the scaffold and translated into 
numerical code for printing onto autoclaved glass slides at 15 oC. The applied pressure for 
optimal bioink was 1.5-2.0 bar. Following printing, scaffolds were immersed in 2% w/v 
calcium chloride for 10 min for crosslinking[10].  
4.2.4 Mechanical measurement of bioink 
Variations of bioink in extrusion force were measured during sample deposition in real-time. 
Samples were loaded into a syringe with the plunger coupled to the upper clamp of an EZ-S 
mechanical tester (Shimadzu). Measurements were performed in compression mode using a 
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10 N load cell, with a constant strain applied at 0.2 mm s-1, and recording the force over time. 
Distilled water was used as a control.   
Indentation modulus (EInd) was also evaluated using an EZ-S mechanical tester but a flat 
stainless-steel indenter (1 mm in diameter) with a 2 N load cell was used to indent the 
samples at a rate of 0.1 mm/min. Again, three different samples were tested at a minimum of 
four different locations per sample.   
4.2.5 Diffusion studies 
Diffusion of solute into the gels was measured similarly to the previously described method 
[8, 11] as detailed described in Section 2.6.5. Briefly, three cylindrical hydrogels (n=3) of 2 
cm x 0.35 cm diameter were immersed in PBS containing fluorescently labelled bovine 
serum albumin (FITC-BSA, 250 µg/mL, Sigma) and maintained at a constant temperature of 
37 ºC in a shaking water bath. Protein uptake was determined by sampling the solution and 
measuring the loss of protein over time until it reached equilibrium using a micro-plate reader 
(Fluostar Omega, BMG Labtech). Concentrations of BSA were calculated from a standard 
curve. Diffusion coefficients of FITC-BSA in the gels were calculated using a nonlinear 
regression method and modelled using the finite element method (COMSOL 4.2)[11-13].  
4.2.6 Live/Dead human NSC analysis 
Calcein AM (5 μg/mL) and propidium iodide (PI, 5 μg/mL) were used to identify live and 
dead cells respectively, according to Section 2.8.1. Briefly, hNSC-laden constructs were 
incubated with Calcein AM at 37 oC for 10 min, followed by a media change, incubation with 
PI for 1 min, and a further media change. A confocal microscope (Leica TSC SP5 II) was 
used for image acquisition, with images from a minimum of five optical planes per construct 
merged (to capture the maximal projection of whole cell aggregates) for analysis using Fiji 
(Image J) software. Three independent samples were evaluated for each gel composition. 
Depth coding of cells shown in Figure 4-1 was performed using the 3D Projection Tool in 
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Leica Application Suite X (LAS X) software (Leica). 
 
 
Figure 4-1 The distribution and the thickness measurement of the printed human NSC 
constructs. 
Assessment by confocal microscopy of human NSCs  encapsulated within an optimal 5% w/v 
Al, 5% w/v CMC and 1.5% Ag gel construct at day 7 after printing, with the left panel 
depicting the centre (star) and edge of a construct at a single optical plane, middle panel 
showing the mid-region of a construct at a single optical plane, and right panel showing depth 
coding of cells along the Z-axis (0 – 369 µm; ie. different colours represent different planes 
along the Z-axis). 
 
4.2.7 Human NSC proliferation analysis 
PrestoBlue™ cell viability reagent was used for human NSC proliferation studies, according 
to the manufacturer’s instructions. Briefly, at each time point measured, three hNSC-laden 
constructs were incubated with the reagent in culture medium for 1 hr at 37 oC. Following 
incubation, for each sample, 100 µl supernatant was transferred to a well of a 96-well plate 
and screened by a microplate reader (POLARstar Omega) to read fluorescence intensity. 
After processing, constructs were rinsed in culture medium and returned to culture, with the 
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process repeated for each time point until the study was completed.   
4.2.8 Immunocytochemistry 
The general method has been described in Section 2.8.3. Particularly, samples were fixed 
with 3.7 % PFA solution in PBS at RT for 30 min, rinsed in PBS, and then blocked and 
permeabilized overnight at 37 oC with 5% (v/v) donkey serum in PBS containing 0.3% (v/v) 
Triton X-100 (Sigma). Samples were subsequently incubated with fluorescence conjugated 
antibodies GFAP (mouse, 1:100; Cell signalling), SOX2 (rabbit, 1:100; Cell signalling), 
vimentin (rabbit, 1:200; Cell signalling), OLIGO2 (mouse, 1:100; Millipore), KI67 (mouse, 
1:200; Invitrogen), TUJ1 (mouse, 1:100; Abcam) and nestin (mouse, 1:100; Invitrogen), or 
unconjugated primary antibodies synaptophysin (rabbit, 1:200; Millipore), GABA (rabbit, 
1:200; Sigma) and GAD (rabbit, 1:500; Millipore) at 4°C overnight.  On the second day, 
samples were rinsed with 0.1% Triton X-100 in PBS three times, and samples with 
unconjugated primary antibody were incubated with Alexa Fluor tagged secondary antibody 
(1:1000; Invitrogen) for 1 hr at 37 °C. Nuclei were visualised with 4',6-diamidino-2-
phenylindole (DAPI, 10 μg/mL) at RT for 10 min and antifade reagent (Invitrogen) was 
employed to preserve the fluorescence signal. Samples were mounted onto glass coverslips 
using Aquamount (ThermoScientific) and imaged on a confocal microscope  (Leica TSC SP5 
II). Images were collected and analysed using Leica Application Suite AF (LAS AF) software 
(Leica).  
4.2.9 RT-qPCR of 2D and 3D samples 
The general method of RT-qPCR has been described in Section 2.8.5. Particularly, gel-
encapsulated cells were extracted for subsequent RNA isolation by treatment with 0.05 M 
EDTA for 10 min to dissolve the gel [14]. After treatment, samples were centrifuged at 600 g 
for 5 min to collect the cells. For primer sequences, see Table 4-1. 
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Table 4-1 Primers used for RT-qPCR in NSC printing 
Name Forward Reverse Length (bp)  
Tuj1 ACACAGGCGTCCACAGTT GTTCCAGGTCCACCAGAATG 167 
 
GFAP ATCAACTCACCGCCAACA CTTCATCTGCTTCCTGTCTATA 153 
 
Oligo2 TTGCTCCTCTTCCTCCTT GGCTTCCAACTAACTTGTG 129 
 
SYP TTGCCTTCCTCTACTCCAT GCCATCTTCACATCTGACA 172  
GABA GTCCAGGTCTGTCTGACTGTCTT CTTCACTTCGGTTACACGCTCTC 197 
 
NKX2.1 CCTTGCTATACGGTCGGA GTGGATGGTGGTCTGTGT 103 
 
MYST GATAGCACCTGGCATTCTG GCATCCTTCACTGTCTTGG 155  
DAT ATCGTGCTGCTCTACTTC CTCTGATGCCGTCTATGG 145 
 
vGLT ATCTCCTTCCTGGTCCTA CGAGTCTTGTGCTTAGTC 182  
SERT CTCCGAGGACAACATCAC CTTGCCAGAGGTCTTGAC 199 
 
PET-1 CGTCTTCTCCTCCTTGTC GGATCTGGCAGGTACATG 177  
β-Actin AGGCATCCTCACCCTGAAGTA CACACGCAGCTCATTGTAGA 103 
 
 
4.2.10 Calcium imaging 
For calcium imaging, the general method has been described in Section 2.8.4. Here, 3D 
samples were loaded with 2 µM Fluo-4 in fresh culture medium, incubated for 30 min at 37 
oC, and washed with Tyrode’s solution (5 mM KCl, 129mM NaCl, 2mM CaCl2, 1mM 
MgCl2, 30mM D-Glucose and 25 mM HEPES, Ph 7.4) [15]. Samples were mounted on 
coverslips and imaging was performed at RT on a confocal microscope (Leica TSC SP5 II). 
LAS AF Lite software (Leica) was used to collect and quantify time-lapse excitation ratio 
images. GABA(A) receptor antagonist bicuculline (50 µM; Sigma) was added into Tyrode’s 
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solution for 3 min to induce intracellular calcium. Depth coding of cells was performed using 
the 3D Projection Tool in LAS AF software (Leica). 
4.2.11 Statistical analyses 
Statistical analyses were performed in OriginPro 2015 (Version b9.2.272) using one-way 
analysis of variance (ANOVA) with Bonferroni multiple comparison post hoc test or two-
way ANOVA with Bonferroni post hoc test. Homogeneity of variance tests were performed 
to confirm that statistical assumptions were met for ANOVA.  Statistical significance was set 
at P < 0.05.  
4.3 Results and discussion 
4.3.1 Printable properties of Al-CMC-Ag gel 
To generate hNSC-laden gel constructs, an optimal printable bioink of 5% weight per volume 
(w/v) Al, 5% w/v CMC and 1.5% w/v Ag (Al-CMC-Ag) was developed, as described in 
Chapter 3. To further support the results, specification of the properties of the gels was 
attempted. Printability of the optimal bioink was supported by its uniform consistency, with 
minimal fluctuations in extrusion force (around 8.5 N) required for printing and indicative of 
homogeneity within the solution (Figure 4-2). As expected, lower viscosity water, as control, 
showed a similarly constant but lower magnitude (around 2 N) extrusion force profile 
(Figure 4-2). Ink gelation following ionic-crosslinking resulted in an initial compression 
modulus (EComp) of around 7.5 kilopascals (kPa), with an indentation modulus (EInd) of 
around 4.75 kPa. While subsequent temporal analysis of EInd indicated decreasing stiffness of 




Figure 4-2 Consistency/homogeneity of the bioink.  
The bioink Al-CMC-Ag (green line) consistency/homogeneity is demonstrated by the 
extrusion force required for printing. Water control (blue line) was employed for comparison. 
 
 
Figure 4-3 Indentation modulus (EInd; blue bars) of Al-CMC-Ag over time. 
The data are shown as (mean ± S.D.; n = 3) and % modulus (green dots) remained at a 
specified time point relative to the initial modulus at day 0 (EInd0). 
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4.3.2 BSA diffusion in Al-CMC-Ag gels 
Intrinsic gel permeability was studied by measuring the uptake of bovine serum albumin 
(BSA) by 5% and 3.5% w/v CMC gels and applying a non-steady state diffusion model[11]. 
For both gels, BSA uptake reached equilibrium by 8 h (Figure 4-4A), also shown by finite 
element modelling (COMSOL; Figure 4-5). The diffusion coefficients were 6.56 x 10-7 and 
5.56 x 10-7 cm2/s for 5% and 3.5% w/v CMC gels respectively. The subsequent release 
appeared to be slower than the uptake (Figure 4-4B); these results indicated that nutrients, 
growth factor and cellular wastes can move in and out of the gels. Confocal microscopy 
imaging of FITC-BSA was performed at a single optical plane that was distant from the point 
of delivery, demonstrating diffusion throughout the 5% w/v CMC gels (Figure 4-6). The 
image-based analysis confirmed the rate of uptake and diffusion of BSA throughout the gel 
(Figure 4-7). The quantitative data show increasing fluorescence intensity from the point of 



















































































Figure 4-4 Diffusion of FITC-BSA from solution into and out of gels. 
 A) Uptake by diffusion of FITC-BSA from immersion solution into 5% and 3.5% w/v CMC 
gels. Diffusion of BSA from solution into submerged gels is indicated by decreasing 
measures of fluorescence in solution (data for a specific time point normalised against data 
for initial time point; Ct/C0). B) Release by diffusion of FITC-BSA from 5% and 3.5% w/v 
CMC gels into the bath solution, which is indicated by increasing measures of fluorescence in 
the bath solution.  
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Alg-CMC (3.5%)-Ag 
          
Alg-CMC (5%)-Ag 
          
Figure 4-5 Finite element model of BSA diffusion into Al-CMC-Ag containing 5% and 3.5% 
w/v CMC.  
The model was simulated using COMSOL Multiphysics 5.0: 2D axisymmetric; 2 domains: 
gel (small/inset rectangle) and solution (large/enclosing rectangle). 
142 
 
Figure 4-6 Schematic of set up for temporal analysis of FITC-BSA diffusion through Al-
CMC-Ag gel.  
FITC-BSA diffused from the top of the gel with 4mm thickness and imaged every 5 mintutes. 
 
Figure 4-7 Assessment by confocal microscopy of FITC-BSA diffusion through optimal 5% 
w/v CMC gel. 
The time course (0, 2h, 4h, 6h after loading FITC-BSA) of the fluorescent intensity at the 
bottom of the gel. 
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Figure 4-8 Fluorescence intensity. 
Photomicrographs and quantitative data show increasing fluorescence intensity at a single 
optical plane and distant from the point of delivery, supporting diffusion throughout the gel. 
 
4.3.3 Bioprinting human NSC-laden Al-CMC-Ag gel constructs 
Figure 4-9 illustrates the main processes of human NSC printing and in situ differentiation. 
Simply, the bioink without cells was first prepared from 5% w/v Al, 5% w/v CMC and 1.5% 
w/v Ag. The human NSCs were then mixed together with the hydrogels followed by direct 
printing on the 3D printer. There were two culture systems utilized, for self-renewal and 
differentiation respectively. Homogeneity was also reflected by uniform human NSC 
distribution and viability throughout the construct immediately following printing (Figure 
4-10). Confocal microscopy revealed persistent homogenous live cell distribution throughout 
the constructs, with human NSCs visible as single cells on day 1 following printing, and 
aggregates of cells increasingly apparent thereafter (day 3 – day 11) (Figure 4-11). Further 
growth profiling of viable and dead cells over time within the gels demonstrated relatively 
144 
high (around 25%) cell death immediately after printing (day 0), with the proportion of dead 
human NSCs  subsequently decreasing (F (7, 30) = 14.10, P < 0.0001) to being statistically 
significant on day 4 post-printing (P < 0.001), continuing to around 8% by day 6 (Figure 
4-12). Live cell analysis supported cell proliferation (F (9, 20) = 146.62, P < 0.0001), 
reaching significantly different results on day 5 compared with day 1 after printing (P < 




Figure 4-9 Schematic illustrating the major stages of the method for direct-write printing 
human NSCs with bioink for 3D culture and differentiation. 
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Figure 4-10 Printed hNSC-laden Al-CMC-Ag bioink.  
Left) Printed gel scaffold comprising 5% w/v Al, 5% w/v CMC and 1.5% w/v Ag. Right) 
Live (Calcein AM) and dead (propidium iodide; PI) human NSC staining within printed Al-
CMC-Ag gel scaffold. 
 
 
Figure 4-11 Printed human NSCs within the Al-CMC-Ag gel construct showing 
grid/scaffold structure at specific time points.  
Human NSCs  are initially visible as single cells immediately following printing (day 1), with 
aggregates of cells increasingly apparent over time (day 3 – day 11). 
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Figure 4-12 Dead cell content versus time post printing. 
Time course of dead human NSC content of Al-CMC-Ag gel from day 0 to day 7 after 
printing (mean ± S.D.; n = 3). One-way ANOVA with Bonferroni post hoc test. * P < 0.001 
(day 4 vs day 0).  
 


























Figure 4-13 Cell proliferation in printed hydrogel. 
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Time course of live (PrestoBlue™ cell viability indicator) human NSC content of optimal 5% 
w/v CMC gel from day 1 to day 19 after printing (mean ± S.D.; n = 3). One-way ANOVA 
with Bonferroni post hoc test. * P < 0.0001 (day 5 vs day 1). 
 
4.3.4 Characterization of encapsulated human NSCs  
Immunophenotyping at three weeks post-printing demonstrated human NSCs expressed 
undifferentiated cell markers SOX2 (Figure 4-14A, C), vimentin (Figure 4-14A, D) and 
nestin (Figure 4-14B), as well as the nuclear proliferation marker KI67 (Figure 4-14B). 
Negligible levels of the differentiation and neuronal-specific cytoskeleton protein TUJ1 
(Figure 4-14C), astrocyte marker glial fibrillary acidic protein (GFAP) and oligodendrocyte 
lineage transcription factor 2 (OLIGO2) were expressed (Figure 4-14D).  
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Figure 4-14 Immunophenotyping of human NSCs encapsulated within an Al-CMC-Ag gel 
construct 3 weeks after printing. 
A) Human NSCs stained with DAPI colocalised with SOX2, and expressed vimentin. B) 
Cells also expressed nuclear proliferation marker KI67 and human NSC marker nestin. C) 
Human NSCs expressed negligible levels of differentiated neuron marker TUJ1. D) Human 
NSCs expressed negligible levels of differentiated astrocyte and oligodendroglial lineage 
markers GFAP and OLIGO2 respectively. 
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4.3.5 Characterisation of in situ differentiated human NSCs  
Based on human NSC growth profiling consideration was given to exploring in situ 
differentiation by inducing human NSCs to functional neurons and neuroglia 10 days post-
printing. Immunophenotyping 2 weeks after initiating differentiation revealed neurons had 
expressed TUJ1 (Figure 4-15A), GABAergic markers GABA and glutamic acid 
decarboxylase (GAD) (Figure 4-15B), with concomitant low SOX2 expression (Figure 
4-15A). OLIGO2 and GFAP expression were mutually exclusive (Figure 4-15C), and 
presynaptic vesicle glycoprotein synaptophysin was apparent as small puncta often adjacent 
to cell bodies (Figure 4-15D). In addition, immunolabelling of TUJ1 3 weeks after 
differentiation confirmed persistent cell viability within constructs, with neuronal cell clusters 
interconnected by neurites (Figure 4-15E). 
Gene expression analysis by reverse-transcription quantitative PCR (RT-qPCR) corroborated 
immunophenotyping by showing upregulation of pan-neuronal and neuroglial markers along 
with neuronal sub-type specific markers under differentiation conditions (Figure 4-16).  RT-
qPCR also included comparison between 3D and conventional planar human NSC culture 
and differentiation, with 3D differentiation predominantly associated with higher transcript 
levels for neuronal and neuroglial markers compared with 2D differentiation (Figure 4-16). 
Specifically, in situ 3D differentiation induced a higher expression of TUJ1 (F (3, 4) = 
1380.21), GFAP (F (3, 4) = 55171.42), OLIGO2 (F (3, 4) = 1667.92) and synaptophysin (F (3, 
4) = 315.75) mRNA compared with undifferentiated 3D human NSC constructs, and 
conventional 2D culture and differentiation (Figure 4-16). Interestingly, GFAP expression 
was markedly increased. Also, 3D gel-based differentiation accelerated upregulation of 
GABAergic neuronal marker GABA (F (3, 4) = 1239.48), and to a lesser extent other 
GABAergic markers NKX2.1 (F (3, 4) = 69.52) and MYST (F (3, 4) = 2172.40), as well as 
transcripts relevant to other neuronal subtypes included, vesicular glutamate transporter 
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(VGLT; F (3, 4) = 769.13), serotonin transporter (SRT; F (3, 4) = 315.75) and serotonin 
neuronal maker PET1 (F (3, 4) = 11.66) (Figure 4-16). 
The next step was the investigation of functional maturation of in situ differentiated human 
NSCs by measuring spontaneous and bicuculline-induced calcium response of neurons.  
Neurons displayed spontaneous calcium spikes (Figure 4-17A), and recurrent bursting 
activity was induced through disinhibition of cells by application of bicuculline, a GABA(A) 
receptor antagonist (Figure 4-17B). 
A final assessment of neurons within the 3D construct was made by SEM, revealing cells 
with rounded soma and extensive neurite outgrowth (Figure 4-17C).  
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Figure 4-15 Immunophenotyping and gene expression of differentiated human NSCs 
encapsulated within an Al-CMC-Ag gel construct. 
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A) Cells (24 days post-printing, including 14 days differentiation) stained with DAPI and 
expressed neuronal marker TUJ1 with negligible levels of human NSC marker SOX2. B) 
Neurons expressing GABAergic neuron markers GABA and GAD. C) Gliogenesis within 
neural constructs supported by astrocyte and oligodendroglial lineage markers GFAP and 
OLIGO2 respectively. D) Synaptogenesis within neural constructs illustrated by presynaptic 
protein synaptophysin. E) Cells (31 days post-printing, including 21 days differentiation) 
stained with DAPI and expressed TUJ1, with cell clusters interconnected by neurites. The 
lower right panel shows depth coding of cells along the Z-axis (0 – 59 µm). 
 
 
Figure 4-16 Comparative gene expression between conventional 2D and printed 3D human 
NSC culture and differentiation. 
The culture duration was 3 weeks and differentiation duration was 5 days initial human NSC 
culture followed by 16 days of differentiation. Relative gene expression represents data 
normalized to β-actin and expressed relative to 2D human NSCs.  Mean ± S.D.; n = 3. One-




Figure 4-17 Functional maturation of in situ differentiated human NSCs in printed Al-CMC-
Ag construct. 
A) Time course of live calcium imaging of neurons within a 3D construct, with the lower left 
panel showing depth coding of cells along the Z-axis (0 – 169 µm; i.e. different colors 
represent different planes along the Z-axis), and average measurements of spontaneous 
activity for cells 1-3 of photomicrographs demonstrated by the corresponding plot. 
Arrowheads indicate active cells. B) Time course of live calcium imaging of neurons within a 
3D construct, with the middle right panel showing depth coding of cells along the Z-axis (0 – 
107 µm), and average measurements of bicuculline-induced calcium response for cells 1-2 of 
photomicrographs demonstrated by the corresponding plot. Arrowheads indicate active cells. 
C) SEM image showing a neuron inside a porous 3D construct, with an arrowhead and arrow 




3D extrusion bioprinting offers a versatile platform for fabricating human cell-based tissue 
constructs from novel clinically-relevant biomaterial-cell combinations. To date, several 
examples of cell printing have been described and include human dermal fibroblasts and 
umbilical vein endothelial cells (HUVECs) [16], hepatocarcinoma cells (HepG2)[4], adipose 
stem cells[5, 6], and mesenchymal stromal cells[6]. Non-human cell printing has included 
murine embryonic stem cells for in situ embryoid body formation[7], and primary murine 
cortical neurons and myoblasts[8, 9].  
Here we describe the first example of direct-write printing of hNSC-laden bioink to engineer 
a novel functional 3D nMTC. Co-printing of cells with the bioink provides an efficient, 
defined and simple approach to biomaterial-cell interfacing, with post-printing gelation 
resulting in cell encapsulation for in situ human NSC expansion and differentiation. The 3D 
tissues generated are amenable to characterisation for studying neural development and 
function, including understanding how microenvironmental features affect cell and tissue 
phenotypes, and has the potential to be adapted to other stem cell types for generating 
neuronal and non-neuronal tissues in vitro.  Importantly, the bioink comprises widely 
available, inexpensive and well characterised components Al, CMC and Ag that have been 
optimally combined to form a printable, clinically-compatible gel. The consistency of the 
bioink solution underpins its reliability for printing constructs anew and constructs that are 
homogenous for uniform cell supportability. This is reflected by demonstrated homogenous 
human NSC distribution and viability throughout the construct following printing. Studies of 
modulus after gelation quantitate the mechanical stiffness and therefore construct integrity 
necessary for post-printing maintenance and handling, and cell support.  Interestingly, the 
stiffness of the investigated gel is in the range of human brain tissue, with previous reports of 
in vivo stiffness ranging from 0.5 - 14 kPa [16-19]. While temporal studies of indentation 
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modulus suggest an initial rapid decrease in stiffness, the diminishing rate of reduction 
combined with human NSC survival, proliferation and differentiation support enduring 
biocompatibility with lower gel moduli.   
The mechanical properties of a gel, including the modulus and porosity of the matrix 
environment, affect cell behaviour such as proliferation and differentiation[20]. Thus, Al was 
initially chosen as the basis of the gel due to its recognised stability as a 3D structure, low 
toxicity, and cytocompatible gelation, whilst CMC sustained human NSC survival ostensibly 
by influencing gel porosity and permeability, and Ag provided requisite bioink viscosity for 
optimal Al-CMC printing. Other known properties conceivably beneficial to this approach 
include high moisture retention of CMC, and antimicrobial and low inflammatory responses 
of both Al and CMC, all features conducive to cell support and survival [21, 22]. Moreover, 
as a derivative of chitosan, CMC is deemed to have low to absent toxicity, no mutagenic 
effects, affects cellular expression of growth factors, and promotes cell adhesion, migration 
and proliferation [23, 24].  
Characterisation of cells within this system supports human NSC self-renewal for several 
weeks following printing and therefore the ability to scale-up human NSC number in situ 
prior to differentiation.  Importantly, human NSCs  can be induced to functional neurons and 
supporting neuroglia, with gene expression analysis by RT-qPCR indicating differentiation of 
stem cells in the 3D constructs may be advantageous compared to conventional 2D platforms 
for accelerated neuronal, neuroglial and synapse formation. Interestingly, the highly 
expressed glial marker GFAP is consistent with its key role in central nervous system (CNS) 
processes including astrocyte-neuron interactions as well as cell-cell communication, with the 
latter extending to astrocyte mediated synapse formation and function [25-27]. The system 
may also bias neuronal differentiation to GABAergic lineage, making it attractive for 
inhibitory neuronal and tissue modelling. Notwithstanding, the occurrence of other neuronal 
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subtypes including glutamatergic and serotonergic, indicate the potential for more expansive 
modelling, with the possibility of enriching subtype neuronal expression through, for 
example, cytokine supplementation [28]. 
Finally, calcium imaging of functioning neurons within the 3D construct together with SEM 
imaging of neurons and neurites with complex 3D morphologies demonstrate platform utility 
for modelling human neural cell form and activity, and fabricating functional 3D human 
neural tissue. As such, the platform is amenable to translational drug-screening in vitro, 
studying human neurodevelopment and disease, and possibly neural tissue engineering for 
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Chapter 5  
3D Bioprinting human iPSC Constructs 
for in situ Cell Proliferation and 
Successive Multi-lineage Differentiation 
________________________________________________________ 
Most parts of this chapter present work that has appeared in the published article “3D 
bioprinting human induced pluripotent stem cell constructs for in situ cell proliferation and 
successive multilineage differentiation” by Gu, Q., Tomaskovic-Crook, E., Wallace, G.G., 
and Crook, J.M. (2016). Adv Healthc Mater 5, 1429-1438. (cover) 
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5 3D Bioprinting human iPSC constructs for in situ cell proliferation and 
successive multi-lineage differentiation 
5.1 Introduction 
Human iPSCs, like embryonic stem cells, have the ability to self-renew for large-scale 
expansion whilst maintaining the capacity to differentiate to all cell types (~200) of the 
human body [1-3]. These qualities together with the potential for autologous application 
make iPSCs compelling candidates for cell replacement therapies, tissue and organ 
engineering, and pharmacology and toxicology screening.  
Since their discovery a decade ago, the development of culture protocols for human iPSCs 
has primarily focused on clinical-compliance [4], cell line stability [5], and efficiency of 
differentiation to desired cell lineages [6], all the while retaining conventional monolayer 
culture. Recent interest in recapitulating the 3D cytoarchitecture of native tissues in vitro to 
better simulate cell behavior in vivo is driving the application of 3D configured biomaterials 
to further advance stem cell (including iPSC) research and therapy [7]. By mimicking 
important features of a target tissue including the extracellular microenvironment, a 3D-
biomaterial has the potential to instruct cell fate and function in a way not previously 
attainable with 2D culture [8]. Therefore, although still exploratory, it is envisioned that the 
synergism of stem-cell biology and 3D-biomaterial technology will be influential in iPSC-
based research and translation.  
Of the small number of 3D systems for iPSC culture reported to date, they all rely on the 
ability of iPSCs to self-organise by seeding onto or casting within supporting material such as 
conventional tumour-derived Matrigel® basement membrane preparation or more defined 
polymeric scaffolds [9-12]. An alternative, although previously untested, approach to 
bioengineering 3D iPSC constructs is to apply advanced 3D bioprinting for direct-write (or 
co-) printing of stem cells together with biomaterial to reproducibly generate tissue of a 
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desired architecture. 3D printing is one fast way to promote  future regenerative medicine[13]. 
Co-printing represents a single-step approach to rapidly fabricate a 3D cell-material construct 
whereby iPSCs are immediately integrated with biomaterials by encapsulation for direct and 
complete contact with extracellular elements that more closely mimic the native cell 
microenvironment.  
Here is described a body of work relating to iPSC printing following on from the PhD 
candidate’s previously published report of human neural stem cell (NSC) printing [14]. By 
utilizing the defined clinically-amenable polysaccharide-based bioink containing Al, CMC 
and Ag optimization has been achieved for extrusion printing of iPSCs (Figure 5-1A); able to 
be maintained as self-renewing stem cells within the printed construct, with cell proliferation 
enduring for at least 9 days post-printing (Figure 5-1B). Furthermore, stem cells can be 
differentiated in situ to self-assembling 3D cell aggregates called embryoid bodies with cells 
constituting all three primitive germ layers – mesoderm, ectoderm and endoderm (Figure 
5-1C). Finally, following transition of the printed iPSC constructs to neural 
induction/differentiation media, more homogeneous neural tissues can be generated with 
neurons and supporting neuroglia (Figure 5-1D). Neurons are active, form synapses, 
participate in network activity and show migratory behaviour within a construct.  
These findings affirm the efficacy of the PhD candidate’s previously described bioprinting 
platform for generating 3D tissues from human stem cells. Having now adapted the platform 
for iPSC printing and differentiation, its versatility has been verified for generating both 
neural and non-neural tissues including amenability to “notoriously difficult to culture” cell 
types such as human iPSCs [15, 16]. 
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Figure 5-1 Schematic of the method for extrusion printing of iPSCs for 3D culture and 
differentiation.  
A) Bioink is prepared by suspending iPSCs with clinically-amenable polysaccharides Al, 
CMC and Ag, followed by bioprinting and crosslinking for gelation. B) 3D iPSC-laden 
scaffolds are maintained in iPSC-culture medium for stem cell proliferation/self-renewal 
within the printed construct. C) iPSCs can be differentiated in situ to self-assembling 3D EBs 
comprising cells of all three primitive germ layers – mesoderm, ectoderm and endoderm, or 
D) more homogeneous neural tissues using neural induction/differentiation media. Neural 
constructs include functional neurons (including migrating) and supporting neuroglia. 
 
5.2 Experimental 
5.2.1 Human iPSC culture and differentiation 
General 2D human iPSC culture has been detailed in Section 2.4.2. For 3D human iPSC 
culture and differentiation, the same media were used as 2D culture and differentiation. For 
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EB and neural differentiation, the media were replaced with corresponding media on the 5th 
day after printing. For 3D iPSC differentiation to neural lineage, neural induction medium 
(comprising DMEM/F12 supplemented with 1×N2 supplement, 2 µg/mL heparin (H3149, 
Sigma) and 1×MEM NEAA) was applied on the 3rd day after printing, and then 2-3 weeks 
later, the medium was changed to neuronal differentiation medium containing 2 parts DMEM 
F-12 : 1 part neurobasal supplemented with 2% StemPro, 0.5 % N2 and 50 ng/mL brain-
derived neurotrophic factor (BDNF) for 3 weeks culture.  
5.2.2 Bioink preparation and bioprinting  
The bioink was prepared as previously described in section 2.3.1 [14]. Briefly, agarose was 
dissolved in PBS by heating in a microwave oven to give 1.5% (w/v), followed by addition of 
Al and CMC to give 5% (w/v). After 1 hr stirring at 60 °C, the final solution was cooled to 
RT and 4x107 iPSCs were added per 0.5 mL bioink.  
Bioprinting platform and items have been described in Section 2.5. Bioink samples were 
loaded into the barrel and centrifuged at 300 g at 15 oC for 1 min to remove air bubbles, 
followed by printing onto autoclaved glass slides. After printing, the scaffolds were immersed 
in 2% w/v calcium chloride for 10 min for crosslinking. After gelation, the constructs were 
rinsed three times in culture medium followed by 2 x 10 min washes and incubation in fresh 
culture medium for 1 h to remove excess calcium ions. 
5.2.3 SEM of printed 3D constructs for human iPSCs 
The general process SEM has been described in Section 2.6.2. For SEM of printed constructs, 
samples were submerged in human iPSC culture media for 24 hr, freeze dried overnight using 
a Christ Alpha 2-4 LD Freeze Dryer, then coated with 20 nm gold using an Edwards sputter 
coater, and kept desiccated until analysed. SEM was performed using a JSM-7500FA LV 
Scanning Electron Microscope. For studies of internal structure, samples were fixed with 3.7% 
paraformaldehyde (PFA, Fluka) for 30 min, immersed in liquid nitrogen for 60 seconds, and 
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then freeze-fractured using a cold razor blade. The fractured samples were immediately 
observed on the JSM-6490 LV Scanning Electron Microscope.  
5.2.4 Live/dead iPSC analysis 
The method has been described in section 2.8.1. Briefly, printed human iPSC constructs were 
incubated at 37 oC with Calcein AM for 10 min, followed by PI for 1 min. A Leica TSC SP5 
II confocal microscope was used for image acquisition, with images from a minimum of five 
optical planes per construct merged (to capture the maximal projection of whole cell 
aggregates) for analysis using Fiji (Image J) software. Three independent samples were 
evaluated for each gel composition. Depth coding of constructs was performed using the 3D 
Projection Tool in Leica Application Suite X (LAS X) software (Leica). 
5.2.5 Immunocytochemistry 
The general process of staining has been described in Section 2.8.3. Particularly, the 2D and 
3D human iPSC samples were fixed with 3.7 % PFA in PBS for 30 min at RT. Samples were 
then blocked and permeabilized overnight with 5% (v/v) donkey serum in PBS containing 0.3% 
(v/v) Triton X-100 (Sigma) at 4 °C. Samples were subsequently incubated with primary 
antibodies against OCT4 (mouse, 1:200, STEMCELL Technologies), SSEA4 (mouse, 1:200, 
STEMCELL Technologies), TRA-1-60 (mouse, 1:200, STEMCELL Technologies), PAX6 
(rabbit, 1:100, Sigma), nestin (mouse, 1:100; Invitrogen), synaptophysin (rabbit, 1:200; 
Millipore), TUJ1 (Chicken, 1:200, Millipore) and GABA (rabbit, 1:200; Sigma) or 
fluorescence conjugated antibodies GFAP (mouse, 1:100; Cell signalling), MAP2 (mouse, 
1:100, Millipore), SOX2 (rabbit, 1:100; Cell Signalling) at 4 °C overnight. On the second day, 
samples were rinsed with 0.1% Triton X-100 in PBS three times and samples with 
unconjugated primary antibody were incubated with Alexa Fluor tagged secondary antibody 
(1:1000; Invitrogen) for 1 hr at 37 °C. Nuclei were labelled with 4',6-diamidino-2-
phenylindole (DAPI, 10 μg/mL) at RT for 10 min and antifade reagent (Invitrogen) was 
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employed to preserve fluorescence signal. Samples were mounted onto glass coverslips using 
Aquamount (ThermoScientific) and imaged with a Leica TSC SP5 II confocal microscope. 
Images were collected and analysed using Leica Application Suite AF (LAS AF) software 
(Leica). 
5.2.6 Human iPSC proliferation analysis 
PrestoBlue™ cell viability reagent was used for iPSC proliferation studies, according to the 
Section 2.8.2. Briefly, at each time point measured, three cell-laden constructs were 
incubated with the reagent in culture medium for 1 hr at 37 oC. For each construct, 100 µl 
supernatant was transferred to a well of a 96-well plate and screened by a microplate reader 
(POLARstar Omega) to read fluorescence intensity. Constructs were subsequently rinsed in 
culture medium and returned to culture, with the process repeated for each time point until 
the study was completed.   
5.2.7 RT-qPCR of 2D and 3D samples 
General RT-qPCR process has been demonstrated in Section 2.8.5. For RNA isolation, 
conventional 2D cultured iPSCs, EBs and neural cells were treated with Trizol™ Reagent. 
3D gel-encapsulated cells were first treated with 0.05 M disodium EDTA for 10 min, fluxed 
with a pipette, followed by centrifugation at 600 g for 5 min. The left processes were similar 
with Section 2.8.5 and not described again. Primer sequence information is provided in Table 
5-1. 
Table 5-1 Primers used for RT-qPCR in iPSC printing 
Name Forward Reverse Length (bp)  
OCT4 CAATTTGCCAAGCTCCTGA CGTTTGGCTGAATACCTTCC 105  
SOX2 TGCTGCCTCTTTAAGACTAGGAC GCCGCCGATGATTGTTATTA 117  
NANOG TACCTCAGCCTCCAGCAGAT TGCGTCACACCATTGCTATT 146  
TDGF1 CTTCAGAGATGACAGCATTTGG CAGCAGGTTCTGTTTAGCTCCT 114  
169 
UTF1 CGCCGCTACAAGTTCCTTA ATGAGCTTCCGGATCTGCT 86  
H19 GCAAGAAGCGGGTCTGTTT GCTGGGTAGCACCATTTCTT 105  
HAND1 AAGCGGAAAAGGGAGCTG ACTCCAGCGCCCAGACTT 112  
NESTIN GCCCTGACCACTCCAGTTTA GGAGTCCTGGATTTCCTTCC 200  
PDX1 CCTTTCCCATGGATGAAGTC GGAACTCCTTCTCCAGCTCTA 145  
IGF2 CTGTTTCCGCAGCTGTGAC GGGGTATCTGGGGAAGTTGT 118  
TUJ1 ACACAGGCGTCCACAGTT GTTCCAGGTCCACCAGAATG 167 
 
GFAP ATCAACTCACCGCCAACA CTTCATCTGCTTCCTGTCTATA 153 
 







NKX2.1 CCTTGCTATACGGTCGGA GTGGATGGTGGTCTGTGT 103 
 
PET1 CGTCTTCTCCTCCTTGTC GGATCTGGCAGGTACATG 177  
β-Actin AGGCATCCTCACCCTGAAGTA CACACGCAGCTCATTGTAGA 103 
 
 
5.2.8 Flow cytometry 
3D samples were first extracted from the 3D structures described above. 2D and 3D cultured 
iPSCs were initially digested in 0.02% EDTA for 5 min and 10 min respectively, triturated, 
and passed through a 40 µm sieve to generate single cell preparations. After trituration, single 
cells were pelleted followed by centrifugation at 300 g for 5 min and fixed with 3.7% 
paraformaldehyde solution in PBS on ice for 10 min. After 2 washes in PBS/0.1% (v/v) 
Triton X-100, cells were resuspended in blocking buffer (5% Goat Serum plus 0.3% Triton-
x-100 in PBS) and placed on ice for 30 min. Cells were then incubated with primary 
antibodies for OCT4, SSEA4 and TRA-1-60 described above and SOX2 (rabbit, 1:200; 
STEMCELL Technologies), and diluted in wash buffer on ice for 30 min. Following a further 
2-3 washes, secondary antibodies conjugated with Alexa Fluor tagged secondary antibody 
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(1:1000; Invitrogen) and diluted in blocking buffer were applied for 30 min on ice in the dark. 
Cells were then washed again before being resuspended in 2% FBS/PBS and analysed by a 
BD Accuri C6 system (BD Biosciences). 
5.2.9 Calcium imaging 
The whole process has been detailed in Section 4.2.10. 
5.2.10 Statistical Analyses 
Statistical analyses were performed in OriginPro 2015 (Version b9.2.272) using one-way 
analysis of variance (ANOVA) with Bonferroni multiple comparison post hoc test or two-
way ANOVA with Bonferroni post hoc test. Homogeneity of variance tests were performed 
to confirm that statistical assumptions were met for ANOVA.  Statistical significance was set 
at P < 0.05.  
5.3 Results and discussion 
5.3.1 iPSC bioprinting, survival and in situ proliferation 
There was homogenous distribution of human iPSCs after 3D printing (Figure 5-2). 
Extrusion printing of optimal iPSC-laden bioink resulted in the generation of scaffolds 
containing uniformly distributed stem cells throughout (Figure 5-2A, B and D). Encapsulated 
cells were viable with negligible cell death apparent immediately after ink gelation by ionic-
crosslinking, persisting through extended culture in excess of 7 days (Figure 5-2). iPSCs 
showed characteristic pluripotent cell morphology, similar to embryonic stem cells (ESCs), 
being round in shape with large nuclei and sparse cytoplasm. During the course of 
maintaining constructs for stem cell expansion, single iPSCs proliferated to form aggregates 
of cells culminating in large spheroids by day 7. Spheroids could be clearly seen abutting the 
lumen of scaffolds and dispersed throughout the gel. The phenomenon of spheroid formation 
is consistent with colony formation during conventional 2D culture, but with spheroids 
reflecting well-defined clusters of tightly packed cells within a 3D system as compared to 
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classical sharp-edged, flat, tightly packed colonies.[16] iPSC-growth profiling showed cell 
proliferation increased from the time of printing and peaking at day 9 (Figure 5-3). 
 
 
Figure 5-2 Printed human iPSCs pattern in the hydrogels. 
Live (Calcein AM) and dead (Propidium iodide; PI) iPSC staining within a printed construct 
at days 1, 3 and 7 post-printing. Initially encapsulated iPSCs are visible as evenly distributed 
single cells, with aggregates of cells increasingly apparent over time. By day 7 cell 
aggregates appear as large spheroids, abutting the lumen of scaffolds, though dispersed 
throughout the gel. 
 
 
Figure 5-3 Cell proliferation in the printed hydrogels. 
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Time course of live (PrestoBlue cell viability indicator) iPSC content of gel constructs up to 
day 11 after printing (mean ± S.D.; n = 3). One-way ANOVA with Bonferroni post hoc test. 
*P < 0.0001 (day 7 vs day 1). 
 
5.3.2 Pluripotency of human iPSCs in 3D printed constructs 
Different methods were used to determine the pluripotency of human iPSCs in the 3D gels. 
Flow cytometry of iPSCs extracted from printed constructs after 10 days culture revealed 
ubiquitous expression of pluripotency cell markers OCT4, SOX2, TRA-1-60 and SSEA4, 
consistent with a persistent pluripotent stem cell state (Figure 5-4A) compared with 
conventional 2D cultured human iPSCs (Figure 5-5). Cell pluripotency was also confirmed 
by formation of prototypical iPSC-colonies from similarly extracted spheroids that were sub-
cultured by the conventional 2D-planar method (Figure 5-4B). Moreover, 
immunophenotyping with confocal microscopy showed that iPSC-spheroids within constructs 
again expressed OCT4, SOX2, TRA-1-60, and SSEA4, which corresponded to flow 
cytometry analysis (Figure 5-6). 
 
 
Figure 5-4 Pluripotency of human iPSCs in 3D printed gels.  
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A) Flow cytometry of iPSCs extracted from 3D constructs 10 days post-printing (See also 
Figure S1). B) Following extraction of iPSC-spheroids from 3D printed constructs (ie. 11 
days post-printing) they could be recovered for conventional planar sub-culture forming 
classical iPSC-colonies on Matrigel® basement membrane matrix. Scale bars as indicated. 
 
 
Figure 5-5 Flow cytometry of conventional 2D cultured human iPSCs. 
Cells were maintained in 5% CO2 at 37°C, mTeSR™1 on Matrigel® basement membrane 




Figure 5-6 Immunostaining of printed human iPSCs in 3D. 
Immunophenotyping of 3D bioprinted human iPSCs 10 days post-printing. iPSCs formed 
spheroids and stained with DAPI colocalized with pluripotency markers A) OCT4 and B) 
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SOX2, and expressed C) SSEA4 and D) TRA-1-60. Pseudocoloured images as indicated by 
colour of text. Scale bars as indicated. 
 
5.3.3 In situ differentiation of iPSCs to EBs comprising cells of three germ lineages –
endoderm, ectoderm, and mesoderm  
The differentiation potential of printed constructs was initially investigated by directing 3D 
bioprinted iPSCs to form EBs within constructs. EBs are 3D cell aggregates, which mimic 
many of the hallmarks of embryonic development. As EBs develop, differentiated cell 
phenotypes of all three germ lineages arise.[17] Therefore in addition to demonstrating multi-
lineage cell and tissue formation, the induction of EBs represents another (ie. functional) test 
of pluripotency.   
EBs formed within 3D constructs following modification of the iPSC culture media to basic 
fibroblast growth factor (bFGF) -free medium 5 days post-printing (Figure 5-7A). They 
displayed archetypal morphology, with radiating and retracting projections (Figure 5-7B). 
The observed projections are consistent with EBs often exhibiting tissue-like structures, such 
as the patterning of neurite extensions indicative of neuron organization.[18] Notwithstanding 
the evidence for neural cell lineage, assessment of gene expression of extracted EBs by 
reverse-transcription quantitative PCR (RT-qPCR) confirmed downregulation of pluripotency 
markers OCT4, NANOG, TDGF1, and UTF1 compared with undifferentiated EB-controls, 
with increased expression of endodermal (H19 and PSX1), mesodermal (HAND1 and IGF2) 
and ectodermal (NESTIN and TUJ-1) markers confirming iPSC differentiation to all germ 
lineages (Figure 5-7A, Figure 5-8). Taken together, these data substantiate the potential to 
form multiple cell and tissue types within and from the bioprinted constructs. Secondarily, 
the results are consistent with having maintained iPSC status for the period of preserving 
constructs in culture after printing, prior to differentiation.  
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Figure 5-7 In situ formation of EBs from 3D bioprinted human iPSCs 15 days post-printing 
(including 10 days iPSC differentiation). 
A) EB formation within 3D constructs (arrowheads) which could be extracted for further RT-
qPCR. B) EBs formed within 3D constructs, displayed typical morphology, with elongated 
cell projections resembling neurite extensions radiating out and retracting over time 
(arrowheads). Scale bars as indicated. 
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Figure 5-8 Gene expression relative to conventional 2D culture cells. 
Comparative gene expression (OCT4, NANOG, TDGF1 and UTF1: pluripotency markers; 
H19 and PDX1: endodermal markers; Hand-1 and IGF2: mesodermal markers; NESTIN and 
TUJ-1: ectodermal markers) between conventional 2D and 3D iPSCs and EBs. Relative gene 
expression represents data normalized to β-actin and expressed relative to 2D iPSCs. Mean ± 




5.3.4 Directed differentiation of 3D bioprinted iPSC constructs to neural tissues 
While without specific medium supplements pluripotent stem cells have a tendency to 
differentiate to derivatives of the three germ lineages, alternative media compositions 
(including the use of defined growth factor additives) can promote differentiation toward one 
or another lineage. [6] Given the PhD candidate’s earlier work on generating neural tissues 
using bioprinted NSCs, attention was drawn towards similarly generating neural tissue from 
the 3D bioprinted iPSCs.  
Differentiation involved an intermediate progenitor phase by culturing constructs in neural 
induction medium for 2-3 weeks from the third day after printing, followed by differentiation 
(using further modified medium including brain-derived neurotrophic factor; BDNF) into 
mature cells with phenotypes representative of different neuronal subtypes and supporting 
neuroglia. Consistent with forming iPSC-derived neural progenitors, immunophenotyping of 
constructs following 17 days of neural induction (20 days post-printing) revealed cells 
expressing neural progenitor markers PAX6 and NESTIN (Figure 5-9). Subsequent analysis 
of further differentiated constructs (> 30 days of neural induction) confirmed maturation to 
tissues comprising cells expressing pan-neuronal markers microtubule-associated protein 2 
(MAP2; Figure 5-10A and D) and class III beta-tubulin protein (TUJ1; Figure 5-10C), as 
well as radial glial and astrocyte marker glial fibrillary acid protein (GFAP; Figure 5-10B 
and D) and presynaptic vesicle glycoprotein synaptophysin (Figure 5-10C). MAP2-
expressing neurons often abutted the neuroglia (Figure 6D) and synaptophysin colocalised to 
neurites and neuronal cell soma, including longer neurite projections between neuronal cell 
clusters (Figure 5-10C).  
Further immunocytochemistry together with RT-qPCR substantiated discrete neural cell 
subtypes including gamma-aminobutyric acid (GABA) expressing neurons (Figure 6E), 
corroborated the findings by transcript for NKX2.1, as well as serotonergic marker PET1 and 
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oligodendrocyte lineage transcription factor 2 (OLIG2) (Figure 5-11).  RT-qPCR also 
confirmed increased transcript for neuronal marker NESTIN, TUJ1 and GFAP, with highest 
levels of expression for 3D differentiated iPSCs compared to undifferentiated controls and 
2D differentiated iPSCs, as well as concomitant downregulation of pluripotency markers 
OCT4, NANOG, and SOX2 (Figure 5-11). Finally, consistent with the presence of 
GABAergic neurons, neurons displayed recurrent increases in extracellular calcium 
concentration in response to GABA receptor-A antagonist bicuculline (Figure 5-12A). 
Functionality was also supported by neuronal cell migration within constructs, including 
characteristic long and dynamic leading processes (Figure 5-12B). Migrating neurons 
generally exhibit a leading process, with some being branched and others single. [19] The 
example presently shown is a neuron with a “relatively unbranched process” that appears to 
retract and extend and a tip that clearly moves forward as the cell traverses the construct.   
Taken together, the above findings verify the ability to differentiate iPSCs within the 
bioprinted constructs and in particular their conversion to functional neural cells for 3D 
neural tissue formation. 
 
 
Figure 5-9 Characterization of neural precursors differentiated from human iPSCs in 3D 
constructs.  
180 
Immunophenotyping of 3D bioprinted human iPSCs 20 days post-printing including 17 days 
of neural induction. A) Cells stained with DAPI and expressed neural progenitor markers 
PAX6 and nestin.  B) Depth coding of cells along the Z-axis of a 3D printed construct (0 – 
107 µm). Pseudocoloured images as indicated by colour of text. White dashed lines of DAPI 




Figure 5-10 Immunophenotyping of 3D bioprinted human iPSCs 40 days post-printing 
including 30-37 days of neural induction. 
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A) Cells stained with DAPI and expressed pan-neuronal marker MAP2 revealing neural 
processes extending throughout constructs, as well as B) radial glia and astrocyte marker 
GFAP; also shown, depth coding of cells along the Z-axis 0 – 63 µm and 0 – 56 µm 
respectively. C) Cells stained with DAPI and pan neuronal-marker TUJ1. Synaptophysin 
colocalised with TUJ1-labelled processes extending between neuronal cell clusters. D) MAP2 
expressing neurons with neurites abutting and partially colocalised with GFAP expressing 
glial cells. E) GABAergic subtype neurons expressing GABA. Pseudocoloured images as 




Figure 5-11 Comparative gene expression between conventional 2D and 3D (bioprinted) 
human iPSC and neural derivative cultures. 
(Pluripotency: OCT4, Nanog, SOX2; Neural: nestin, TUJ1, GFAP, GABA, NKX2.1, PET1, 
OLIG2). Mean ± S.D.; n = 3. One-way ANOVA with Bonferroni post hoc test. *P < 0.05; 




Figure 5-12 Live cell imaging of calcium flux and cell migration showing functional neurons 
forming networks within 3D structures 40 days after printing iPSCs including 37 days of 
neural induction. 
A) Time course of bicuculline-induced calcium flux for individual neurons 1-2 within a 3D 
construct. The photomicrographs and corresponding line-plots show active cells (arrowheads) 
and average measurements of calcium flux respectively. Also shown, is the depth coding of 
cells along the Z-axis of the 3D printed construct (0 – 137 µm). B) Live cell imaging 
demonstrating neuronal cell migration within a 3D construct (large arrows: cell soma; small 
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arrows: leading process). Pseudocoloured images as indicated by colour of text. Scale bars as 
indicated. 
 
5.3.5 3D printing growth factors to drive human iPSCs growth and penetration 
To prove cell growth and cell movement in the 3D hydrogel, the PhD candidate’s previous 
data have shown that cells could expand with immuno-staining. Until now, there is still no 
report indicating live cell growth or recording the details of cells in 3D. The samples were 
mounted on the Leica Confocal Microscope platform with the live cell culture system after 
printing and differentiation of iPSCs.  A few neuronal-like axons elongated from the EBs and 
the single cell migration in 3D system (Figure 5-7B, Figure 5-12B) were observed. Tissue 
function is dependent on the cell gradients, and growth factors are well known to regulate cell 
behaviours. The bFGF nano-particles (Figure 5-14A) were selected to be printed in parallel 
alongside human iPSCs printing. There were two barrels used, which contain two different 
bioinks respectively (one ink was the gel with human iPSCs and the other one just containing 
the beads with or without bFGF) as Figure 5-13 shows. Cell growth analysis supported the 
higher cell proliferation in comparison with the blank beads (Figure 5-14B). There were also 
obvious colonies and migration observed in the group of bFGF beads (Figure 5-14C). 
 
Figure 5-13 Constructs printed from two different bioinks. 
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The scheme of 3D printing beads (A) and the samples printed from two different materials 
(B). There were two types of beads chosen: the beads with bFGF and the beads without bFGF, 
which are commercially available. 
 
 
Figure 5-14 Cell growth and migration under 3D printed bFGF influence.  
A) bFGF nano beads. B) Live/dead images of the group of blank beads and bFGF beads at 
day 3 and day 10 during cell growth in the printed pattern. The dash lines demonstrate the 
boundary of the two inks. C) Time course analysis of the growth rate of blank group and 
bFGF bead group.  
 
5.4 Conclusion 
This work represents a first demonstration of bioprinting iPSCs for ensuing culture and 
expansion within a printed construct. In addition, the results demonstrate the ability to 
sequentially differentiate printed iPSCs in situ to multiple lineages representative of all three 
germ layers – mesoderm, ectoderm and endoderm, as well as form more homogeneous neural 
tissues. To the best of the PhD candidate’s knowledge, the only other example of bioprinting 
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pluripotent stem cells, and more specifically iPSCs, involved printing with cell culture media 
for subsequent immediate testing of post-printing cell viability and pluripotency.[20] iPSCs 
were neither cultured nor differentiated following printing, and supporting biomaterial was 
not employed in the bioink. Accordingly, this work has overcome reputed difficulties with 
maintaining and differentiating iPSCs, in spite of printing, by using a bioink with well-
characterised and inexpensive components, having optimal viscosity for initial cell support 
during printing, and continuing support after printing and gelation. Al, CMC and Ag are 
widely available and used for clinical purposes, each having inherent qualities beneficial to 
the bioprinting process and/or cell survival. [14, 21, 22]  While brief details of their 
individual and combined properties have been previously given, Al enables cytocompatible 
gelation using calcium chloride, with CMC providing favorable porosity and related 
permeability, and Ag is necessary for optimum bioink viscosity. [14]  Moreover, CMC has 
other known beneficial properties such as high moisture retention, low inflammatory, toxicity 
and antimicrobial responses, and promotion of cell adhesion, migration and proliferation.[22-
24] The stem cells in 3D conditions maintain good migration ability and the involvement of 
specific factor/condition could enhance the effect. 
In summary, the ability to 3D print human iPSCs to then expand and generate cells of 
different lineages provides an unprecedented opportunity to form different, authentic and 
renewable body tissues. To this end, the present body of work represents an important first 
step, with further refinement of the method expected to benefit enhancement of tissue identity, 
architecture and function to better model development and diseases; for pharmaceuticals 
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6 Conductive material development for pluripotent stem cell stimulation  
6.1 Introduction 
The previous work mainly described the development of printable biomaterials for stem cells 
and stem cell growth in the 3D printed structure. To improve the property of materials for 
pluripotent stem cells for future use, iPSC stimulation was investigated. 
Pluripotent stem cells have attracted much interest because of their capability of 
differentiation into many cell types. Electric fields, generated from the difference between the 
interior and the exterior of a biological cell, contribute to embryonic development and direct 
cell-cell communication in the human body [1, 2]. Electrical stimulation of neural tissues, 
both peripheral and central, has been widely used to study and/or treat spinal cord injury, 
nerve injury and deep brain injury [3-5]. Conductive polymers (CPs), also known as 
electroactive polymers, were discovered several decades ago and it has been found that 
doping is essential for good conductivity of these polymer[6]. CPs are experiencing a rapid 
increase in interest as biomaterials used in tissue engineering applications. Conductive 
substrates are able to improve nerve cell activity and could also be used to support cardiac 
progenitor cell growth [7, 8]. In the body, some cell types including nerve and muscle cells 
were found to react to electrical signals and some biocompatible CPs have been developed to 
stimulate them [9, 10].   
PPy is a type of conductive polymers which has been treated with different dopants including 
anionic dopant dodecylbenzenesulfonate (DBS), para-toluene sulfonate (pTS) and the sodium 
salt of chondroitin sulfate (CS) during the process of oxidative polymerization [11]. PPy has 
been used in various fields including fuel cells [12], stimulation systems [9], biosensors [13] 
and for drug delivery[14]; and has been proven to possess good chemical stability and good 
biocompatibility in vitro and in vivo [15, 16]. An increase in bioactivity has been observed 
which was due to the doping or conjugation of growth factors and bio-proteins [17, 18].  
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The strategy of electrical stimulation of stem cells offers advantages including proliferation 
and differentiation of neural stem cells [19], cardiac differentiation from mesenchymal stem 
cells (MSCs) [20] and neurite growth and neural differentiation [9]. There have been some 
reports of embryonic stem cell (ESC) stimulation. However the cells stimulated were 
embryoid bodies which were generated from mouse and human ESCs [21, 22]. There were 
various differences between different cell types  in terms of morphology, differentiation 
ability and genotype[23]. The role of stimulation in the culture of human pluripotent stem 
cells remains unclear. Here, human iPSCs were able to proliferate on a film of PPy-DBS 
substrate and then could be differentiated into neurons after the application of electrical fields. 
The 2D stimulation results contributed to the subsequent complex 3D stimulation.  
6.2 Experimental 
6.2.1 Preparation of polymer films 
The detailed PPy-DBS film preparation process was described in Section 2.3.2. Briefly, 
Polymer electrosynthesis was performed in a three-electrode cell with the gold-coated mylar 
as the working electrode, a platinum mesh counter electrode (CE), and Ag|AgCl reference 
electrode (RE). The films were washed with ddH2O and dried using N2 gas after growth. 
Then the custom modules were assembled with culture chamber (Nunc® Lab-Tek® Chamber 
Slide™) as in Figure 2-16 and then stored under sterile conditions until use. 
6.2.2 Cyclic voltammetry 
Cyclic voltammetry (CV) was performed with a CH Instruments 660D Electrochemical 
Workstation using a three-electrode cell with a 3 cm2 PPy-DBS coated mylar working 
electrode, a platinum mesh counter electrode (CE) and an Ag|AgCl reference electrode (RE). 
A scan rate of 0.1 V/s over the potential range of – 0.7 to + 0.7 V was used. 
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6.2.3 Human iPSC culture and stimulation 
Normal human iPSCs culture has been described in Section 2.4.2. The PPy-DBS films were 
coated with Matrigel® at 4°C overnight before use. The colonies were mechanically cut into 
smaller colonies then relocated onto PPy-DBS films in pre-warmed mTeSR™1 and cultured 
for 24h (this time was set as Day 1) before stimulation to allow colonies to adhere to the PPy-
DBS substrates. Cells were stimulated for 8h per 24h until Day 4 using a current density of 
±0.1 mA/cm2 and then 8h per two days at ±0.25 mA/cm2 to Day 10. The cells were 
stimulated at 250Hz using a biphasic waveform of 100 ms pulses with 20 ms interphase open 
circuit potential. In response to the current pulse applied, the voltage waveform across the 
electrode area was recorded and total impedance (Zt) was calculated from maximum voltage 
(Vt) divided by the measured current output (i) (Zt = Vt/i). The access résistance and 
polarization impedance were obtained from the initial voltage drop (Ra = Va/i) and the 
remaining voltage drop (Zp = Vp/i) respectively. 
6.2.4 RT-qPCR of the stimulation samples 
For RNA isolation, the cells were treated with TRIzol™ on the PPy-DBS film followed by 
precipitation of RNA using isopropanol. The other processes have been described in Section 
2.8.5. CFX software was used to collect the data which were analysed according to delta-
delta Ct method. Primer sequence information is provided in Table 6-1. 
Table 6-1 Primers used for RT-qPCR in iPSC stimulation 
Name Forward Reverse Length (bp)  
OCT4 CAATTTGCCAAGCTCCTGA CGTTTGGCTGAATACCTTCC 105  
NANOG TACCTCAGCCTCCAGCAGAT TGCGTCACACCATTGCTATT 146  
H19 GCAAGAAGCGGGTCTGTTT GCTGGGTAGCACCATTTCTT 105  
HAND1 AAGCGGAAAAGGGAGCTG ACTCCAGCGCCCAGACTT 112  
196 
NESTIN GCCCTGACCACTCCAGTTTA GGAGTCCTGGATTTCCTTCC 200  
PDX1 CCTTTCCCATGGATGAAGTC GGAACTCCTTCTCCAGCTCTA 145  
IGF2 CTGTTTCCGCAGCTGTGAC GGGGTATCTGGGGAAGTTGT 118  
TUJ1 ACACAGGCGTCCACAGTT GTTCCAGGTCCACCAGAATG 167 
 
GFAP ATCAACTCACCGCCAACA CTTCATCTGCTTCCTGTCTATA 153 
 
OLIG2 TTGCTCCTCTTCCTCCTT GGCTTCCAACTAACTTGTG 129 
 
GABA GTCCAGGTCTGTCTGACTGTCTT CTTCACTTCGGTTACACGCTCTC 197 
 
NKX2.1 CCTTGCTATACGGTCGGA GTGGATGGTGGTCTGTGT 103 
 
PET1 CGTCTTCTCCTCCTTGTC GGATCTGGCAGGTACATG 177  




The general method has been described in Section 2.8.3. Particularly, the stimulated and 
control samples were fixed with 3.7 % PFA in PBS for 10 min at RT. Samples were then 
permeabilized and blocked in 0.3% (v/v) Triton X-100 mixed in PBS containing 5% (v/v) 
donkey serum. The samples were subsequently incubated with primary antibodies for OCT4 
(mouse, 1:200), SOX2 (rabbit, 1:200), SSEA4 (mouse, 1:200), TUJ1 (Chicken, 1:200) or 
fluorescence conjugated antibodies GFAP (mouse, 1:100) and VIMENTIN (rabbit, 1:200) at 
4 °C overnight. Subsequently, the cells were rinsed with 0.1% Triton X-100 in PBS three 
times and then were incubated with Alexa Fluor tagged secondary antibody (1:1000) for the 
samples with unconjugated primary antibody incubation for 1 hr at 37 °C. Nuclei were 
stained with DAPI (10 μg/mL) at RT for 10 min, the chambers were carefully removed and 
antifade reagent was used to preserve the fluorescence density. Samples were covered with 
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glass coverslips and imaged on Leica confocal system (Leica TSC SP5 II) with software 
Leica Application Suite AF (LAS AF) for image collection.  
6.2.6 Statistical Analyses 
Statistical analyses were performed using OriginPro 2015 (Version b9.2.272) with 
application of a one-way analysis of variance (ANOVA) with Bonferroni multiple 
comparison post hoc test or two-way ANOVA with Bonferroni post hoc test. Homogeneity of 
variance tests was performed to confirm statistical assumptions were met for ANOVA.  
Statistical significance was set at P < 0.05.  
6.3 Results and discussion 
6.3.1 Human iPSC culture on PPy-DBS film 
Figure 6-1 shows the method for human iPSC stimulation. The pyrrole with dopant DBS was 
initially polymerized on the gold film and then the custom devices were made (Figure 6-2). 
The cyclic voltammogram (CV) demonstrated the electroactivity of PPy-DBS with the 
typical oxidation and reduction processes (Figure 6-3). Three impedances of the substrate 
were calculated using Ohm's law and the values were monitored during the stimulation period 
(Figure 6-4), which consisted of total impedance (Zt = Vt/i), access resistance (Ra = Va/i; 
relating to changes in the electrolyte), and polarization impedance (Zp = Vp/i; relating to 
changes at the electrode surface) [9, 24]. The iPSC colonies were manually cut into small 
samples, and then transferred into the custom cell culture and stimulation module. After one 
day of recovery, the iPSC stimulation began. The simulation of human iPSCs into neurons 
follows the same steps as shown in Figure 6-1A. At first, the iPSCs were stimulated every 
day up to four days and then once every two days until the tenth day. There was obvious 
morphological transformation from Day 4 to Day 10 as Figure 6-1B shows. The 
conventional colonies could be formed on the Matrigel-coated PPy-DBS film without 
stimulation compared with the stimulation groups, where there was neuronal-like elongation.  
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Figure 6-1  Schematic of human iPSC stimulation.  
A) Schematic of cell culture and stimulation setup illustrating the major stages of the method 
for iPSC stimulation. Human iPSCs were seeded on the custom module for cell culture and 
stimulation with counter electrode and culture chamber (as the real module shown in Figure 
S1). B) Detailed time course of iPSC stimulation. The iPSCs started to be stimulated from 
Day 1 using alternating current at ±0.1 mA/cm2 every day to Day 4 and then at ±0.25 
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Figure 6-2 Electroactive PPy-DBS substrate. 
A custom-made human iPSCs culture chamber and stimulation module comprising gold-
coated Mylar film with polymerized PPy-DBS and platinum mesh counter electrode. 
 
 




Figure 6-4 One example of the biphasic current waveform used, overlayed with the output 
voltage. 
 
6.3.2 The characterization of stimulated human iPSCs  
The kinetic status of stimulated human iPSCs is illustrated in Figure 6-5A demonstrating a 
wide scope of morphological changes post ten days (Figure 6-5B). Immunophenotyping with 
confocal microscopy demonstrated neural differentiation of stimulated iPSCs in Figure 6-6, 
where pan neuronal-marker TUJ1 and VIMENTIN and glial cell marker GFAP were 
immunoreactive. The undifferentiated iPSCs, maintained the classical morphology with the 
expression of pluripotent stem cell markers OCT4, SOX2, and SSEA4 (Figure 6-7). RT-
qPCR was used to corroborate immunophenotyping to quantify the effect of electrical 
stimulation on iPSC differentiation. This revealed upregulation of pan-neuronal and 
neuroglial markers. Specifically, electrical stimulation induced higher expression of 
SYNAPTOPHYSIN (F (1, 4) = 3518.615), TUJ1 (F (1, 4) = 421.390), GABA (F (1, 4) = 
940.309), OLIG2 (F (1, 4) = 93.018) and SERT (F (1, 4) = 1021.836) with concomitant 
lower expression of OCT4 (F (1, 4) = 1105.359) and NANOG (F (1, 4) = 1299.920) (Figure 
6-8). There was no difference between the astrocyte marker GFAP and GABAergic marker 
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GAD. Interestingly, SYNAPTOPHYSIN expression was markedly increased. RT-qPCR also 
confirmed increased transcript for ectoderm germ layer marker CERBERUS (F (1, 4) = 
831.632) and HAND1 (F (1, 4) = 837.351), mesoderm marker H19 (F (1, 4) = 7845.837) and 
IGF2 (F (1, 4) = 414.442) with marked increase for HAND1 (Figure 6-9). 
 
 
Figure 6-5 Time course of stimulated human iPSCs. 
A) Images of stimulated human iPSCs on the PPy-DBS substrates at specific time points. B) 
Brightfield micrographs of human iPSCs on the PPy-DBS with stimulation (left) and with 




Figure 6-6 Immunostaining of differentiated human iPSCs. 
A) Immunocytochemistry showing GFAP and TUJ1 expression for stimulated human iPSCs 
with DAPI staining 12 days post-first-stimulation. B) VIMENTIN expression in the 




Figure 6-7 Immunophenotyping of human iPSCs on PPy-DBS substrates. 
A) Cells stained with DAPI and expressed pluripotent nucleus marker OCT4. B) Cells stained 
with DAPI and expressed pluripotent nucleus marker SOX2. C) Cells stained with DAPI and 
expressed pluripotent membrane marker SSEA4. Scale bars as indicated. 
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Figure 6-8  Gene expression of stimulated human iPSCs on PPy-DBS substrates.  
Comparative gene expression of neural markers between stimulated and non-stimulated 
iPSCs on PPy-DBS substrates 12 days post-first-stimulation. Relative gene expression 
represents data normalized to β-actin and expressed for the non-stimulated iPSCs. Mean ± 




Figure 6-9 Endodermal and mesodermal gene expression stimulated human iPSCs on PPy-
DBS substrates.  
Comparative gene expression between stimulated and non-stimulated iPSCs on PPy-DBS 
substrates 12 days post-first-stimulation. Relative gene expression represents data normalized 
to β-actin and expressed for the non-stimulated iPSCs. Mean ± S.D.; n = 3. One-way 
ANOVA with Bonferroni post hoc test. * P<0.05; ** P<0.01; ***P<0.001. 
 
6.4 Conclusion 
This work represents the first demonstration of stimulation for the improvement of iPSC 
differentiation without inducing factors such as BDNF and NGF. To the best of the PhD 
candidate’s knowledge, there is as yet no report of the stimulation of human pluripotent stem 
cells. Trials of electrical stimulation of human iPSCs have been carried out and found to have 
an effect on human iPSCs with successful generation of neuronal-like cells after 
approximately ten days of stimulation. The differentiation time frame has been shortened 
compared with conventional methods [25, 26]. Furthermore, the mechanism of stimulation 
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effects on the differentiation of stem cells needs further investigation. In summary, the results 
presented here have explored a new way to facilitate neural differentiation from human 
pluripotent stem cells.  
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7 CONCLUSIONS AND RECOMMENDATIONS 
7.1 Conclusion 
The work presented in this thesis aimed to demonstrate the utilization of 3D printing with a 
novel bioink as well as conductive materials with electrical stimulation for the control of stem 
cell fate in order to generate functional tissues for future research and potential clinical 
application.  
Direct-write printing of stem cells within biomaterials presents an opportunity to engineer 
tissue for in vitro modeling and regenerative medicine. Reported here is the first example of 
the construction of neural tissue by printing human NSCs that were differentiated in situ to 
functional neurons and supporting neuroglia. The supporting biomaterial incorporated a novel 
clinically relevant polysaccharide-based bioink comprising Al, CMC and Ag. The printed 
bioink was found to gel rapidly by stable crosslinking to form a porous 3D scaffold 
encapsulating stem cells for in situ expansion and differentiation. Differentiated neurons were 
spontaneously active, showed a bicuculline-induced increased calcium response, and 
predominantly expressed gamma-aminobutyric acid (GABA). The 3D tissues will facilitate 
investigation of human neural development, function and disease, and may be adaptable for 
engineering other 3D tissues from different stem cell types. 
The ability to create 3D tissues from human iPSCs is poised to revolutionize stem cell 
research and regenerative medicine. There are, however, few examples of 3D tissue 
engineering using iPSCs, with in vitro stem cell culture and differentiation predominantly 
planar (2D) for either monolayer cell support or substrate-dependent induction of self-
organizing embryoids and organoids. Although not previously described, bioprinting iPSCs 
with advanced functional biomaterials promises to augment efforts to develop discrete 3D 
tissues, ideally comprising direct-write printing of stem cells for encapsulation, proliferation, 
and successive directed differentiation. Such a method is described here. A clinically-
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amenable polysaccharide-based bioink, Al-CMC-Ag, is the first example of bioprinting 
human iPSCs for in situ expansion and sequential differentiation for 3D tissue fabrication. 
Specifically, this work has demonstrated extrusion printing of bioink encapsulating iPSCs for 
gelation to a stable and porous 3D construct, proliferation of the iPSCs within the construct 
and differentiation of the same iPSCs into either EBs comprising cells of three germ lineages 
– endoderm, ectoderm, and mesoderm, or more homogeneous neural tissues containing 
functional (including migrating) neurons and supporting neuroglia. It is envisaged that this 
fully defined, scalable and versatile platform will be useful in human iPSC research and 
translation for pharmaceutical development and regenerative medicine. 
Finally, electrical stimulation has been applied towards organ repair in clinical settings in 
recent years. Stimulus-responsive biomaterials hold great promise for tissue engineering 
because an electrical signal is an important regulation method for embryo development and 
cell-cell communication. In this study, PPy films have been evaluated as substrates for human 
iPSC culture. Conventional colony morphology was observed. In addition, the films were 
used to stimulate human iPSCs. The results demonstrated a significant increase in neural 
differentiation compared with those that were not stimulated. These findings indicate the 
potential of stimulation for improving pluripotent stem cell differentiation. 
7.2 Recommendations 
Biomaterials contribute to stem cell support and derivative tissue architecture. The 
biocompatibility and nanoscale modification of materials will therefore benefit stem cell 
research and translation [1]. Currently, individual materials cannot satisfy all requirements of 
stem cells and so different monomers have been combined together with specific 
modification to be used in complex bio-research [2, 3]. Nonetheless, methods to direct stem 
cells into functional cells under 3D conditions are still under-explored. Composites of 
materials could assist with cell patterning of different cell types, which is essential for 
213 
fabricating complex tissues [4]. Furthermore, the mechanism by which each property of the 
materials influences stem cell regulation needs to be determined and encapsulation of the 
cells needs to be acheived without loss of viability or desired phenotype. Currently, the 
materials used for encapsulating stem cells are mainly hydrogels because hydrogels have the 
ability to hydrate and maintain the water content for cell survival. Intelligent materials may 
have additional properties under specific conditions (e.g., pH, electrical, pressure, magnetic 
and some others) to induce chemical signals, which have been found to induce the conversion 
of stem cell states [5]. An effective combination of the properties of biomaterials to stem cells 
into preferred cell types therefore represents the future of biomaterials interfacing with stem 
cells for 3D tissue engineering. An additional important requirement though will be 
incorporating vasculature to fabricate tissues with (micro) blood vessels Blood vessels in 
native tissue are essential to transport the nutrients and waste, but current materials and 3D 
prototyping technologies still cannot recapitulate in vivo vasculature form and function. 
Nonetheless, potentially suitable biomaterials are being developed and studied towards the 
next generation of smart biomaterials towards having an entire gamut of suitable 
materials/properties to efficiently control stem cells in 3D and generate bona fide human 






[1] D. Huh, G.A. Hamilton, D.E. Ingber, From 3D cell culture to organs-on-chips, Trends in 
Cell Biology 21(12) (2011) 745-54. 
[2] C.J. Ferris, K.J. Gilmore, G.G. Wallace, M.I.H. Panhuis, Modified gellan gum hydrogels 
for tissue engineering applications, Soft Matter 9(14) (2013) 3705-3711. 
[3] A. Gelmi, M.J. Higgins, G.G. Wallace, Resolving Sub-Molecular Binding and Electrical 
Switching Mechanisms of Single Proteins at Electroactive Conducting Polymers, Small 9(3) 
(2013) 393-401. 
[4] H. Sekine, T. Shimizu, K. Sakaguchi, I. Dobashi, M. Wada, M. Yamato, E. Kobayashi, M. 
Umezu, T. Okano, In vitro fabrication of functional three-dimensional tissues with perfusable 
blood vessels, Nature Communications 4 (2013) 1399. 
[5] R.A. Young, Control of the embryonic stem cell state, Cell 144(6) (2011) 940-54. 
 
